Patient-Formulary-2015.Pdf

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 17 08 2015

Formulary Title Section Annotation Status

Rare paediatric conditions On Formulary Prescribing for children DTC oﬃcer decision

CHARCOAL, ACTIVATED On Formulary Removal and elimination->Removal from the gastro-intestinal tract

Removal and elimination->Removal from the gastro-intestinal Actidose-Aqua® Advance On Formulary tract->CHARCOAL, ACTIVATED

Removal and elimination->Removal from the gastro-intestinal Carbomix® On Formulary tract->CHARCOAL, ACTIVATED

Removal and elimination->Removal from the gastro-intestinal Charcodote® On Formulary tract->CHARCOAL, ACTIVATED

ACETYLCYSTEINE On Formulary Speciﬁc drugs->Analgesics (non-opioid)

Acetylcysteine On Formulary Speciﬁc drugs->Analgesics (non-opioid)->ACETYLCYSTEINE

Parvolex® On Formulary Speciﬁc drugs->Analgesics (non-opioid)->ACETYLCYSTEINE

NALOXONE HYDROCHLORIDE On Formulary Speciﬁc drugs->Analgesics (opioid)

Naloxone On Formulary Speciﬁc drugs->Analgesics (opioid)->NALOXONE HYDROCHLORIDE

Minijet® Naloxone On Formulary Speciﬁc drugs->Analgesics (opioid)->NALOXONE HYDROCHLORIDE

DESFERRIOXAMINE MESILATE On Formulary Speciﬁc drugs->Iron salts

DICOBALT EDETATE On Formulary Other poisons->Cyanides

Dicobalt Edetate On Formulary Other poisons->Cyanides->DICOBALT EDETATE

SODIUM THIOSULFATE On Formulary Other poisons->Cyanides

Sodium Thiosulfate On Formulary Other poisons->Cyanides->SODIUM THIOSULFATE

PRALIDOXIME CHLORIDE On Formulary Other poisons->Pesticides

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids ALUMINIUM HYDROXIDE On Formulary and simeticone->Aluminium- and magnesium-containing antacids

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids Co-magaldrox On Formulary and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids Maalox® On Formulary and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE->Co-magaldrox

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids MAGNESIUM TRISILICATE On Formulary and simeticone->Aluminium- and magnesium-containing antacids

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids Magnesium Trisilicate Mixture, BP On Formulary and simeticone->Aluminium- and magnesium-containing antacids->MAGNESIUM TRISILICATE

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.1 Antacids Infacol® Restricted during endoscopies as a surfactant only and simeticone->Simeticone alone

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.2 Peptac® On Formulary Compound alginates and proprietary indigestion preparations->Alginate raft-forming oral suspensions

1.1 Dyspepsia and gastro-oesophageal reﬂux disease->1.1.2 Gaviscon Infant® Restricted Compound alginates and proprietary indigestion preparations->Other Paediatrics compound alginate preparations

1.2 Antispasmodics and other drugs altering gut ATROPINE SULFATE On Formulary Tablets for Myaesthenia gravis only motility->Antimuscarinics

1.2 Antispasmodics and other drugs altering gut Atropine On Formulary Tablets for Myaesthenia gravis only motility->Antimuscarinics->ATROPINE SULFATE

1.2 Antispasmodics and other drugs altering gut HYOSCINE BUTYLBROMIDE On Formulary motility->Antimuscarinics

1.2 Antispasmodics and other drugs altering gut Buscopan® On Formulary motility->Antimuscarinics->HYOSCINE BUTYLBROMIDE

1.2 Antispasmodics and other drugs altering gut motility->Other MEBEVERINE HYDROCHLORIDE On Formulary not MR preparations antispasmodics

1.2 Antispasmodics and other drugs altering gut motility->Other Mebeverine Hydrochloride On Formulary antispasmodics->MEBEVERINE HYDROCHLORIDE

1.2 Antispasmodics and other drugs altering gut motility->Other PEPPERMINT OIL On Formulary antispasmodics

1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor the dispersible tablets are not stocked RANITIDINE On Formulary antagonists DTC oﬃcer decision

1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor Ranitidine On Formulary antagonists->RANITIDINE

1.3 Antisecretory drugs and mucosal protectants->1.3.4 Prostaglandin Consultant Obstetricians only as per RCOG protocol for post partum haemorrhage MISOPROSTOL Restricted analogues Not for GI use

1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump LANSOPRAZOLE On Formulary Capsules only. See the entry for Zoton® for restrictions on orodispersible tablets inhibitors

1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Lansoprazole On Formulary inhibitors->LANSOPRAZOLE

1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Zoton® Restricted FasTab® for swallowing diﬃculties only inhibitors->LANSOPRAZOLE

Second line - CAUTION: Interactions! 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump OMEPRAZOLE Restricted inhibitors MUPS® are restricted to paediatrics only PPI choices Lansoprazole is the preferred proton pump inhibitor and omeprazole second-line

1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Omeprazole On Formulary Second line - caution Interactions! inhibitors->OMEPRAZOLE

1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Losec® Restricted MUPS® - Paediatrics only inhibitors->OMEPRAZOLE

CODEINE PHOSPHATE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Gastroenterology and oncology for chronic diarrhoea and stoma care

LOPERAMIDE HYDROCHLORIDE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs N.B. the melts are non-formulary

1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE Loperamide On Formulary HYDROCHLORIDE

1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE Imodium® On Formulary HYDROCHLORIDE

MORPHINE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs

BALSALAZIDE SODIUM Restricted 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Patients intolerant of Mesalazine or Sulfasalazine

1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->BALSALAZIDE Colazide® Restricted Patients intolerant of Mesalazine or Sulfasalazine SODIUM

MESALAZINE On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates

Asacol® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE

Asacol® MR On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Pentasa® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE

Salofalk® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE

SULFASALAZINE On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates

Sulfasalazine On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE

BUDESONIDE Restricted 1.5 Chronic bowel disorders->1.5.2 Corticosteroids Gastroenterology

PREDNISOLONE On Formulary 1.5 Chronic bowel disorders->1.5.2 Corticosteroids

1.5 Chronic bowel disorders->1.5.2 Predsol® On Formulary Corticosteroids->PREDNISOLONE->Rectal preparations

1.5 Chronic bowel disorders->1.5.3 Drugs aﬀecting the immune AZATHIOPRINE Restricted for oncology treatment and for immunological therapy by those experienced response

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 1.5 Chronic bowel disorders->1.5.3 Drugs aﬀecting the immune ADALIMUMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. response->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 1.5 Chronic bowel disorders->1.5.3 Drugs aﬀecting the immune INFLIXIMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. response->Cytokine modulators

For all other patients please complete this pro forma.

1.5 Chronic bowel disorders->1.5.3 Drugs aﬀecting the immune Preparations Restricted In accordance with NICE guidelines only response->Cytokine modulators->INFLIXIMAB

ISPAGHULA HUSK On Formulary 1.6 Laxatives->1.6.1 Bulk-forming laxatives use cheapest preparation available

METHYLCELLULOSE On Formulary 1.6 Laxatives->1.6.1 Bulk-forming laxatives

DANTRON Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives Palliative care - n.b. only co-danthramer syrup and co-danthrusate capsules are stocked

With poloxamer ‘188’ (as Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON palliative care - Syrup only co-danthramer)

1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON->With poloxamer Palliative care Co-danthramer Restricted ‘188’ (as co-danthramer) DTC oﬃcer decision

With docusate sodium (as Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON Palliative care - capsules only co-danthrusate)

1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON->With docusate Co-danthrusate Restricted Palliative care sodium (as co-danthrusate)

the adult strength solution is NOT stocked DOCUSATE SODIUM On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives DTC oﬃcer decision

GLYCEROL On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives

Glycerol Suppositories, BP On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives->GLYCEROL

SENNA On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives

Senna On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives->SENNA

Senokot® On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives->SENNA Supply problems with Senokot - statement from Reckitt Benckiser

SODIUM PICOSULFATE On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives

Sodium Picosulfate On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives->SODIUM PICOSULFATE

LACTULOSE On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives

Lactulose On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives->LACTULOSE

MACROGOLS Restricted 1.6 Laxatives->1.6.4 Osmotic laxatives Third-line use after bulk forming laxative and osmotic or stimulant laxatives have failed

Movicol® Restricted 1.6 Laxatives->1.6.4 Osmotic laxatives->MACROGOLS Third-line use after bulk forming laxative and osmotic or stimulant laxatives have failed

Movicol® Paediatric Restricted 1.6 Laxatives->1.6.4 Osmotic laxatives->MACROGOLS Third-line use after bulk forming laxative and osmotic or stimulant laxatives have failed

PHOSPHATES (RECTAL) On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives

Fleet® Ready-to-use Enema On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives->PHOSPHATES (RECTAL)

SODIUM CITRATE (RECTAL) On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives

Relaxit Micro-enema® On Formulary 1.6 Laxatives->1.6.4 Osmotic laxatives->SODIUM CITRATE (RECTAL)

Klean-Prep® On Formulary 1.6 Laxatives->1.6.5 Bowel cleansing preparations->MACROGOLS

1.6 Laxatives->1.6.5 Bowel cleansing preparations->PHOSPHATES Fleet Phospho-soda® On Formulary (ORAL)

1.6 Laxatives->1.6.5 Bowel cleansing preparations->SODIUM Picolax® Restricted bowel cleansing prior to endoscopy, radiotherapy PICOSULFATE WITH MAGNESIUM CITRATE

Lubiprostone will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this LUBIPROSTONE NICE-approved 1.6 Laxatives->1.6.7 Other drugs used in constipation pro forma

Pruclaopride will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via PRUCALOPRIDE NICE-approved 1.6 Laxatives->1.6.7 Other drugs used in constipation this pro forma

1.7 Local preparations for anal and rectal disorders->1.7.2 Compound Anusol-HC® On Formulary haemorrhoidal preparations with corticosteroids

Rectal sclerosants Restricted 1.7 Local preparations for anal and rectal disorders Sclerosing agent for haemorrhoids and hydroceles

1.7 Local preparations for anal and rectal disorders->1.7.3 Rectal PHENOL Restricted Sclerosing agent for haemorrhoids and hydroceles sclerosants

1.7 Local preparations for anal and rectal disorders->1.7.3 Rectal Oily Phenol Injection, BP Restricted Sclerosing agent for haemorrhoids and hydroceles sclerosants->PHENOL

Management of anal ﬁssures Restricted 1.7 Local preparations for anal and rectal disorders

1.7 Local preparations for anal and rectal disorders->1.7.4 GLYCERYL TRINITRATE Restricted for anal ﬁssures only Management of anal ﬁssures

1.7 Local preparations for anal and rectal disorders->1.7.4 Rectogesic® Restricted for use in anal ﬁssures only Management of anal ﬁssures->GLYCERYL TRINITRATE

1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary URSODEOXYCHOLIC ACID On Formulary composition and flow

1.9 Drugs affecting intestinal secretions->1.9.1 Drugs affecting biliary Ursodeoxycholic Acid On Formulary composition and flow->URSODEOXYCHOLIC ACID

Bile acid sequestrants On Formulary 1.9 Drugs aﬀecting intestinal secretions

COLESTYRAMINE On Formulary 1.9 Drugs aﬀecting intestinal secretions->1.9.2 Bile acid sequestrants

1.9 Drugs aﬀecting intestinal secretions->1.9.4 Creon® 10 000 On Formulary Pancreatin->PANCREATIN

1.9 Drugs aﬀecting intestinal secretions->1.9.4 Pancrex V® On Formulary Pancreatin->PANCREATIN

1.9 Drugs aﬀecting intestinal secretions->1.9.4 Higher-strength preparations Restricted Consultants only Pancreatin->PANCREATIN

1.9 Drugs aﬀecting intestinal secretions->1.9.4 Creon® 25 000 Restricted Consultants only Pancreatin->PANCREATIN->Higher-strength preparations

DIGOXIN On Formulary 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides Digoxin injection on ITU/NNU , Cardiology, A&E and MAU only

Digoxin On Formulary 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides->DIGOXIN Dogoxin injection (500microgram in 2mL) is restricted to Critical Care, Neo-natal unit, Cardiology, A&E, & MAU

Digoxin-speciﬁc antibody Restricted 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides Poisons unit ENOXIMONE Restricted 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase type-3 inhibitors For Cardiology, Critical Care and Neo-natal use only

2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase type-3 Perfan® Restricted For Cardiology, Critical Care and Neo-natal use only inhibitors->ENOXIMONE

BENDROFLUMETHIAZIDE On Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.2 Diuretics->2.2.1 Thiazides and related Bendroﬂumethiazide On Formulary The tablets can be dissolved in water diuretics->BENDROFLUMETHIAZIDE

Specialist consultants only INDAPAMIDE Restricted 2.2 Diuretics->2.2.1 Thiazides and related diuretics DTC oﬃcer decision

Indapamide Restricted 2.2 Diuretics->2.2.1 Thiazides and related diuretics->INDAPAMIDE Specialist consultants only

Modiﬁed release Restricted 2.2 Diuretics->2.2.1 Thiazides and related diuretics->INDAPAMIDE Specialist consultants only

2.2 Diuretics->2.2.1 Thiazides and related Natrilix SR® Restricted Specialist consultants only diuretics->INDAPAMIDE->Modiﬁed release

METOLAZONE On Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

BUMETANIDE On Formulary 2.2 Diuretics->2.2.2 Loop diuretics The IV form is non formulary

Bumetanide On Formulary 2.2 Diuretics->2.2.2 Loop diuretics->BUMETANIDE

FUROSEMIDE On Formulary 2.2 Diuretics->2.2.2 Loop diuretics

Furosemide On Formulary 2.2 Diuretics->2.2.2 Loop diuretics->FUROSEMIDE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone AMILORIDE HYDROCHLORIDE On Formulary antagonists

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone Amiloride On Formulary antagonists->AMILORIDE HYDROCHLORIDE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone strictly in line with NICE guidance for licensed indication, otherwise DTC approval required EPLERENONE Restricted antagonists->Aldosterone antagonists DTC oﬃcer decision

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone SPIRONOLACTONE On Formulary antagonists->Aldosterone antagonists

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone Spironolactone On Formulary antagonists->Aldosterone antagonists->SPIRONOLACTONE

CO-AMILOFRUSE On Formulary 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with other diuretics

MANNITOL Restricted 2.2 Diuretics->2.2.5 Osmotic diuretics Glaucoma, cerebral oedema, poisons unit

Mannitol Restricted 2.2 Diuretics->2.2.5 Osmotic diuretics->MANNITOL Glaucoma, cerebral oedema, poisons unit

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for ADENOSINE On Formulary arrhythmias->Supraventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Adenocor® Restricted arrhythmias->Supraventricular arrhythmias->ADENOSINE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Dronedarone will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this DRONEDARONE NICE-approved arrhythmias->Supraventricular arrhythmias pro forma

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for AMIODARONE HYDROCHLORIDE On Formulary arrhythmias->Supraventricular and ventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Amiodarone On Formulary arrhythmias->Supraventricular and ventricular arrhythmias->AMIODARONE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for FLECAINIDE ACETATE Restricted Cardiology arrhythmias->Supraventricular and ventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Flecainide Restricted arrhythmias->Supraventricular and ventricular Cardiology arrhythmias->FLECAINIDE ACETATE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for PROPAFENONE HYDROCHLORIDE Restricted Cardiology arrhythmias->Supraventricular and ventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular LIDOCAINE HYDROCHLORIDE On Formulary arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular Lidocaine On Formulary arrhythmias->LIDOCAINE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular Minijet® Lignocaine On Formulary arrhythmias->LIDOCAINE HYDROCHLORIDE

PROPRANOLOL HYDROCHLORIDE On Formulary 2.4 Beta-adrenoceptor blocking drugs

Propranolol On Formulary 2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL HYDROCHLORIDE

ATENOLOL On Formulary 2.4 Beta-adrenoceptor blocking drugs

Atenolol On Formulary 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL

BISOPROLOL FUMARATE On Formulary 2.4 Beta-adrenoceptor blocking drugs

Bisoprolol Fumarate On Formulary 2.4 Beta-adrenoceptor blocking drugs->BISOPROLOL FUMARATE

CARVEDILOL Restricted 2.4 Beta-adrenoceptor blocking drugs Second-line, use bisoprolol ﬁrst line before starting carvedilol.

Carvedilol Restricted 2.4 Beta-adrenoceptor blocking drugs->CARVEDILOL Second-line, use bisoprolol ﬁrst line before starting carvedilol.

ESMOLOL HYDROCHLORIDE Restricted 2.4 Beta-adrenoceptor blocking drugs Cardiology, ITU/NNU

Brevibloc® Restricted 2.4 Beta-adrenoceptor blocking drugs->ESMOLOL HYDROCHLORIDE Cardiology, ITU/NNU

LABETALOL HYDROCHLORIDE On Formulary 2.4 Beta-adrenoceptor blocking drugs

Labetalol Hydrochloride On Formulary 2.4 Beta-adrenoceptor blocking drugs->LABETALOL HYDROCHLORIDE

METOPROLOL TARTRATE On Formulary 2.4 Beta-adrenoceptor blocking drugs

Metoprolol Tartrate On Formulary 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL TARTRATE

SOTALOL HYDROCHLORIDE Restricted 2.4 Beta-adrenoceptor blocking drugs Cardiology

Sotalol Restricted 2.4 Beta-adrenoceptor blocking drugs->SOTALOL HYDROCHLORIDE Cardiology

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive HYDRALAZINE HYDROCHLORIDE On Formulary drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive Hydralazine On Formulary drugs->HYDRALAZINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive ILOPROST Restricted Cardiology, Vascular Surgery and Rheumatology drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive Ventavis® Restricted Cardiology, Vascular Surgery and Rheumatology drugs->ILOPROST

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive MINOXIDIL Restricted Cardiology, Hypertension drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive Loniten® Restricted Cardiology, Hypertension drugs->MINOXIDIL

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive SODIUM NITROPRUSSIDE Restricted ITU, Cardiology drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive Sodium Nitroprusside Restricted ITU, Cardiology drugs->SODIUM NITROPRUSSIDE

2.5 Hypertension and heart failure->2.5.2 Centrally acting CLONIDINE HYDROCHLORIDE On Formulary Patches - Pain clinic & Injection - ITU/NNU antihypertensive drugs 2.5 Hypertension and heart failure->2.5.2 Centrally acting Catapres® On Formulary antihypertensive drugs->CLONIDINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.2 Centrally acting METHYLDOPA On Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally acting Methyldopa On Formulary antihypertensive drugs->METHYLDOPA

2.5 Hypertension and heart failure->2.5.2 Centrally acting MOXONIDINE Restricted Cardiology, Hypertension antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally acting Moxonidine Restricted Cardiology, Hypertension antihypertensive drugs->MOXONIDINE

2.5 Hypertension and heart failure->2.5.3 Adrenergic neurone blocking GUANETHIDINE MONOSULFATE Restricted Theatres drugs

2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking DOXAZOSIN On Formulary drugs

2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking Doxazosin On Formulary drugs->DOXAZOSIN

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- 12.5mg tablets for emergency use by consultant paediatricians, other indications DTC approval only CAPTOPRIL Restricted angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors DTC oﬃcer decision

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- Captopril Restricted angiotensin system->2.5.5.1 Angiotensin-converting enzyme 12.5mg tablets for emergency use by consultant paediatricians, other indications DTC approval only inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- LISINOPRIL On Formulary angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- Lisinopril On Formulary angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- PERINDOPRIL ERBUMINE On Formulary angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- RAMIPRIL On Formulary angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- Ramipril On Formulary angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->RAMIPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- CANDESARTAN CILEXETIL Restricted for patients with heart failure - use losartan ﬁrst-line angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- IRBESARTAN Restricted Diabetic nephropathy angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- Aprovel® Restricted angiotensin system->2.5.5.2 Angiotensin-II receptor Diabetic nephropathy antagonists->IRBESARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- LOSARTAN POTASSIUM On Formulary angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs aﬀecting the renin- Cozaar® Restricted angiotensin system->2.5.5.2 Angiotensin-II receptor Use Candesartan ﬁrst - second line antagonists->LOSARTAN POTASSIUM

2.6 Nitrates, calcium-channel blockers, and other antianginal GLYCERYL TRINITRATE On Formulary drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other antianginal Glyceryl Trinitrate On Formulary drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

for use in spontaneous intracerebral haemorrhage in adults as per stroke protocol 2.6 Nitrates, calcium-channel blockers, and other antianginal Parenteral preparations Restricted drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE An emergency stock is kept in the out-of-hours cupboard suﬃcient to treat one patient

2.6 Nitrates, calcium-channel blockers, and other antianginal Deponit® On Formulary drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

2.6 Nitrates, calcium-channel blockers, and other antianginal ISOSORBIDE DINITRATE On Formulary Injection only drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other antianginal Isosorbide Dinitrate On Formulary drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other antianginal Isoket Retard® On Formulary drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Modiﬁed-release preparations

2.6 Nitrates, calcium-channel blockers, and other antianginal ISOSORBIDE MONONITRATE On Formulary drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other antianginal Isosorbide Mononitrate On Formulary drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other antianginal Modiﬁed release On Formulary cheapest preparation available drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other antianginal Chemydur® 60XL On Formulary drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modiﬁed release

2.6 Nitrates, calcium-channel blockers, and other antianginal AMLODIPINE On Formulary drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal Amlodipine On Formulary drugs->2.6.2 Calcium-channel blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other antianginal DILTIAZEM HYDROCHLORIDE On Formulary drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal Tildiem® On Formulary drugs->2.6.2 Calcium-channel blockers->DILTIAZEM HYDROCHLORIDE->Standard formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal Longer-acting formulations On Formulary cheapest brand drugs->2.6.2 Calcium-channel blockers->DILTIAZEM HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other antianginal NIFEDIPINE On Formulary Nifedipine drops 20mg/ ml available drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal Nifedipine On Formulary drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other antianginal Modiﬁed release On Formulary not all Brands available - check! drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other antianginal Adalat® LA On Formulary drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modiﬁed release

2.6 Nitrates, calcium-channel blockers, and other antianginal Adalat® Retard On Formulary drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modiﬁed release

2.6 Nitrates, calcium-channel blockers, and other antianginal NIMODIPINE Restricted Sub-arachnoid haemorrhage drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal Nimotop® Restricted Sub-arachnoid haemorrhage drugs->2.6.2 Calcium-channel blockers->NIMODIPINE 2.6 Nitrates, calcium-channel blockers, and other antianginal VERAPAMIL HYDROCHLORIDE On Formulary DTC oﬃcer decision drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal Verapamil On Formulary drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other antianginal Modiﬁed release On Formulary cheapest brand 120mg and 240mg drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other antianginal Ivabradine will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this IVABRADINE NICE-approved drugs->2.6.3 Other antianginal drugs pro forma

2.6 Nitrates, calcium-channel blockers, and other antianginal NICORANDIL Restricted Cardiology drugs->2.6.3 Other antianginal drugs

2.6 Nitrates, calcium-channel blockers, and other antianginal Naftidrofuryl will be made available in the Trust for patients who meet the NICE criteria if a clinician requests NAFTIDROFURYL OXALATE NICE-approved drugs->2.6.4 Peripheral vasodilators and related drugs its use via this pro forma

DOBUTAMINE Restricted 2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics Cardiology, ITU/NNU, Theatres

2.7 Sympathomimetics->2.7.1 Inotropic Dobutamine Restricted Cardiology, ITU/NNU, Theatres sympathomimetics->DOBUTAMINE

DOPAMINE HYDROCHLORIDE Restricted 2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics Cardiology, ITU/NNU, Theatres

2.7 Sympathomimetics->2.7.1 Inotropic Dopamine Restricted Cardiology, ITU/NNU, Theatres sympathomimetics->DOPAMINE HYDROCHLORIDE

METARAMINOL Restricted 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics ITU/ NNU, Theatres, Urologists

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Metaraminol Restricted ITU/ NNU, Theatres, Urologists sympathomimetics->METARAMINOL

NORADRENALINE/NOREPINEPHRINE Restricted 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics ITU/ NNU, Theatres

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Noradrenaline/Norepinephrine Restricted ITU/ NNU, Theatres sympathomimetics->NORADRENALINE/NOREPINEPHRINE

PHENYLEPHRINE HYDROCHLORIDE Restricted 2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics ITU/ NNU, Theatres, Cardiology

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Phenylephrine Restricted ITU/ NNU, Theatres, Cardiology sympathomimetics->PHENYLEPHRINE HYDROCHLORIDE

ADRENALINE/EPINEPHRINE On Formulary 2.7 Sympathomimetics->2.7.3 Cardiopulmonary resuscitation

Adrenaline/Epinephrine 1 in 10 2.7 Sympathomimetics->2.7.3 Cardiopulmonary On Formulary 000, Dilute resuscitation->ADRENALINE/EPINEPHRINE

Heparin On Formulary 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral HEPARIN On Formulary anticoagulants->Heparin

Low molecular weight heparins On Formulary 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral ENOXAPARIN SODIUM On Formulary anticoagulants->Low molecular weight heparins

Heparinoids Restricted 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants on advise of Consultant Haematologist only

2.8 Anticoagulants and protamine->2.8.1 Parenteral DANAPAROID SODIUM Restricted on advice of Consultant Haematologists only anticoagulants->Heparinoids

2.8 Anticoagulants and protamine->2.8.1 Parenteral Orgaran® Restricted on advise of Consultant Haematologist only anticoagulants->Heparinoids->DANAPAROID SODIUM

Hirudins Restricted 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Consultant Cardiologists as per HOB protocol

2.8 Anticoagulants and protamine->2.8.1 Parenteral BIVALIRUDIN Restricted Consultant Cardiologists as per HOB protocol anticoagulants->Hirudins

2.8 Anticoagulants and protamine->2.8.1 Parenteral Angiox® Restricted Consultant Cardiologists as per HOB protocol anticoagulants->Hirudins->BIVALIRUDIN

Heparin ﬂushes On Formulary 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Sodium On Formulary anticoagulants->Heparin ﬂushes

Epoprostenol Restricted 2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants ITU/NNU, Rheumatology

2.8 Anticoagulants and protamine->2.8.1 Parenteral EPOPROSTENOL Restricted ITU/NNU, Rheumatology anticoagulants->Epoprostenol

2.8 Anticoagulants and protamine->2.8.1 Parenteral Flolan® Restricted ITU/NNU, Rheumatology anticoagulants->Epoprostenol->EPOPROSTENOL

2.8 Anticoagulants and protamine->2.8.2 Oral WARFARIN SODIUM On Formulary anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Warfarin On Formulary The oral suspension is non-formulary anticoagulants->Coumarins and phenindione->WARFARIN SODIUM

2.8 Anticoagulants and protamine->2.8.2 Oral ACENOCOUMAROL Restricted Patients who are allergic to warfarin while the supply problems with phenindione persist anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral PHENINDIONE Restricted Patients who are allergic to warfarin anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Phenindione Restricted Patients who are allergic to warfarin anticoagulants->Coumarins and phenindione->PHENINDIONE

Rivaroxaban is an option for the prevention of venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery according to the restrictions or treatment of atrial fibrillation in patients or treatment of deep vein trombosis or secondary prevention of deep vein thrombosis. 2.8 Anticoagulants and protamine->2.8.2 Oral DABIGATRAN ETEXILATE NICE-approved anticoagulants->Dabigatran etexilate Rivaroxaban is preferred over dabigatran or apixban, however, dabigatran will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this pro forma.

The APC have produced RICaDs for AF and DVT/PE which should be completed when transferring patients to the community.

Rivaroxaban is an option for the prevention of venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery according to the restrictions or treatment of atrial fibrillation in patients or treatment of deep vein trombosis or secondary prevention of deep vein thrombosis. 2.8 Anticoagulants and protamine->2.8.2 Oral APIXABAN NICE-approved Rivaroxaban is preferred over dabigatran or apixaban, however, apixaban will be made available in the Trust for patients who meet the anticoagulants->Apixaban NICE criteria if a clinician requests its use via this pro forma

The APC have produced RICaDs for AF and DVT/PE which should be completed when transferring patients to the community.

Rivaroxaban is an option 1. for the prevention of venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery according to the restrictions; or 2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN Restricted 2. treatment of atrial fibrillation; or anticoagulants->Rivaroxaban 3. treatment of deep vein trombosis or secondary prevention of deep vein thrombosis

It is preferred over dabigatran or apixaban.

PROTAMINE SULFATE Restricted 2.8 Anticoagulants and protamine->2.8.3 Protamine sulfate Heparin overdose

2.8 Anticoagulants and protamine->2.8.3 Protamine Protamine Sulfate Restricted Heparin overdose sulfate->PROTAMINE SULFATE

ABCIXIMAB Restricted 2.9 Antiplatelet drugs Cardiology in line with NICE guidance

ASPIRIN (antiplatelet) On Formulary 2.9 Antiplatelet drugs DISPERSIBLE tablets only for use in the Trust

Aspirin On Formulary 2.9 Antiplatelet drugs->ASPIRIN (antiplatelet) DISPERSIBLE tablets only for use in the Trust in accordance with NICE guidelines and in patients with stents CLOPIDOGREL Restricted 2.9 Antiplatelet drugs For use prior to primary angioplasty the 300mg tablets may be given on recommendation by the cardiology team and the 75mg tablets for pre-admission before elective angioplasty by the specialist cardiac nurses

DIPYRIDAMOLE Restricted 2.9 Antiplatelet drugs Neurology, Elderly care ----use only syrup for neurology, elderly care - plain tablets not on formulary!

Dipyridamole Restricted 2.9 Antiplatelet drugs->DIPYRIDAMOLE Neurology, Elderly care ----use only syrup for swallowing diﬃculties

Modiﬁed release Restricted 2.9 Antiplatelet drugs->DIPYRIDAMOLE Neurology, Elderly care

Persantin® Retard Restricted 2.9 Antiplatelet drugs->DIPYRIDAMOLE->Modiﬁed release Neurology, Elderly care

PRASUGREL Restricted 2.9 Antiplatelet drugs Treatment in accordance with NICE guidelines and criteria

Treatment by Consultant Cardiologists and Cardiology Associate Specialists in accordance with NICE guidelines and criteria TICAGRELOR Restricted 2.9 Antiplatelet drugs only

TIROFIBAN Restricted 2.9 Antiplatelet drugs Cardiology

2.10 Stable angina, acute coronary syndromes, and Cardiology, A&E, Vascular surgery, Eye Theatres (for intravitreal use) and for use in ischaemic stroke patients ALTEPLASE Restricted ﬁbrinolysis->2.10.2 Fibrinolytic drugs

2.10 Stable angina, acute coronary syndromes, and STREPTOKINASE On Formulary ﬁbrinolysis->2.10.2 Fibrinolytic drugs

2.10 Stable angina, acute coronary syndromes, and TENECTEPLASE Restricted Cardiology ﬁbrinolysis->2.10.2 Fibrinolytic drugs

2.10 Stable angina, acute coronary syndromes, and UROKINASE Restricted The 25,000 unit injection is available for unblocking lines ﬁbrinolysis->2.10.2 Fibrinolytic drugs

TRANEXAMIC ACID On Formulary 2.11 Antiﬁbrinolytic drugs and haemostatics

Tranexamic acid On Formulary 2.11 Antiﬁbrinolytic drugs and haemostatics->TRANEXAMIC ACID

FRESH FROZEN PLASMA On Formulary 2.11 Antiﬁbrinolytic drugs and haemostatics->Blood-related products

ATORVASTATIN Restricted 2.12 Lipid-regulating drugs->Statins Consultants only

Lipid Clinic only ROSUVASTATIN Restricted 2.12 Lipid-regulating drugs->Statins DTC oﬃcer decision

SIMVASTATIN On Formulary 2.12 Lipid-regulating drugs->Statins

Simvastatin On Formulary 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN

COLESTYRAMINE On Formulary 2.12 Lipid-regulating drugs->Bile acid sequestrants

Colestyramine On Formulary 2.12 Lipid-regulating drugs->Bile acid sequestrants->COLESTYRAMINE

EZETIMIBE Restricted 2.12 Lipid-regulating drugs->Ezetimibe Dr L Hughes, Dr A Basu

CIPROFIBRATE Restricted 2.12 Lipid-regulating drugs->Fibrates Dr L Hughes, Dr A Basu

Dr L Hughes, Dr A Basu FENOFIBRATE Restricted 2.12 Lipid-regulating drugs->Fibrates DTC oﬃcer decision

Fenoﬁbrate Restricted 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE Dr L Hughes, Dr A Basu

Lipantil® Restricted 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE Dr L Hughes, Dr A Basu

Supralip® 160 Restricted 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE Dr L Hughes, Dr A Basu

NICOTINIC ACID Restricted 2.12 Lipid-regulating drugs->Nicotinic acid group Dr L Hughes, Dr A Basu

Modiﬁed release Restricted 2.12 Lipid-regulating drugs->Nicotinic acid group->NICOTINIC ACID 21 day starter pack only to be used - Dr L Hughes, Dr A Basu

Dr L Hughes , Dr A Basu OMEGA-3-ACID ETHYL ESTERS Restricted 2.12 Lipid-regulating drugs->Omega-3 fatty acid compounds DTC oﬃcer decision

2.12 Lipid-regulating drugs->Omega-3 fatty acid compounds->OMEGA- Omacor® Restricted Dr L Hughes, Dr A Basu 3-ACID ETHYL ESTERS

SODIUM TETRADECYL SULFATE Restricted 2.13 Local sclerosants Sclerotherapy

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective SALBUTAMOL On Formulary beta2 agonists

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective Salbutamol Restricted Oral solution for paediatric use beta2 agonists->SALBUTAMOL->Oral

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective Ventolin® On Formulary beta2 agonists->SALBUTAMOL->Parenteral

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective Salbutamol On Formulary beta2 agonists->SALBUTAMOL->Inhalation

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective SALMETEROL On Formulary beta2 agonists

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective TERBUTALINE SULFATE Restricted Respiratory, Paediatricians with special interest in respiratory medicine beta2 agonists

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective Oral and parenteral Restricted Respiratory, Paediatricians with special interest in respiratory medicine beta2 agonists->TERBUTALINE SULFATE

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective Inhalation Restricted Respiratory, Paediatricians with special interest in respiratory medicine beta2 agonists->TERBUTALINE SULFATE

3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.2 Other EPHEDRINE HYDROCHLORIDE Restricted DTC oﬃcer decision adrenoceptor agonists

GLYCOPYRRONIUM Restricted 3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators Respiratory, Paediatricians with special interest in respiratory medicine

IPRATROPIUM BROMIDE On Formulary 3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators

3.1 Bronchodilators->3.1.2 Antimuscarinic Ipratropium Bromide On Formulary bronchodilators->IPRATROPIUM BROMIDE

3.1 Bronchodilators->3.1.2 Antimuscarinic Atrovent® On Formulary bronchodilators->IPRATROPIUM BROMIDE

TIOTROPIUM Restricted 3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators Respiratory, Paediatricians with special interest in respiratory medicine

THEOPHYLLINE Restricted 3.1 Bronchodilators->3.1.3 Theophylline Respiratory, ITU and Paeditricians in a HDU, ITU/NNU setting

Modiﬁed release Restricted 3.1 Bronchodilators->3.1.3 Theophylline->THEOPHYLLINE Respiratory, Paediatricians with special interest in respiratory medicine

AMINOPHYLLINE Restricted 3.1 Bronchodilators->3.1.3 Theophylline Respiratory, ITU and Paeditricians in a HDU, ITU/NNU setting

Aminophylline Restricted 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE Respiratory, ITU and Paeditricians in a HDU, ITU/NNU setting

Modiﬁed release Restricted 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE Respiratory, ITU and Paeditricians in a HDU, ITU/NNU setting

Respiratory, ITU and Paediatricians in a HDU, ITU/NNU setting 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE->Modiﬁed Phyllocontin Continus® Restricted release Only the 225mg tablets are in the formulary

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Standard Range Peak Flow Meter On Formulary nebulisers->Peak ﬂow meters

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Low Range Peak Flow Meter On Formulary nebulisers->Peak ﬂow meters

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Able Spacer® On Formulary nebulisers->Drug delivery devices

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and AeroChamber® Plus On Formulary nebulisers->Drug delivery devices

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Haleraid® On Formulary nebulisers->Drug delivery devices

3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Volumatic® On Formulary nebulisers->Drug delivery devices 3.1 Bronchodilators->3.1.5 Peak ﬂow meters, inhaler devices and Sodium Chloride On Formulary nebulisers->Nebuliser diluent

BECLOMETASONE DIPROPIONATE On Formulary 3.2 Corticosteroids The only available CFC-free inhaler available is Clenil Modulite

Beclometasone On Formulary 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE

Clenil Modulite® On Formulary 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE

3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE->Compound Fostair® On Formulary preparations

Paediatrics BUDESONIDE Restricted 3.2 Corticosteroids DTC oﬃcer decision

Budesonide Restricted 3.2 Corticosteroids->BUDESONIDE Paediatrics

Pulmicort® Restricted 3.2 Corticosteroids->BUDESONIDE Paediatricians

Symbicort® Restricted 3.2 Corticosteroids->BUDESONIDE->Compound preparations Respiratory, and Paediatricians with a special interest in respiratory medicine

Seretide® Restricted 3.2 Corticosteroids->FLUTICASONE->Compound preparations Respiratory, Paediatricians with a special interest in respiratory medicine

3.3 Cromoglicate and related therapy, leukotriene receptor MONTELUKAST Restricted antagonists, and phosphodiesterase type-4 inhibitors->3.3.2 Respiratory, Paediatricians Leukotriene receptor antagonists

3.3 Cromoglicate and related therapy, leukotriene receptor Roﬂumilast will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this ROFLUMILAST NICE-approved antagonists, and phosphodiesterase type-4 inhibitors->3.3.3 pro forma Phosphodiesterase type-4 inhibitors

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 CETIRIZINE HYDROCHLORIDE On Formulary DTC oﬃcer decision Antihistamines->Non-sedating antihistamines

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Cetirizine On Formulary Antihistamines->Non-sedating antihistamines->CETIRIZINE HYDROCHLORIDE

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 LORATADINE On Formulary Antihistamines->Non-sedating antihistamines

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 There is a manufacturer's delay on the syrup. Where a syrup is indicated use desloratadine instead. This issue is likely to be Loratadine On Formulary Antihistamines->Non-sedating antihistamines->LORATADINE resolved by September.

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 CHLORPHENAMINE MALEATE On Formulary Antihistamines->Sedating antihistamines

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Chlorphenamine On Formulary Antihistamines->Sedating antihistamines->CHLORPHENAMINE MALEATE

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Do not prescribe hydroxyzine to people with a prolonged QT interval or risk factors for QT interval prolongation HYDROXYZINE HYDROCHLORIDE On Formulary Antihistamines->Sedating antihistamines https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/424764/Drug_Safety_Update_-_April_2015.pdf

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 PROMETHAZINE HYDROCHLORIDE On Formulary Antihistamines->Sedating antihistamines

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Pharmalgen® NICE-approved Allergen immunotherapy->BEE AND WASP ALLERGEN EXTRACTS

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Grass pollen extract Restricted Patients being treated by a Consultant Immunologist Allergen immunotherapy->GRASS AND TREE POLLEN EXTRACTS

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Grazax® Restricted Allergen immunotherapy->GRASS AND TREE POLLEN EXTRACTS->Grass Consultant immunologists pollen extract

Omalizumab will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this 3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 pro forma OMALIZUMAB NICE-approved Allergen immunotherapy->Omalizumab N .B. NICE TA201 has now been replaced by TA278

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 ADRENALINE/EPINEPHRINE On Formulary Allergic emergencies->Anaphylaxis

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic Adrenaline/Epinephrine 1 in 1000 On Formulary emergencies->Anaphylaxis->ADRENALINE/EPINEPHRINE->Intramuscular or subcutaneous

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic Minijet® Adrenaline 1 in 1000 On Formulary emergencies->Anaphylaxis->ADRENALINE/EPINEPHRINE->Intramuscular or subcutaneous

3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 C1-ESTERASE INHIBITOR Restricted Peadiatrics and named patients Allergic emergencies->Angioedema

3.5 Respiratory stimulants and pulmonary surfactants->3.5.1 DOXAPRAM HYDROCHLORIDE Restricted ITU, Theatres Respiratory stimulants

3.5 Respiratory stimulants and pulmonary surfactants->3.5.2 PORACTANT ALFA Restricted NNU Pulmonary surfactants

Cystic ﬁbrosis, ITU CARBOCISTEINE Restricted 3.7 Mucolytics DTC oﬃcer decision

Carbocisteine Restricted 3.7 Mucolytics->CARBOCISTEINE Cystic ﬁbrosis, ITU

Dornase alfa Restricted 3.7 Mucolytics Cystic ﬁbrosis

DORNASE ALFA Restricted 3.7 Mucolytics->Dornase alfa Cystic ﬁbrosis

Mannitol dry powder will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use MANNITOL NICE-approved 3.7 Mucolytics->Mannitol via this pro forma

Benzoin Tincture, Compound, BP On Formulary 3.8 Aromatic inhalations

Codeine is now contraindicated in children under the age of 12. CODEINE PHOSPHATE Restricted 3.9 Cough preparations->3.9.1 Cough suppressants See MHRA advice here

3.9 Cough preparations->3.9.1 Cough suppressants->CODEINE Codeine Linctus, BP On Formulary PHOSPHATE

PHOLCODINE On Formulary 3.9 Cough preparations->3.9.1 Cough suppressants

Pholcodine Linctus, BP On Formulary 3.9 Cough preparations->3.9.1 Cough suppressants->PHOLCODINE sugar-free

METHADONE HYDROCHLORIDE Restricted 3.9 Cough preparations->3.9.1 Cough suppressants->Palliative care For palliative care

MORPHINE HYDROCHLORIDE On Formulary 3.9 Cough preparations->3.9.1 Cough suppressants->Palliative care

3.9 Cough preparations->3.9.2 Demulcent and expectorant cough Simple Linctus, BP On Formulary sugar-free preparations

3.9 Cough preparations->3.9.2 Demulcent and expectorant cough Simple Linctus, Paediatric, BP On Formulary sugar-free preparations

Pirfenidone cannot be made available in the Trust for patients who meet the NICE criteria as the Trust is not a specialist PIRFENIDONE NICE-approved 3.11 Antiﬁbrotics centre. If a clinician requests its use please use the patient's own supply, or arrange supply from specilaist centre.

TEMAZEPAM On Formulary 4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Benzodiazepines

4.1 Hypnotics and anxiolytics->4.1.1 Temazepam On Formulary Hypnotics->Benzodiazepines->TEMAZEPAM

4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Zaleplon, zolpidem, ZOPICLONE On Formulary and zopiclone

4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Zaleplon, zolpidem, Zopiclone On Formulary and zopiclone->ZOPICLONE

4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Chloral and NNU, or in line with childhood sedation policy CHLORAL HYDRATE Restricted derivatives DTC oﬃcer decision 4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Chloral and Chloral Mixture, BP 2000 Restricted derivatives->CHLORAL HYDRATE

PROMETHAZINE HYDROCHLORIDE On Formulary 4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Antihistamines

DIAZEPAM On Formulary 4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines

4.1 Hypnotics and anxiolytics->4.1.2 Diazepam On Formulary Anxiolytics->Benzodiazepines->DIAZEPAM

LORAZEPAM On Formulary 4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines

4.1 Hypnotics and anxiolytics->4.1.2 Lorazepam On Formulary Anxiolytics->Benzodiazepines->LORAZEPAM

CHLORPROMAZINE 4.2 Drugs used in psychoses and related disorders->4.2.1 On Formulary HYDROCHLORIDE Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 Chlorpromazine On Formulary Antipsychotic drugs->First-generation antipsychotic drugs->CHLORPROMAZINE HYDROCHLORIDE

4.2 Drugs used in psychoses and related disorders->4.2.1 FLUPENTIXOL Restricted DTC oﬃcer decision Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 HALOPERIDOL On Formulary DTC oﬃcer decision Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 Haloperidol On Formulary Antipsychotic drugs->First-generation antipsychotic drugs->HALOPERIDOL

4.2 Drugs used in psychoses and related disorders->4.2.1 LEVOMEPROMAZINE Restricted Palliative care Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 PROCHLORPERAZINE On Formulary Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 PROMAZINE HYDROCHLORIDE On Formulary Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 Promazine On Formulary Antipsychotic drugs->First-generation antipsychotic drugs->PROMAZINE HYDROCHLORIDE

4.2 Drugs used in psychoses and related disorders->4.2.1 TRIFLUOPERAZINE On Formulary Antipsychotic drugs->First-generation antipsychotic drugs

4.2 Drugs used in psychoses and related disorders->4.2.1 Triﬂuoperazine On Formulary Antipsychotic drugs->First-generation antipsychotic drugs->TRIFLUOPERAZINE

Consultants for use in patients with Parkinson's disease and psychiatrists; named senior pharmacists may continue to supply Senior 4.2 Drugs used in psychoses and related disorders->4.2.1 these drugs only if a) they were started by a psychiatrist prior to admission; b) they are suitable for the patient; and c) the AMISULPRIDE pharmacist Antipsychotic drugs->Second-generation antipsychotic drugs patient's admission is not related to an adverse reaction to the drug approval DTC oﬃcer decision

Senior 4.2 Drugs used in psychoses and related disorders->4.2.1 Consultants for use in patients with Parkinson's disease and psychiatrists; named senior pharmacists may continue to supply Amisulpride pharmacist Antipsychotic drugs->Second-generation antipsychotic these drugs only if a) they were started by a psychiatrist prior to admission; b) they are suitable for the patient; and c) the approval drugs->AMISULPRIDE patient's admission is not related to an adverse reaction to the drug

DTC oﬃcer decision Senior 4.2 Drugs used in psychoses and related disorders->4.2.1 ARIPIPRAZOLE pharmacist Named senior pharmacists may continue to supply this drugs only if a) it was started by a psychiatrist prior Antipsychotic drugs->Second-generation antipsychotic drugs approval to admission; b) it is suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the drug

Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist Senior 4.2 Drugs used in psychoses and related disorders->4.2.1 prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to CLOZAPINE pharmacist Antipsychotic drugs->Second-generation antipsychotic drugs the drug approval DTC oﬃcer decision

4.2 Drugs used in psychoses and related disorders->4.2.1 Acute mania and schizophrenia in accordance with NICE guidelines OLANZAPINE Restricted Antipsychotic drugs->Second-generation antipsychotic drugs DTC oﬃcer decision

Acute mania, add-on therapy for patients not responding to SSRIs in obsessive-compulsive disorder, and schizophrenia 4.2 Drugs used in psychoses and related disorders->4.2.1 according to NICE guidelines QUETIAPINE Restricted Antipsychotic drugs->Second-generation antipsychotic drugs The XL preparations are non-formulary DTC oﬃcer decision

4.2 Drugs used in psychoses and related disorders->4.2.1 Acute mania, add-on therapy for patients who have not responded adequately to SSRIs in obsessive-compulsive disorder, and RISPERIDONE Restricted Antipsychotic drugs->Second-generation antipsychotic drugs schizophrenia according to NICE guidelines

Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist Senior prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to 4.2 Drugs used in psychoses and related disorders->4.2.2 FLUPENTIXOL DECANOATE pharmacist the drug Antipsychotic depot injections approval The 100mg/ml preparation (Depixol Conc®) is non-formulary

Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist Senior prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to 4.2 Drugs used in psychoses and related disorders->4.2.2 FLUPHENAZINE DECANOATE pharmacist the drug Antipsychotic depot injections approval N.B. Not all strengths are stocked

4.2 Drugs used in psychoses and related disorders->4.2.2 Fluphenazine decanoate Restricted Psychiatrists Antipsychotic depot injections->FLUPHENAZINE DECANOATE

4.2 Drugs used in psychoses and related disorders->4.2.2 HALOPERIDOL Restricted Psychiatrists Antipsychotic depot injections

4.2 Drugs used in psychoses and related disorders->4.2.2 Haldol Decanoate® Restricted Psychiatrists Antipsychotic depot injections->HALOPERIDOL

Senior Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist 4.2 Drugs used in psychoses and related disorders->4.2.2 RISPERIDONE pharmacist prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to Antipsychotic depot injections approval the drug

4.2 Drugs used in psychoses and related disorders->4.2.2 Risperdal Consta® Restricted Psychiatrists Antipsychotic depot injections->RISPERIDONE

4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used Carbamazepine Restricted for mania and hypomania

Senior Named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist prior to 4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used Valproate pharmacist admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the for mania and hypomania approval drug

Senior only for patients already on Lithium; named senior pharmacists may continue to supply these drugs only if a) they were 4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used Lithium pharmacist started by a psychiatrist prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related for mania and hypomania approval to an adverse reaction to the drug

4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used only for patients already on lithium - the products stocked are Priadel® 200mg and 400mg, and Camcolit® 400mg LITHIUM CARBONATE Restricted for mania and hypomania->Lithium DTC oﬃcer decision

4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used LITHIUM CITRATE Restricted only for patients already on lithium - the only prodyuct stocked is Li-Liquid® for mania and hypomania->Lithium

4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant AMITRIPTYLINE HYDROCHLORIDE On Formulary drugs->Tricyclic antidepressants

4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant Amitriptyline On Formulary drugs->Tricyclic antidepressants->AMITRIPTYLINE HYDROCHLORIDE

Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist Senior 4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to CLOMIPRAMINE HYDROCHLORIDE pharmacist drugs->Tricyclic antidepressants the drug approval DTC oﬃcer decision 4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant Clomipramine Restricted Psychiatrists drugs->Tricyclic antidepressants->CLOMIPRAMINE HYDROCHLORIDE

Named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist prior to Senior 4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the LOFEPRAMINE pharmacist drugs->Tricyclic antidepressants drug approval DTC oﬃcer decision

4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant TRAZODONE HYDROCHLORIDE On Formulary drugs->Tricyclic-related antidepressants

4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant Trazodone On Formulary drugs->Tricyclic-related antidepressants->TRAZODONE HYDROCHLORIDE

MHRA Drug Safety article on citalopram (December 2011) 4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake The MHRA warned of the association between citalopram and escitalopram and dose-dependent QT interval prolongation in CITALOPRAM On Formulary inhibitors the December 2011 edition of Drug Safety Update. Please follow this link for guidance on maximum daily dose recommendations and monitoring.

MHRA Drug Safety article on citalopram (December 2011) 4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake The MHRA warned of the association between citalopram and escitalopram and dose-dependent QT interval prolongation in Citalopram On Formulary inhibitors->CITALOPRAM the December 2011 edition of Drug Safety Update. Please follow this link for guidance on maximum daily dose recommendations and monitoring.

4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake FLUOXETINE On Formulary inhibitors

4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake Fluoxetine On Formulary inhibitors->FLUOXETINE

Named senior pharmacists may continue to supply paroxtetine tablets only if a) they were started by a psychiatrist prior to Senior 4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the PAROXETINE pharmacist inhibitors drug approval DTC oﬃcer decision

Senior Named senior pharmacists may continue to supply paroxtetine tablets only if a) they were started by a psychiatrist prior to 4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake Paroxetine pharmacist admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the inhibitors->PAROXETINE approval drug

Named senior pharmacists may continue to supply sertraline tablets only if a) they were started by a psychiatrist prior to Senior 4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to the SERTRALINE pharmacist inhibitors drug approval DTC oﬃcer decision

On Pain Clinic advice only and for dispensing only on completion of a pro forma DULOXETINE Restricted 4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs Use of duloxetine for urinary indications is non-formulary

FLUPENTIXOL Restricted 4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs Psychiatrists

Second-line MIRTAZAPINE Restricted 4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs DTC oﬃcer decision

Psychiatrists; named senior pharmacists may continue to supply these drugs only if a) they were started by a psychiatrist Senior prior to admission; b) they are suitable for the patient; and c) the patient's admission is not related to an adverse reaction to VENLAFAXINE pharmacist 4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs the drug approval DTC oﬃcer decision

4.3 Antidepressant drugs->4.3.4 Other antidepressant Modiﬁed release Restricted Psychiatrists drugs->VENLAFAXINE

METHYLPHENIDATE 4.4 CNS stimulants and drugs used for attention deﬁcit hyperactivity Restricted Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability HYDROCHLORIDE disorder

4.4 CNS stimulants and drugs used for attention deﬁcit hyperactivity Methylphenidate Hydrochloride Restricted Consultant Neurologists, Consultant Paediatricians specialising in neuro-disability disorder->METHYLPHENIDATE HYDROCHLORIDE

4.4 CNS stimulants and drugs used for attention deﬁcit hyperactivity Modiﬁed release Restricted Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability disorder->METHYLPHENIDATE HYDROCHLORIDE

Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability. 4.4 CNS stimulants and drugs used for attention deﬁcit hyperactivity Concerta® XL Restricted disorder->METHYLPHENIDATE HYDROCHLORIDE->Modiﬁed release Only the 18 mg strength is stocked

4.4 CNS stimulants and drugs used for attention deﬁcit hyperactivity Medikinet XL® Restricted Consultant Community Paediatricians disorder->METHYLPHENIDATE HYDROCHLORIDE->Modiﬁed release

4.5 Drugs used in the treatment of obesity->4.5.1 Anti-obesity drugs ORLISTAT Restricted For use in the weight management clinic by Dr E Hughes and Dr A Basu in accordance with NICE guidelines acting on the gastro-intestinal tract

CINNARIZINE On Formulary 4.6 Drugs used in nausea and vertigo->Antihistamines

Cinnarizine On Formulary 4.6 Drugs used in nausea and vertigo->Antihistamines->CINNARIZINE

CYCLIZINE On Formulary 4.6 Drugs used in nausea and vertigo->Antihistamines

PROMETHAZINE HYDROCHLORIDE On Formulary 4.6 Drugs used in nausea and vertigo->Antihistamines

CHLORPROMAZINE 4.6 Drugs used in nausea and vertigo->Phenothiazines and related On Formulary HYDROCHLORIDE drugs

4.6 Drugs used in nausea and vertigo->Phenothiazines and related PROCHLORPERAZINE On Formulary drugs

4.6 Drugs used in nausea and vertigo->Phenothiazines and related Prochlorperazine On Formulary drugs->PROCHLORPERAZINE

4.6 Drugs used in nausea and vertigo->Phenothiazines and related TRIFLUOPERAZINE On Formulary drugs

4.6 Drugs used in nausea and vertigo->Domperidone and DOMPERIDONE On Formulary metoclopramide

4.6 Drugs used in nausea and vertigo->Domperidone and Domperidone On Formulary metoclopramide->DOMPERIDONE

METOCLOPRAMIDE 4.6 Drugs used in nausea and vertigo->Domperidone and On Formulary HYDROCHLORIDE metoclopramide

4.6 Drugs used in nausea and vertigo->Domperidone and Metoclopramide On Formulary metoclopramide->METOCLOPRAMIDE HYDROCHLORIDE

ONDANSETRON Restricted 4.6 Drugs used in nausea and vertigo->5HT3-receptor antagonists Second line treatment - after antihistamines have been tried

4.6 Drugs used in nausea and vertigo->Neurokinin-receptor Second-line agent in patients who have failed with 5HT 3 antagonists APREPITANT Restricted antagonists DTC oﬃcer decision

HYOSCINE HYDROBROMIDE On Formulary 4.6 Drugs used in nausea and vertigo->Hyoscine

4.6 Drugs used in nausea and vertigo->Hyoscine->HYOSCINE Patches On Formulary HYDROBROMIDE

4.6 Drugs used in nausea and vertigo->Other drugs for Ménière's BETAHISTINE DIHYDROCHLORIDE On Formulary disease

4.6 Drugs used in nausea and vertigo->Other drugs for Ménière's Betahistine Dihydrochloride On Formulary disease->BETAHISTINE DIHYDROCHLORIDE

Compound analgesic 4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic Restricted DTC oﬃcer decision co-proxamol preparations preparations

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic Dispersible tablets and suppositories for use in the Trust ASPIRIN On Formulary preparations DTC oﬃcer decision

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic Aspirin On Formulary Dispersible tablets and suppositories for use in the Trust preparations->ASPIRIN

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic CO-CODAMOL On Formulary Only the 30/500 strength is on the formulary preparations

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic With codeine phosphate 30 mg On Formulary preparations->CO-CODAMOL 4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic CO-DYDRAMOL On Formulary preparations

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic PARACETAMOL On Formulary Consider using paracetamol fastmelts before using suppositories preparations

4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic Paracetamol On Formulary preparations->PARACETAMOL

for post-op pain in theatres and for use on ITU only paracetamol oro-dispersible (‘Melt’) preferred 4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic Perfalgan® Restricted preparations->PARACETAMOL

DTC oﬃcer decision

Patches are non-formulary. BUPRENORPHINE Restricted 4.7 Analgesics->4.7.2 Opioid analgesics See chapter 4.10 for restricted use of tablets in opioid dependency DTC oﬃcer decision

Injection is restricted to A&E, ITU only

CODEINE PHOSPHATE Restricted 4.7 Analgesics->4.7.2 Opioid analgesics Codeine is now contraindicated in children under the age of 12.

See MHRA advice here

Codeine Phosphate Restricted 4.7 Analgesics->4.7.2 Opioid analgesics->CODEINE PHOSPHATE Injection is restricted to A&E, ITU and BTC childrens theatres only

DIAMORPHINE HYDROCHLORIDE On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics

4.7 Analgesics->4.7.2 Opioid analgesics->DIAMORPHINE Diamorphine On Formulary HYDROCHLORIDE

DIHYDROCODEINE TARTRATE On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics

Dihydrocodeine On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics->DIHYDROCODEINE TARTRATE

Patches for Rheumatology, Palliative care, Pain team. The 12 mcg patches are not stocked FENTANYL Restricted 4.7 Analgesics->4.7.2 Opioid analgesics The lozenges are non-formulary DTC oﬃcer decision

Palliative care, Rheumatology, Pain team Patches Restricted 4.7 Analgesics->4.7.2 Opioid analgesics->FENTANYL The 12 mcg patches are not stocked

Palliative care, Rheumatology, Pain team Durogesic DTrans® Restricted 4.7 Analgesics->4.7.2 Opioid analgesics->FENTANYL->Patches The 12 mcg patches are not stocked

4.7 Analgesics->4.7.2 Opioid analgesics->METHADONE Methadone Restricted as per protocol for addicts, palliative care HYDROCHLORIDE

MORPHINE SALTS On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics

4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE SALTS->Oral Morphine Oral Solutions On Formulary solutions

4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE SALTS->Oral Oramorph® On Formulary solutions

Sevredol® On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE SALTS->Tablets the 50mg tablet is restricted to a named-patient basis in patients with sickle cell crisis

4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE SALTS->Modiﬁed- Zomorph® On Formulary release 12-hourly oral preparations

4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE Morphine On Formulary SALTS->Suppositories

4.7 Analgesics->4.7.2 Opioid analgesics->MORPHINE Morphine Sulfate On Formulary SALTS->Injections

PAPAVERETUM Restricted 4.7 Analgesics->4.7.2 Opioid analgesics Theatres

Papaveretum Restricted 4.7 Analgesics->4.7.2 Opioid analgesics->PAPAVERETUM Theatres

PETHIDINE HYDROCHLORIDE On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics

Pethidine On Formulary 4.7 Analgesics->4.7.2 Opioid analgesics->PETHIDINE HYDROCHLORIDE

Rheumatology consultants and Pain team (see also acute pain guidelines) TRAMADOL HYDROCHLORIDE Restricted 4.7 Analgesics->4.7.2 Opioid analgesics DTC oﬃcer decision

Tramadol Hydrochloride Restricted 4.7 Analgesics->4.7.2 Opioid analgesics->TRAMADOL HYDROCHLORIDE Rheumatology consultants and Pain team (see also acute pain guidelines)

4.7 Analgesics->4.7.4 Antimigraine drugs->4.7.4.1 Treatment of acute Nasal spray not on formulary SUMATRIPTAN On Formulary migraine->5HT1-receptor agonists DTC oﬃcer decision

4.7 Analgesics->4.7.4 Antimigraine drugs->4.7.4.2 Prophylaxis of PIZOTIFEN On Formulary migraine

4.7 Analgesics->4.7.4 Antimigraine drugs->4.7.4.2 Prophylaxis of Pizotifen On Formulary migraine->PIZOTIFEN

4.8 Antiepileptic drugs->4.8.1 Control of the CARBAMAZEPINE On Formulary The chewable tablets (Chewtabs®) are non-formulary epilepsies->Carbamazepine and related antiepileptics

4.8 Antiepileptic drugs->4.8.1 Control of the Carbamazepine On Formulary epilepsies->Carbamazepine and related antiepileptics->CARBAMAZEPINE

Neurology 4.8 Antiepileptic drugs->4.8.1 Control of the OXCARBAZEPINE Restricted The 600mg tablets are non-formulary epilepsies->Carbamazepine and related antiepileptics DTC oﬃcer decision

ETHOSUXIMIDE Restricted 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Ethosuximide To be initiated by consultant paediatricians with epilepsy interest / consultant neurologists. Oral liquid only.

4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin GABAPENTIN On Formulary and pregabalin

4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin Gabapentin On Formulary and pregabalin->GABAPENTIN

Pain Clinic and for dispensing only on completion of a pro forma 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin PREGABALIN Restricted and pregabalin DTC oﬃcer decision

LAMOTRIGINE On Formulary 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Lamotrigine

4.8 Antiepileptic drugs->4.8.1 Control of the Lamotrigine On Formulary epilepsies->Lamotrigine->LAMOTRIGINE

Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability or epilepsy. The injection is restricted 4.8 Antiepileptic drugs->4.8.1 Control of the LEVETIRACETAM Restricted to treatment following the Status Epilepticus Guidelines. epilepsies->Levetiracetam DTC oﬃcer decision

PERAMPANEL Restricted 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Perampanel Consultant Neurologists or Associate Specialists in Neurology for third- or fourth- line use in accordance with a RICaD

4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital The Trust has standardized on a liquid formulation of strength 50mg in 5mL. The 15mg in 5mL will only be supplied if DTC PHENOBARBITAL On Formulary and primidone approval is obtained.

4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital Phenobarbital On Formulary and primidone->PHENOBARBITAL

4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital Neurologists and in movement disorder PRIMIDONE Restricted and primidone DTC oﬃcer decision

PHENYTOIN On Formulary 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenytoin

4.8 Antiepileptic drugs->4.8.1 Control of the Phenytoin On Formulary epilepsies->Phenytoin->PHENYTOIN

Retigabine will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this RETIGABINE NICE-approved 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Retigabine pro forma Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability or epilepsy TOPIRAMATE Restricted 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Topiramate DTC oﬃcer decision

SODIUM VALPROATE On Formulary 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Valproate Drug Safety Update January 2015

4.8 Antiepileptic drugs->4.8.1 Control of the Sodium Valproate On Formulary epilepsies->Valproate->SODIUM VALPROATE->Oral

VIGABATRIN Restricted 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Vigabatrin Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability or epilepsy

ZONISAMIDE Restricted 4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Zonisamide Consultant Neurologists or Associate Specialists in Neurology for third- or fourth- line use in accordance with a RICaD

4.8 Antiepileptic drugs->4.8.1 Control of the Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability or epilepsy CLOBAZAM Restricted epilepsies->Benzodiazepines DTC oﬃcer decision

4.8 Antiepileptic drugs->4.8.1 Control of the CLONAZEPAM Restricted Consultant Neurologists and Consultant Paediatricians specialising in neuro-disability or epilepsy epilepsies->Benzodiazepines

DIAZEPAM On Formulary 4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus

4.8 Antiepileptic drugs->4.8.2 Drugs used in status Diazepam On Formulary epilepticus->DIAZEPAM

LORAZEPAM On Formulary 4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus

MIDAZOLAM Restricted 4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus for use in status epilepticus for patients attending school

PHENOBARBITAL SODIUM On Formulary 4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus

4.8 Antiepileptic drugs->4.8.2 Drugs used in status Phenobarbital On Formulary use 60mg/ ml injections epilepticus->PHENOBARBITAL SODIUM

PHENYTOIN SODIUM On Formulary 4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus

4.8 Antiepileptic drugs->4.8.2 Drugs used in status Phenytoin On Formulary epilepticus->PHENYTOIN SODIUM

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Neurologists and Parkinson's disease APOMORPHINE HYDROCHLORIDE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor DTC oﬃcer decision agonists

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Neurologists and Parkinson's disease second-line noting MHRA guidance (it is also allowed in O&G for consultant CABERGOLINE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor gynaecologists and in endocrinology - see chapter 6) agonists

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Neurologists and Parkinson's disease PERGOLIDE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor FDA announces voluntary withdrawal of pergolide 29/3/07 agonists

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Pergolide Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor Neurologists and Parkinson's disease agonists->PERGOLIDE

Neurologists and Parkinson's disease 4.9 Drugs used in parkinsonism and related disorders->4.9.1 PRAMIPEXOLE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor n.b. only the 88 and 180 microgram strengths are stocked agonists DTC oﬃcer decision

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Neurologists and Parkinson's disease ROPINIROLE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor Only the 1 and 2 mg tablets are stocked. All other strengths are non-formulary agonists DTC oﬃcer decision

4.9 Drugs used in parkinsonism and related disorders->4.9.1 ROTIGOTINE Restricted Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor therapy for paents who are nil-by-mouth only agonists

4.9 Drugs used in parkinsonism and related disorders->4.9.1 CO-BENELDOPA On Formulary DTC oﬃcer decision Dopaminergic drugs used in Parkinson's disease->Levodopa

4.9 Drugs used in parkinsonism and related disorders->4.9.1 CO-CARELDOPA On Formulary Dopaminergic drugs used in Parkinson's disease->Levodopa

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Patients of Dr Clarke and Dr Nicholls for third-line use RASAGILINE Restricted Dopaminergic drugs used in Parkinson's disease->Monoamine- DTC oﬃcer decision oxidase-B inhibitors

4.9 Drugs used in parkinsonism and related disorders->4.9.1 SELEGILINE HYDROCHLORIDE On Formulary Dopaminergic drugs used in Parkinson's disease->Monoamine- oxidase-B inhibitors

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Selegiline Hydrochloride On Formulary Dopaminergic drugs used in Parkinson's disease->Monoamine- oxidase-B inhibitors->SELEGILINE HYDROCHLORIDE

4.9 Drugs used in parkinsonism and related disorders->4.9.1 Neurologists and Consultant Geriatricians with a special interest in Parkinson's disease ENTACAPONE Restricted Dopaminergic drugs used in Parkinson's disease->Catechol- DTC oﬃcer decision O-methyltransferase inhibitors

4.9 Drugs used in parkinsonism and related disorders->4.9.2 ORPHENADRINE HYDROCHLORIDE On Formulary Antimuscarinic drugs used in parkinsonism

4.9 Drugs used in parkinsonism and related disorders->4.9.2 Orphenadrine Hydrochloride On Formulary Antimuscarinic drugs used in parkinsonism->ORPHENADRINE HYDROCHLORIDE

4.9 Drugs used in parkinsonism and related disorders->4.9.2 PROCYCLIDINE HYDROCHLORIDE On Formulary Antimuscarinic drugs used in parkinsonism

4.9 Drugs used in parkinsonism and related disorders->4.9.2 Procyclidine On Formulary Antimuscarinic drugs used in parkinsonism->PROCYCLIDINE HYDROCHLORIDE

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 4.9 Drugs used in parkinsonism and related disorders->4.9.3 Drugs RILUZOLE NICE-approved For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. used in essential tremor, chorea, tics, and related disorders

For all other patients please complete this pro forma.

4.9 Drugs used in parkinsonism and related disorders->4.9.3 Drugs TETRABENAZINE Restricted Consultant Neurologists and Consultant Paediarticians specialising in neuro-disability or epilepsy used in essential tremor, chorea, tics, and related disorders

Named Neurologists, Vascular, and Maxillo-facial consultants for licensed indications. Also Consultant Ophthalmologists for strabismus and induction of ptosis; Consultant Urologists and Urogynaecologists for bladder instability; and Consultant Dermatologists for hyperhidrosis 4.9 Drugs used in parkinsonism and related disorders->4.9.3 Drugs BOTULINUM TOXIN TYPE A Restricted used in essential tremor, chorea, tics, and related disorders->Torsion For patients who meet the NICE criteria (migraine and torsion dystonia) and if a clinician requests its use. dystonias and other involuntary movements For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient.

For all other patients please complete this pro forma.

4.10 Drugs used in substance dependence->4.10.1 Alcohol for patients who have withdrawn from alcohol and are monitored by a specialist team such as the Anchor team. ACAMPROSATE CALCIUM Restricted dependence->Acamprosate DTC oﬃcer decision

4.10 Drugs used in substance dependence->4.10.2 Nicotine BUPROPION HYDROCHLORIDE On Formulary dependence->Bupropion

4.10 Drugs used in substance dependence->4.10.2 Nicotine NICOTINE On Formulary Patches, gums and inhalator dependence->Nicotine replacement therapy

4.10 Drugs used in substance dependence->4.10.2 Nicotine NiQuitin® On Formulary Patches only dependence->Nicotine replacement therapy->NICOTINE

4.10 Drugs used in substance dependence->4.10.2 Nicotine VARENICLINE Restricted Treatment by the smoking cessation service in accordance with NICE guidelines and criteria dependence->Varenicline

In line with Trust opioid policy in patients with opioid dependency and in accordance with the NICE guidelines and criteria. 4.10 Drugs used in substance dependence->4.10.3 Opioid BUPRENORPHINE Restricted dependence->Opioid substitution therapy 2mg sublingual tablets only are stocked 4.10 Drugs used in substance dependence->4.10.3 Opioid METHADONE HYDROCHLORIDE Restricted As per protocol for patients with opioid dependence in accordance with the NICE guidelines and criteria dependence->Opioid substitution therapy

4.10 Drugs used in substance dependence->4.10.3 Opioid Methadone Restricted dependence->Opioid substitution therapy->METHADONE as per protocol for patients with opioid dependence HYDROCHLORIDE

4.10 Drugs used in substance dependence->4.10.3 Opioid Naltrexone will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this NALTREXONE HYDROCHLORIDE NICE-approved dependence->Opioid-receptor antagonists pro forma

DONEPEZIL HYDROCHLORIDE Restricted 4.11 Drugs for dementia Donepezil has the lowest acquistion costs and should be used ﬁrst-line for continuation of treatment

Donepezil has the lowest acquistion costs and should be used ﬁrst-line GALANTAMINE NICE-approved 4.11 Drugs for dementia This drug is not routinely stocked in the Trust. To use it please complete this pro forma

Donepezil has the lowest acquistion costs and should be used ﬁrst-line MEMANTINE HYDROCHLORIDE NICE-approved 4.11 Drugs for dementia This drug is not routinely stocked in the Trust. To use it please complete this pro forma

Donepezil has the lowest acquistion costs and should be used ﬁrst-line RIVASTIGMINE NICE-approved 4.11 Drugs for dementia All stengths of patches are non-formulary. This drug is not routinely stocked in the Trust. To use the oral preparions please complete this pro forma

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and BENZYLPENICILLIN SODIUM On Formulary phenoxymethylpenicillin

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and PHENOXYMETHYLPENICILLIN On Formulary phenoxymethylpenicillin

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and Phenoxymethylpenicillin On Formulary phenoxymethylpenicillin->PHENOXYMETHYLPENICILLIN

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase- FLUCLOXACILLIN On Formulary resistant penicillins

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase- Flucloxacillin On Formulary resistant penicillins->FLUCLOXACILLIN

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum AMOXICILLIN On Formulary penicillins

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum Amoxicillin On Formulary penicillins->AMOXICILLIN

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum CO-AMOXICLAV On Formulary DTC oﬃcer decision penicillins

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum Co-amoxiclav Restricted For use in accordance with the antibiotic policy penicillins->CO-AMOXICLAV

The generic product will be supplied. 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal PIPERACILLIN WITH TAZOBACTAM Restricted penicillins Neutropenic sepsis, treatment of hospital-acquired pneumonia as per protocol, otherwise with microbiological advice only

Neutropenic sepsis, treatment of hospital-acquired pneumonia as per protocol (see link), otherwise with microbiological 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal advice only Piperacillin with tazobactam Restricted penicillins->PIPERACILLIN WITH TAZOBACTAM HAP protocol

5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal Timentin Restricted If no supply of Tazocin penicillins->TICARCILLIN WITH CLAVULANIC ACID

PIVMECILLINAM HYDROCHLORIDE Restricted 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.5 Mecillinams Treatment of uncomplicated ESBL UTI only

O&G wards, not to medical wards except with microbiological advice 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and CEFALEXIN Restricted N.B. the tablets are non-formulary Notes other beta-lactams->5.1.2.1 Cephalosporins The tablets are non-formulary

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and Surgical and O&G wards, not to medical wards except with microbiological advice Notes Cefalexin Restricted other beta-lactams->5.1.2.1 Cephalosporins->CEFALEXIN The tablets are non-formulary

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and CEFIXIME Restricted GUM – treatment of gonorrhoea according to BAASH guidelines other beta-lactams->5.1.2.1 Cephalosporins

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and CEFOTAXIME Restricted Pregnant women and paediatrics only, or on Microbiology advice other beta-lactams->5.1.2.1 Cephalosporins

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and CEFTAZIDIME Restricted On Microbiology advice only other beta-lactams->5.1.2.1 Cephalosporins

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and For meningitis, pelvic inﬂammatory disease, outpatient treatment of cellulitis, or on Microbiology advice only CEFTRIAXONE Restricted other beta-lactams->5.1.2.1 Cephalosporins DTC oﬃcer decision

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and Injection: sub-conjunctival use only, in accordance with ophthalmology guidelines. For intra-cameral CEFUROXIME Restricted other beta-lactams->5.1.2.1 Cephalosporins injections see Aprokam ®

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and For the treatment of severe infection in penicillin-allergic patients with diabetic foot ulcers after Microbiology advice ERTAPENEM Restricted other beta-lactams->5.1.2.2 Carbapenems DTC oﬃcer decision

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and IMIPENEM WITH CILASTATIN Restricted on microbiological advice only other beta-lactams->5.1.2.2 Carbapenems

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and MEROPENEM Restricted on microbiological advice only other beta-lactams->5.1.2.2 Carbapenems

5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and Meropenem Restricted on microbiological advice only other beta-lactams->5.1.2.2 Carbapenems->MEROPENEM

DEMECLOCYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines Hyponatraemia, see Chapter 6.5.2 HYDROCHLORIDE

DOXYCYCLINE On Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines

Doxycycline On Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE

MINOCYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines Named patient for pyoderma gangrenosum otherwise only on microbiological advice

Minocycline Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines->MINOCYCLINE Named patient for pyoderma gangrenosum otherwise only on microbiological advice

OXYTETRACYCLINE On Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines

Oxytetracycline On Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->OXYTETRACYCLINE

GENTAMICIN On Formulary 5.1 Antibacterial drugs->5.1.4 Aminoglycosides also preservative-free preparation

Gentamicin On Formulary 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN

AMIKACIN Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides On microbiological advice for resistant infections

Amikacin Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->AMIKACIN On microbiological advice for resistant infections

NEOMYCIN SULFATE Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides Gastroenterology

Neomycin Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->NEOMYCIN SULFATE Gastroenterology

TOBRAMYCIN Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides Cystic ﬁbrosis

5.1 Antibacterial drugs->5.1.4 Tobramycin Restricted Cystic ﬁbrosis Aminoglycosides->TOBRAMYCIN->Parenteral

GUM Consultant paediatricians in children with chronic respiratory problems,in line with Trust antimicrobial policy for children AZITHROMYCIN Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides Clamydial conjunctivitis Respiratory consultants for the prophylaxis of exacerbations of bronchiectasis in patients who are logged at treatment start and assessed by Microbiology at the end of 6 months treatment

Zedbac® Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN For IV use if oral clarithromycin is unsuitable and IV clarithromycin is unavailable

CLARITHROMYCIN On Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides Clarithromycin On Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN

Modiﬁed release On Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN

5.1 Antibacterial drugs->5.1.5 Klaricid XL® On Formulary Macrolides->CLARITHROMYCIN->Modiﬁed release

GP use and in cases where clarithromycin is contraindicated, e.g. pregnancy, breastfeeding ERYTHROMYCIN Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides Motility agent

GP use and in cases where clarifromycin is contraindicated, e.g. pregnancy, breastfeeding Erythromycin Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Motility agent

Erythromycin Ethyl Succinate Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN GP use and in cases where clarifromycin is contraindicated, e.g. pregnancy, breastfeeding

Erythromycin Lactobionate Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN GP use and in cases where clarifromycin is contraindicated, e.g. pregnancy, breastfeeding

Clindamycin suspension 75mg/5ml for children with penicillin allergy CLINDAMYCIN On Formulary 5.1 Antibacterial drugs->5.1.6 Clindamycin DTC oﬃcer decision

Clindamycin On Formulary 5.1 Antibacterial drugs->5.1.6 Clindamycin->CLINDAMYCIN

5.1 Antibacterial drugs->5.1.7 Some other on microbiological advice only ( injection only). The capsules are non-formulary CHLORAMPHENICOL Restricted antibacterials->Chloramphenicol DTC oﬃcer decision

5.1 Antibacterial drugs->5.1.7 Some other Kemicetine® Restricted on microbiological advice antibacterials->Chloramphenicol->CHLORAMPHENICOL

5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Fusidic Tablets only SODIUM FUSIDATE On Formulary acid DTC oﬃcer decision

5.1 Antibacterial drugs->5.1.7 Some other Injection only. Injection may be used orally. VANCOMYCIN On Formulary antibacterials->Glycopeptides DTC oﬃcer decision

5.1 Antibacterial drugs->5.1.7 Some other Vancomycin Restricted Capsules are for patients with C.diﬀ who are resistant to metronidazole, on discharge or as outpatients only! antibacterials->Glycopeptides->VANCOMYCIN

5.1 Antibacterial drugs->5.1.7 Some other TEICOPLANIN Restricted on microbiological advice only antibacterials->Glycopeptides

5.1 Antibacterial drugs->5.1.7 Some other DAPTOMYCIN Restricted Restricted to use in outpatients treated for MRSA and after approval from Microbiology antibacterials->Daptomycin

on microbiological advice only This is a black triangle drug, please report any adverse drug reaction which you SUSPECT with this drug, however trivial the LINEZOLID Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Linezolid reaction appears Electronic yellow card

COLISTIMETHATE SODIUM Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Polymyxins Cystic ﬁbrosis otherwise on microbiological advice only

5.1 Antibacterial drugs->5.1.7 Some other Colomycin® Restricted Cystic ﬁbrosis otherwise on microbiological advice only antibacterials->Polymyxins->COLISTIMETHATE SODIUM

RIFAXIMIN NICE-approved 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Rifaximin

First-line for mild/moderate severity HAP, also for spontaneous bacterial peritonitis prophylaxis/treatment, CO-TRIMOXAZOLE Restricted 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim ocular toxoplasmosis, Pneumocystis jiroveci pneumonia

5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->CO- Co-trimoxazole Restricted for PCP, second line treatment of ocular toxoplasmosis with microbiological approval TRIMOXAZOLE

TRIMETHOPRIM On Formulary 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim

5.1 Antibacterial drugs->5.1.8 Sulfonamides and Trimethoprim On Formulary trimethoprim->TRIMETHOPRIM

ETHAMBUTOL HYDROCHLORIDE On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs ethambutol suspension restricted to consultant paediatricians for use in patients who cannot take the tablets

5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->ETHAMBUTOL Ethambutol On Formulary HYDROCHLORIDE

ISONIAZID On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs

Isoniazid On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->ISONIAZID

PYRAZINAMIDE Restricted 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Tuberculosis

named patient with microbiological advice only RIFABUTIN Restricted 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs DTC oﬃcer decision

RIFAMPICIN On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs

Rifampicin On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->RIFAMPICIN

5.1 Antibacterial drugs->5.1.9 Antituberculosis Rifater® On Formulary drugs->RIFAMPICIN->Combined preparations

5.1 Antibacterial drugs->5.1.9 Antituberculosis Voractiv® On Formulary drugs->RIFAMPICIN->Combined preparations

RIFAMPICIN WITH ISONIAZID On Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs

DAPSONE Restricted 5.1 Antibacterial drugs->5.1.10 Antileprotic drugs Skin and GUM consultants, and for second-line prophylaxis of Pneumocystis jiroveci pneumonia

Dapsone Restricted 5.1 Antibacterial drugs->5.1.10 Antileprotic drugs->DAPSONE Skin consultants and GUM consultants only

METRONIDAZOLE On Formulary 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole

5.1 Antibacterial drugs->5.1.11 Metronidazole and Metronidazole On Formulary tinidazole->METRONIDAZOLE

CIPROFLOXACIN On Formulary 5.1 Antibacterial drugs->5.1.12 Quinolones 750mg tablets are not stocked

Ciproﬂoxacin On Formulary 5.1 Antibacterial drugs->5.1.12 Quinolones->CIPROFLOXACIN

LEVOFLOXACIN Restricted 5.1 Antibacterial drugs->5.1.12 Quinolones by microbiology approval for second line use in line with the inﬂuenza policy only

For multi-resistant TB follow link on DTC web page Tuberculosis MOXIFLOXACIN Restricted 5.1 Antibacterial drugs->5.1.12 Quinolones

DTC Oﬃcer decision

NITROFURANTOIN On Formulary 5.1 Antibacterial drugs->5.1.13 Urinary-tract infections

5.1 Antibacterial drugs->5.1.13 Urinary-tract Nitrofurantoin On Formulary infections->NITROFURANTOIN

FLUCONAZOLE On Formulary 5.2 Antifungal drugs->5.2.1 Triazole antifungals

Fluconazole On Formulary 5.2 Antifungal drugs->5.2.1 Triazole antifungals->FLUCONAZOLE

ITRACONAZOLE Restricted 5.2 Antifungal drugs->5.2.1 Triazole antifungals on microbiological advice only

Resistant invasive fungal infections after microbiology advice VORICONAZOLE Restricted 5.2 Antifungal drugs->5.2.1 Triazole antifungals DTC oﬃcer decision

AMPHOTERICIN On Formulary 5.2 Antifungal drugs->5.2.3 Polyene antifungals

Fungizone® Restricted 5.2 Antifungal drugs->5.2.3 Polyene antifungals->AMPHOTERICIN for intravitreal injection only

Lipid formulations Restricted 5.2 Antifungal drugs->5.2.3 Polyene antifungals->AMPHOTERICIN On microbiological advice only

5.2 Antifungal drugs->5.2.3 Polyene antifungals->AMPHOTERICIN->Lipid AmBisome® Restricted on microbiological advice only formulations

CASPOFUNGIN Restricted 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals Treatment of febrile neutropenia unless evidence of aspergillosis in which case use voriconazole

MICAFUNGIN Restricted 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals On Microbiology advice only

GRISEOFULVIN Restricted 5.2 Antifungal drugs->5.2.5 Other antifungals Dermatological infection where topical treatment has failed

Griseofulvin Restricted 5.2 Antifungal drugs->5.2.5 Other antifungals->GRISEOFULVIN Dermatological infection where topical treatment has failed TERBINAFINE Restricted 5.2 Antifungal drugs->5.2.5 Other antifungals Dermatology

Terbinaﬁne Restricted 5.2 Antifungal drugs->5.2.5 Other antifungals->TERBINAFINE Dermatology, otherwise with microbiological advice only

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse ABACAVIR Restricted HIV infection transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Trizivir® Restricted transcriptase inhibitors->ABACAVIR->With lamivudine and zidovudine

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse With lamivudine and dolutegravir Restricted Treatment of HIV in patiients in accordance with NHSE gudiance transcriptase inhibitors->ABACAVIR

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse DIDANOSINE Restricted HIV infection transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse EMTRICITABINE Restricted HIV infection transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Emtriva® Restricted transcriptase inhibitors->EMTRICITABINE

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse LAMIVUDINE Restricted HIV, Hepatitis B transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse STAVUDINE Restricted transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse TENOFOVIR DISOPROXIL Restricted HIV and treatment by Consultant Gastroenterologists in accordance with NICE guidelines and criteria transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse With emtricitabine Restricted Treatment of HIV transcriptase inhibitors->TENOFOVIR DISOPROXIL

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Truvada® Restricted HIV infection transcriptase inhibitors->TENOFOVIR DISOPROXIL->With emtricitabine

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse With efavirenz and emtricitabine Restricted Treatment of HIV transcriptase inhibitors->TENOFOVIR DISOPROXIL

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse With emtricitabine and rilpivirine Restricted HIV infection transcriptase inhibitors->TENOFOVIR DISOPROXIL

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Eviplera® Restricted transcriptase inhibitors->TENOFOVIR DISOPROXIL->With emtricitabine HIV infection and rilpivirine

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Stribild® Restricted transcriptase inhibitors->TENOFOVIR DISOPROXIL->With cobicistat, HIV infection in exceptional patients - not for routine use elvitegravir, and emtricitabine

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse ZIDOVUDINE Restricted DTC oﬃcer decision transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse Combivir® Restricted transcriptase inhibitors->ZIDOVUDINE->With lamivudine

ATAZANAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors

DARUNAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors HIV infection

FOSAMPRENAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors

the oral liquid is not in the formulary LOPINAVIR WITH RITONAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors DTC oﬃcer decision

5.3 Antiviral drugs->5.3.1 HIV infection->Protease Kaletra® Restricted inhibitors->LOPINAVIR WITH RITONAVIR

RITONAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors

TIPRANAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors HIV infection

5.3 Antiviral drugs->5.3.1 HIV infection->Non-nucleoside reverse EFAVIRENZ Restricted Treatment of HIV transcriptase inhibitors

5.3 Antiviral drugs->5.3.1 HIV infection->Non-nucleoside reverse NEVIRAPINE Restricted HIV infection transcriptase inhibitors

DOLUTEGRAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals Treatment of HIV in patiients in accordance with NHSE gudiance

5.3 Antiviral drugs->5.3.1 HIV infection->Other With abacavir and lamivudine Restricted Treatment of HIV in patiients in accordance with NHSE gudiance antiretrovirals->DOLUTEGRAVIR

ENFUVIRTIDE Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals

MARAVIROC Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals HIV infection

RALTEGRAVIR Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals HIV infection

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes ACICLOVIR On Formulary simplex and varicella–zoster infection

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes Aciclovir On Formulary simplex and varicella–zoster infection->ACICLOVIR

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes GUM, treatment of acute retinal necrosis by Miss Rauz, Miss Stavrou and Prof Murray only VALACICLOVIR Restricted simplex and varicella–zoster infection DTC oﬃcer decision

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.2 GANCICLOVIR Restricted on microbiological advice only Cytomegalovirus infection

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.2 FOSCARNET SODIUM Restricted Treatment of CMV only Cytomegalovirus infection

5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.2 VALGANCICLOVIR Restricted GUM consultants, otherwise named patient Cytomegalovirus infection

ADEFOVIR DIPIVOXIL Restricted 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.1 Chronic hepatitis B Treatment in accordance with NICE guidelines and criteria

ENTECAVIR Restricted 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.1 Chronic hepatitis B Treatment by Consultant Gastroenterologists in accordance with NICE guidelines and criteria

BOCEPREVIR Restricted 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C Please gain Blueteq approval before prescribing

DACLATASVIR Restricted 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C Please gain Blueteq approval before prescribing

SIMEPREVIR Restricted 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C For patients who fulﬁl the criteria set out by NHS England

SOFOSBUVIR NICE-approved 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C Please gain Blueteq approval prior to prescribing

Boceprevir is ﬁrst-line. Telaprevir will be made available in the Trust for patients who meet the NICE criteria if a clinician TELAPREVIR NICE-approved 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C requests its use via this pro forma

OSELTAMIVIR Restricted 5.3 Antiviral drugs->5.3.4 Inﬂuenza After Microbiology advice in accordance with the NICE guidelines and criteria

Oseltamivir is the preferred treatment in accordance with the NICE guidelines and criteria, except for pregnant women ZANAMIVIR Restricted 5.3 Antiviral drugs->5.3.4 Influenza suspected of having influenza A H1N1 (swine flu)

Can only be prescribed if the funding has been agreed beforehand with the PCT. Patients should meet the criteria laid down PALIVIZUMAB Restricted 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus in the Commissioning document Patients with agreed funding

RIBAVIRIN Restricted 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus Paediatrics and treatment in accordance with NICE guidelines and criteria

CHLOROQUINE On Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine

Meﬂoquine Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials on microbiological advice only

MEFLOQUINE Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Meﬂoquine on microbiological advice only

Primaquine Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials Malaria and GUM consultants

PRIMAQUINE Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Primaquine Malaria and GUM consultants

5.4 Antiprotozoal drugs->5.4.1 Primaquine Restricted Malaria and GUM consultants Antimalarials->Primaquine->PRIMAQUINE PROGUANIL HYDROCHLORIDE Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil Maleria

PROGUANIL HYDROCHLORIDE WITH Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil on microbiological advice only ATOVAQUONE

PYRIMETHAMINE WITH Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Pyrimethamine Malaria SULFADOXINE

Quinine Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials

QUININE On Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine

Quinine Sulfate On Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine->QUININE

Tetracyclines Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials

DOXYCYCLINE On Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Tetracyclines

METRONIDAZOLE On Formulary 5.4 Antiprotozoal drugs->5.4.2 Amoebicides

MEPACRINE HYDROCHLORIDE Restricted 5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs named patient

5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs->MEPACRINE Mepacrine Hydrochloride Restricted named patient HYDROCHLORIDE

PENTAMIDINE ISETIONATE Restricted 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia second line for patients with PCP after treatment with co-trimoxazole has failed

MEBENDAZOLE On Formulary 5.5 Anthelmintics->5.5.1 Drugs for threadworms

Mebendazole On Formulary 5.5 Anthelmintics->5.5.1 Drugs for threadworms->MEBENDAZOLE

Taenicides Restricted 5.5 Anthelmintics->5.5.3 Drugs for tapeworm infections named patient

Hydatid disease Restricted 5.5 Anthelmintics->5.5.3 Drugs for tapeworm infections named patient

named patient Schistosomicides Restricted 5.5 Anthelmintics DTC oﬃcer decision

Filaricides Restricted 5.5 Anthelmintics named patient

Drugs for cutaneous larva named patient Restricted 5.5 Anthelmintics migrans DTC oﬃcer decision

Drugs for strongyloidiasis Restricted 5.5 Anthelmintics named patient

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting Actrapid® Restricted Only for use in in-patients insulins->INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting INSULIN ASPART Restricted second line as per NICE guidelines insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting INSULIN GLULISINE On Formulary insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting Apidra® On Formulary insulins->INSULIN GLULISINE

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting INSULIN LISPRO Restricted Consultants in medicine and paediatrics with special interest in Diabetes and Endocrinology insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.1 Short-acting Humalog® Restricted KwikPen or cartridges, for second-line use insulins->INSULIN LISPRO

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and INSULIN DETEMIR Restricted FlexPen ®, InnoLet ® and cartridges currently available, but will become non-formulary from 1st October 2012 long-acting insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and INSULIN GLARGINE On Formulary long-acting insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Lantus® On Formulary long-acting insulins->INSULIN GLARGINE

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and ISOPHANE INSULIN On Formulary long-acting insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Insulatard® Restricted InnoLet ® only, for second-line use. The cartridges are non-formulary long-acting insulins->ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Humulin I® Restricted Second-line use long-acting insulins->ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Insuman® Basal On Formulary ClikSTAR ® or Solostar ® long-acting insulins->ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and BIPHASIC INSULIN LISPRO Restricted Second line as per NICE guidelines long-acting insulins->Biphasic insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Humalog® Mix50 Restricted KwikPen or cartridges, for second-line use long-acting insulins->Biphasic insulins->BIPHASIC INSULIN LISPRO

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and BIPHASIC ISOPHANE INSULIN On Formulary DTC oﬃcer decision long-acting insulins->Biphasic insulins

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Humulin M3® Restricted long-acting insulins->Biphasic insulins->BIPHASIC ISOPHANE Second-line use INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Insuman® Comb 15 On Formulary long-acting insulins->Biphasic insulins->BIPHASIC ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Insuman® Comb 25 On Formulary long-acting insulins->Biphasic insulins->BIPHASIC ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.1 Insulins->6.1.1.2 Intermediate- and Insuman® Comb 50 On Formulary long-acting insulins->Biphasic insulins->BIPHASIC ISOPHANE INSULIN->Human sequence

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 GLICLAZIDE On Formulary DTC oﬃcer decision Sulfonylureas

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Gliclazide On Formulary Sulfonylureas->GLICLAZIDE

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 GLIMEPIRIDE Restricted Diabetologists Sulfonylureas

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 TOLBUTAMIDE Restricted Second line after Gliclazide Sulfonylureas

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Tolbutamide Restricted Second line after Gliclazide Sulfonylureas->TOLBUTAMIDE

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 METFORMIN HYDROCHLORIDE On Formulary DTC oﬃcer decision Biguanides

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 Metformin On Formulary Biguanides->METFORMIN HYDROCHLORIDE

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 Modiﬁed release Restricted For initiation by diabetologists, Dr E. Hughes and Dr Basu as second line agents to aid compliance in diabetic control. Biguanides->METFORMIN HYDROCHLORIDE

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other ALOGLIPTIN Restricted Consultant diabetologists, and GPs with a special interest. antidiabetic drugs

Canagliflozin will be made available in the Trust for patients who meet the NICE criteria if a clinician 6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other CANAGLIFLOZIN NICE-approved requests its use via this pro forma antidiabetic drugs

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other Dapagliﬂozin will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this DAPAGLIFLOZIN NICE-approved antidiabetic drugs pro forma 6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other EXENATIDE Restricted Consultant diabetologists and GPs with a special interest in diabetes - add-on therapy to prevent introduction of insulin antidiabetic drugs

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other Modiﬁed release Restricted Consultant diabetologists and GPs with a special interest in diabetes antidiabetic drugs->EXENATIDE

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other Bydureon® Restricted Consultant diabetologists and GPs with a special interest in diabetes antidiabetic drugs->EXENATIDE->Modiﬁed release

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other LINAGLIPTIN Restricted Consultant diabetologists, and GPs with a special interest. antidiabetic drugs

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other Exenatide is preferred to liraglutide, however, liraglutide will be made available in the Trust for patients who meet the NICE LIRAGLUTIDE NICE-approved antidiabetic drugs criteria if a clinician requests its use via this pro forma

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other PIOGLITAZONE Restricted Consultants, in line with NICE guidance antidiabetic drugs

6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other REPAGLINIDE Restricted Consultants, in line with NICE guidance antidiabetic drugs

Diabetic ketoacidosis Restricted 6.1 Drugs used in diabetes Hypostop gel is for use in A&E, ITU and Paediatrics only

GLUCAGON On Formulary 6.1 Drugs used in diabetes->6.1.4 Treatment of hypoglycaemia

6.1 Drugs used in diabetes->6.1.4 Treatment of GlucaGen® HypoKit On Formulary hypoglycaemia->GLUCAGON

6.1 Drugs used in diabetes->6.1.4 Treatment of Named patients, hypoglycaemia DIAZOXIDE Restricted hypoglycaemia->Chronic hypoglycaemia DTC oﬃcer decision

LEVOTHYROXINE SODIUM On Formulary 6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid hormones DTC oﬃcer decision

6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid Levothyroxine On Formulary hormones->LEVOTHYROXINE SODIUM

LIOTHYRONINE SODIUM On Formulary 6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid hormones

CARBIMAZOLE On Formulary 6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs

IODINE AND IODIDE On Formulary 6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs

6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs->IODINE Aqueous Iodine Oral Solution On Formulary AND IODIDE

PROPYLTHIOURACIL On Formulary 6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs

6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid Propylthiouracil On Formulary drugs->PROPYLTHIOURACIL

FLUDROCORTISONE ACETATE On Formulary 6.3 Corticosteroids->6.3.1 Replacement therapy

BETAMETHASONE On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy

DEXAMETHASONE On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy

Dexamethasone On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy->DEXAMETHASONE

HYDROCORTISONE On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy DTC oﬃcer decision

Tablets are restricted for the treatment of relapsing multiple sclerosis only METHYLPREDNISOLONE Restricted 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy DTC oﬃcer decision

PREDNISOLONE On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy

Prednisolone On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy->PREDNISOLONE Plain tablets disperse in water. The soluble tablets are restricted to Children's wards and the Skin ward.

TRIAMCINOLONE On Formulary 6.3 Corticosteroids->6.3.2 Glucocorticoid therapy

6.4 Sex hormones->6.4.1 Female sex hormones and their OESTROGENS FOR HRT Restricted modulators->6.4.1.1 Oestrogens and HRT

Conjugated oestrogens with 6.4 Sex hormones->6.4.1 Female sex hormones and their Restricted progestogen modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their Prempak-C® Restricted modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR Gynaecology HRT->Conjugated oestrogens with progestogen

6.4 Sex hormones->6.4.1 Female sex hormones and their Estradiol with progestogen On Formulary modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their Climagest® On Formulary modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR Gynaecologists HRT->Estradiol with progestogen

6.4 Sex hormones->6.4.1 Female sex hormones and their Conjugated oestrogens only On Formulary modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their Premarin® On Formulary modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT->Conjugated oestrogens only

6.4 Sex hormones->6.4.1 Female sex hormones and their Estradiol only Restricted Restricted to Gynaecologists only modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their Evorel® Restricted modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR Gynaecologists HRT->Estradiol only

6.4 Sex hormones->6.4.1 Female sex hormones and their TIBOLONE Restricted Consultant Gynaecologists, Endocrinology modulators->6.4.1.1 Oestrogens and HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their Ethinylestradiol Restricted modulators->6.4.1.1 Oestrogens and HRT

6.4 Sex hormones->6.4.1 Female sex hormones and their ETHINYLESTRADIOL Restricted Consultants in medicine and paediatrics with special interest in Diabetes and Endocrinolog modulators->6.4.1.1 Oestrogens and HRT->Ethinylestradiol

6.4 Sex hormones->6.4.1 Female sex hormones and their Ethinylestradiol Restricted modulators->6.4.1.1 Oestrogens and Consultants in medicine and paediatrics with special interest in Diabetes and Endocrinolog HRT->Ethinylestradiol->ETHINYLESTRADIOL

6.4 Sex hormones->6.4.1 Female sex hormones and their MEDROXYPROGESTERONE ACETATE On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators

6.4 Sex hormones->6.4.1 Female sex hormones and their Provera® On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators->MEDROXYPROGESTERONE ACETATE

6.4 Sex hormones->6.4.1 Female sex hormones and their NORETHISTERONE On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators

6.4 Sex hormones->6.4.1 Female sex hormones and their Norethisterone On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators->NORETHISTERONE

6.4 Sex hormones->6.4.1 Female sex hormones and their PROGESTERONE On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators

6.4 Sex hormones->6.4.1 Female sex hormones and their Cyclogest® On Formulary modulators->6.4.1.2 Progestogens and progesterone receptor modulators->PROGESTERONE

6.4 Sex hormones->6.4.1 Female sex hormones and their ULIPRISTAL ACETATE Restricted modulators->6.4.1.2 Progestogens and progesterone receptor Consultant Obstetricians for patients awaiting ﬁbroid surgery modulators->Progesterone receptor modulators

6.4 Sex hormones->6.4.2 Male sex hormones and Intramuscular On Formulary DTC oﬃcer decision antagonists->TESTOSTERONE AND ESTERS 6.4 Sex hormones->6.4.2 Male sex hormones and Sustanon 250® On Formulary antagonists->TESTOSTERONE AND ESTERS->Intramuscular

6.4 Sex hormones->6.4.2 Male sex hormones and Tostran® On Formulary antagonists->TESTOSTERONE AND ESTERS->Transdermal preparations

6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti- Cyproterone acetate On Formulary androgens

6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti- CYPROTERONE ACETATE On Formulary androgens->Cyproterone acetate

6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti- Cyproterone Acetate On Formulary androgens->Cyproterone acetate->CYPROTERONE ACETATE

6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti- FINASTERIDE On Formulary DTC oﬃcer decision androgens->Dutasteride and ﬁnasteride

Anabolic steroids Restricted 6.4 Sex hormones Oxandrolone on a named patient basis

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 CLOMIFENE CITRATE Restricted Hypothalamic and anterior pituitary hormones and Gynaecologists anti-oestrogens->Anti-oestrogens

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Clomifene Restricted Hypothalamic and anterior pituitary hormones and Gynaecologists anti-oestrogens->Anti-oestrogens->CLOMIFENE CITRATE

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 The depot injection is restricted to Conszultant Paediatricians for the treatment of infantile spasams TETRACOSACTIDE On Formulary Hypothalamic and anterior pituitary hormones and DTC oﬃcer decision anti-oestrogens->Anterior pituitary hormones->Corticotrophins

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and Synacthen® On Formulary anti-oestrogens->Anterior pituitary hormones->Corticotrophins->TETRACOSACTIDE

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and Synacthen Depot® Restricted to Conszultant Paediatricians for the treatment of infantile spasams anti-oestrogens->Anterior pituitary hormones->Corticotrophins->TETRACOSACTIDE

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 CHORIONIC GONADOTROPHIN On Formulary Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones->Gonadotrophins

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 HUMAN MENOPAUSAL On Formulary Hypothalamic and anterior pituitary hormones and GONADOTROPHINS anti-oestrogens->Anterior pituitary hormones->Gonadotrophins

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 SOMATROPIN NICE-approved Hypothalamic and anterior pituitary hormones and For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. anti-oestrogens->Anterior pituitary hormones->Growth hormone For all other patients please complete this pro forma.

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 GONADORELIN On Formulary Hypothalamic and anterior pituitary hormones and anti-oestrogens->Hypothalamic hormones

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 DESMOPRESSIN On Formulary Posterior pituitary hormones and antagonists->Posterior pituitary hormones

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Desmopressin acetate On Formulary Posterior pituitary hormones and antagonists->Posterior pituitary hormones->DESMOPRESSIN

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 TERLIPRESSIN ACETATE Restricted Posterior pituitary hormones and antagonists->Posterior pituitary ITU, Gastroenterology hormones

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 VASOPRESSIN Restricted Posterior pituitary hormones and antagonists->Posterior pituitary ITU, Gastroenterology hormones

6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Synthetic vasopressin Restricted Posterior pituitary hormones and antagonists->Posterior pituitary ITU, Gastroenterology and Gynaecology hormones->VASOPRESSIN

CALCITONIN 6.6 Drugs aﬀecting bone metabolism->6.6.1 Calcitonin and only use injection, Oncology, Endocrinology Restricted (SALMON)/SALCATONIN parathyroid hormone DTC oﬃcer decision

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 6.6 Drugs aﬀecting bone metabolism->6.6.1 Calcitonin and TERIPARATIDE Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. parathyroid hormone

For all other patients please complete this pro forma.

6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and ALENDRONIC ACID On Formulary other drugs aﬀecting bone metabolism->Bisphosphonates

Bonviva injection 3mg/ml Initiation by Consultant Rheumatologists in patients with osteoporosis, who cannot take an oral bisphosphonates. 6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and IBANDRONIC ACID Restricted other drugs affecting bone metabolism->Bisphosphonates The tablets are non-formulary DTC officer decision

6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and PAMIDRONATE DISODIUM On Formulary other drugs aﬀecting bone metabolism->Bisphosphonates

6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and Pamidronate disodium On Formulary other drugs aﬀecting bone metabolism->Bisphosphonates->PAMIDRONATE DISODIUM

6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and RISEDRONATE SODIUM Restricted second line after alendronic acid other drugs aﬀecting bone metabolism->Bisphosphonates

6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and SODIUM CLODRONATE On Formulary other drugs aﬀecting bone metabolism->Bisphosphonates

MRC myeloma trial, use in metastatic prostate cancer and myeloma, and by Consultant Rheumatologists for patients unable 6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and to take oral bisphosphonates. ZOLEDRONIC ACID Restricted other drugs aﬀecting bone metabolism->Bisphosphonates Only the generic product is stocked. All prescriptions for Aclasta ® will be switched to the generic product.

Denosumab will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this 6.6 Drugs aﬀecting bone metabolism->6.6.2 Bisphosphonates and pro forma DENOSUMAB NICE-approved other drugs aﬀecting bone metabolism->Denosumab N .B. the MHRA's Drug Safety Update in February 2013

6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and Rheumatology and Geriatrics in accordance with NICE guidance STRONTIUM RANELATE Restricted other drugs affecting bone metabolism->Strontium ranelate DTC officer link

6.7 Other endocrine drugs->6.7.1 Bromocriptine and other suppression of lactation only BROMOCRIPTINE Restricted dopaminergic drugs DTC oﬃcer decision

6.7 Other endocrine drugs->6.7.1 Bromocriptine and other Consultant gynaecologists and endocrinology, (it is also allowed for Neurologists and Parkinson's disease second-line noting CABERGOLINE Restricted dopaminergic drugs MHRA guidance - see chapter 4)

Gynaecologists, Dermatologists DANAZOL Restricted 6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting gonadotrophins DTC oﬃcer decision

6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting Danazol Restricted Gynaecologists, Dermatologists gonadotrophins->DANAZOL

Gonadorelin analogues Restricted 6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting gonadotrophins see Chapter 8

6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting 3.6 mg - shared care with GP's --- GOSERELIN Restricted gonadotrophins->Gonadorelin analogues 10.8 mg - for use at prostate clinic only 6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting LEUPRORELIN ACETATE Restricted For oncological treatment of those experienced, and in Gynaecology gonadotrophins->Gonadorelin analogues

6.7 Other endocrine drugs->6.7.2 Drugs aﬀecting TRIPTORELIN Restricted For use in precocious puberty only gonadotrophins->Gonadorelin analogues

METYRAPONE Restricted 6.7 Other endocrine drugs->6.7.3 Metyrapone Consultant endocrinologists only

CARBOPROST On Formulary 7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics

DINOPROSTONE On Formulary 7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics The vaginal tablets (Prostin E2 ®) are non-formulary

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and Propess® On Formulary oxytocics->DINOPROSTONE

ERGOMETRINE MALEATE On Formulary 7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and Ergometrine On Formulary Injection only oxytocics->ERGOMETRINE MALEATE

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and With oxytocin Restricted Obstetrics oxytocics->ERGOMETRINE MALEATE

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and Syntometrine® Restricted Obstetrics oxytocics->ERGOMETRINE MALEATE->With oxytocin

GEMEPROST On Formulary 7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and Gemeprost On Formulary oxytocics->GEMEPROST

OXYTOCIN On Formulary 7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics

7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and With ergometrine Restricted Obstetrics oxytocics->OXYTOCIN

MIFEPRISTONE Restricted 7.1 Drugs used in obstetrics->7.1.2 Mifepristone Obstetrics

ATOSIBAN Restricted 7.1 Drugs used in obstetrics->7.1.3 Myometrial relaxants->Atosiban Consultant obstetricians only

7.1 Drugs used in obstetrics->7.1.3 Myometrial relaxants->Beta2 TERBUTALINE SULFATE Restricted For hyperstimulation of the uterus following induction of labour agonists

7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for Ortho-Gynest® On Formulary vaginal and vulval changes->Topical HRT for vaginal atrophy->OESTROGENS, TOPICAL

7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for Ovestin® On Formulary vaginal and vulval changes->Topical HRT for vaginal atrophy->OESTROGENS, TOPICAL

7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for Vagifem® On Formulary vaginal and vulval changes->Topical HRT for vaginal atrophy->OESTROGENS, TOPICAL

7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and Clotrimazole On Formulary vulval infections->Fungal infections->PREPARATIONS FOR VAGINAL AND VULVAL CANDIDIASIS

7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and Dalacin® On Formulary vulval infections->Other infections->PREPARATIONS FOR OTHER VAGINAL INFECTIONS

7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and Zidoval® On Formulary vulval infections->Other infections->PREPARATIONS FOR OTHER VAGINAL INFECTIONS

7.3 Contraceptives->7.3.1 Combined hormonal Logynon® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low GUM and standard strength)->Ethinylestradiol with Levonorgestrel

7.3 Contraceptives->7.3.1 Combined hormonal Microgynon 30® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low GUM Clinic and standard strength)->Ethinylestradiol with Levonorgestrel

7.3 Contraceptives->7.3.1 Combined hormonal Brevinor® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low GUM and standard strength)->Ethinylestradiol with Norethisterone

7.3 Contraceptives->7.3.1 Combined hormonal Norimin® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low Community directorate only and standard strength)->Ethinylestradiol with Norethisterone

7.3 Contraceptives->7.3.1 Combined hormonal Cilest® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low Community directorate only and standard strength)->Ethinylestradiol with Norgestimate

7.3 Contraceptives->7.3.1 Combined hormonal Mercilon® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Desogestrel

7.3 Contraceptives->7.3.1 Combined hormonal Marvelon® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low Community directorate only and standard strength)->Ethinylestradiol with Desogestrel

7.3 Contraceptives->7.3.1 Combined hormonal Yasmin® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low Community directorate only and standard strength)->Ethinylestradiol with Drospirenone

7.3 Contraceptives->7.3.1 Combined hormonal Femodene® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Oral (low Community directorate only and standard strength)->Ethinylestradiol with Gestodene

7.3 Contraceptives->7.3.1 Combined hormonal contraceptives->COMBINED HORMONAL Evra® Restricted Community directorate only CONTRACEPTIVES->Transdermal (standard strength)->Ethinylestradiol with Norelgestromin

7.3 Contraceptives->7.3.1 Combined hormonal NuvaRing® Restricted contraceptives->COMBINED HORMONAL CONTRACEPTIVES->Vaginal Community directorate only (low strength)->Ethinylestradiol with Etonogestrel

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Cerazette® Restricted Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY Community directorate only CONTRACEPTIVES

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Micronor® Restricted Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY GUM CONTRACEPTIVES

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Noriday® Restricted Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY CONTRACEPTIVES

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.2 Depo-Provera® Restricted Parenteral progestogen-only contraceptives->PARENTERAL Community directorate only PROGESTOGEN-ONLY CONTRACEPTIVES->Injectable preparations

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.2 Nexplanon® Restricted Parenteral progestogen-only contraceptives->PARENTERAL Community directorate only PROGESTOGEN-ONLY CONTRACEPTIVES->Implants

INTRA-UTERINE 7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.3 On Formulary PROGESTOGEN-ONLY SYSTEM Intra-uterine progestogen-only device

7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.3 Mirena® On Formulary Intra-uterine progestogen-only device->INTRA-UTERINE PROGESTOGEN-ONLY SYSTEM

Gygel® Restricted 7.3 Contraceptives->7.3.3 Spermicidal contraceptives Community directorate only 7.3 Contraceptives->7.3.4 Contraceptive devices->Intra-uterine Nova-T® 380 On Formulary devices->INTRA-UTERINE CONTRACEPTIVE DEVICES

7.3 Contraceptives->7.3.5 Emergency contraception->Hormonal LEVONORGESTREL On Formulary methods

7.3 Contraceptives->7.3.5 Emergency contraception->Hormonal Levonelle® 1500 On Formulary methods->LEVONORGESTREL

7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary ALFUZOSIN HYDROCHLORIDE On Formulary retention->Alpha-blockers

7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary Xatral® XL On Formulary retention->Alpha-blockers->ALFUZOSIN HYDROCHLORIDE->Modiﬁed release

7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary DOXAZOSIN On Formulary retention->Alpha-blockers

7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary TAMSULOSIN HYDROCHLORIDE Restricted second line after alfuzosin retention->Alpha-blockers

7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary BETHANECHOL CHLORIDE On Formulary retention->Parasympathomimetics

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary MIRABEGRON NICE-approved Mirabegron will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this pro forma frequency, enuresis, and incontinence->Urinary incontinence

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary patches are restricted to patient intolerant to oral oxybutynin OXYBUTYNIN HYDROCHLORIDE On Formulary frequency, enuresis, and incontinence->Urinary incontinence DTC oﬃcer decision

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary Oxybutynin Hydrochloride On Formulary frequency, enuresis, and incontinence->Urinary incontinence->OXYBUTYNIN HYDROCHLORIDE

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary Transdermal preparations Restricted frequency, enuresis, and incontinence->Urinary for use in patients with intolerance to oral oxybutinin only! incontinence->OXYBUTYNIN HYDROCHLORIDE

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary Kentera® Restricted for use in patients with intolerance to oral oxybutinin only! incontinence->OXYBUTYNIN HYDROCHLORIDE->Transdermal preparations

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary PROPIVERINE HYDROCHLORIDE Restricted Urology frequency, enuresis, and incontinence->Urinary incontinence

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary Third-line use by Consultant Urologists or Urogynaecologists strictly in accordance with NICE guidelines SOLIFENACIN SUCCINATE Restricted frequency, enuresis, and incontinence->Urinary incontinence DTC oﬃcer decision

7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary TOLTERODINE TARTRATE On Formulary frequency, enuresis, and incontinence->Urinary incontinence

7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological POTASSIUM CITRATE On Formulary pain->Alkalinisation of urine

7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological Potassium Citrate Mixture BP On Formulary pain->Alkalinisation of urine->POTASSIUM CITRATE

7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological SODIUM CITRATE On Formulary pain->Alkalinisation of urine

7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and GLYCINE On Formulary urological surgery->Urological surgery

7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and Glycine Irrigation Solution On Formulary urological surgery->Urological surgery->GLYCINE

7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and CATHETER PATENCY SOLUTIONS On Formulary urological surgery->Maintenance of indwelling urinary catheters

7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and Chlorhexidine 0.02% On Formulary urological surgery->Maintenance of indwelling urinary catheters->CATHETER PATENCY SOLUTIONS

7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and Sodium chloride 0.9% On Formulary urological surgery->Maintenance of indwelling urinary catheters->CATHETER PATENCY SOLUTIONS

7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile Alprostadil Restricted Urology in accordance with DoH guidelines dysfunction

7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile ALPROSTADIL Restricted Urology in accordance with DoH guidelines dysfunction->Alprostadil

Phosphodiesterase type-5 7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile Restricted inhibitors dysfunction

Urology in accordance with DoH guidelines for erectile dysfunction. 7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile SILDENAFIL Restricted dysfunction->Phosphodiesterase type-5 inhibitors The use of Viagra (25mg, 50mg and 100mg strengths) for pulmonary arterial hypertension is non-formulary.

Urology in accordance with DoH guidelines for erectile dysfunction. 7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile Viagra® Restricted dysfunction->Phosphodiesterase type-5 inhibitors->SILDENAFIL The use of Viagra (25mg, 50mg and 100mg strengths) for pulmonary arterial hypertension is non-formulary.

7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile Papaverine and phentolamine Restricted named patients only dysfunction

8.1 Cytotoxic drugs->Treatment for cytotoxic-induced DEXRAZOXANE Restricted for anthracycline extravasation according to local protocol side-eﬀects->Anthracycline side-eﬀects

8.1 Cytotoxic drugs->Treatment for cytotoxic-induced FOLINIC ACID Restricted side-eﬀects->Chemotherapy-induced mucositis and myelosuppression

8.1 Cytotoxic drugs->Treatment for cytotoxic-induced Calcium Folinate Restricted side-eﬀects->Chemotherapy-induced mucositis and For oncological treatment by those experienced myelosuppression->FOLINIC ACID->Calcium folinate

8.1 Cytotoxic drugs->Treatment for cytotoxic-induced MESNA Restricted For oncological treatment by those experienced side-eﬀects->Urothelial toxicity

Treatment by Consultant Haematologists in accrodance with the NICE guidelines and criteria, or in accordance wih the BENDAMUSTINE HYDROCHLORIDE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs pan-Birmingham network formulary

For oncological treatment by those experienced. BUSULFAN Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

CARMUSTINE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs Treatment in accordance with NICE guidelines and criteria, or in accordance with the pan-Birmingham network formulary

For oncological treatment by those experienced. CHLORAMBUCIL Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

For oncological treatment by those experienced. This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. CYCLOPHOSPHAMIDE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs For further details see the NPSA alert at this link DTC oﬃcer decision

Cyclophosphamide Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs->CYCLOPHOSPHAMIDE For oncological treatment by those experienced

This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. ESTRAMUSTINE PHOSPHATE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs For further details see the NPSA alert at this link

IFOSFAMIDE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs For oncological treatment by those experienced For oncological treatment by those experienced. LOMUSTINE Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

Lomustine Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs->LOMUSTINE For oncological treatment by those experienced

For oncological treatment by those experienced. MELPHALAN Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

For oncological treatment by those experienced. TREOSULFAN Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

Treosulfan Restricted 8.1 Cytotoxic drugs->8.1.1 Alkylating drugs->TREOSULFAN For oncological treatment by those experienced

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic BLEOMYCIN Restricted For oncological treatment by those experienced antibiotics

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Bleomycin Restricted For oncological treatment by those experienced antibiotics->BLEOMYCIN

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic DAUNORUBICIN Restricted For oncological treatment by those experienced antibiotics

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Daunorubicin Restricted For oncological treatment by those experienced antibiotics->DAUNORUBICIN

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic DOXORUBICIN HYDROCHLORIDE Restricted For oncological treatment by those experienced antibiotics

In patients with metastatic breast cancer who fulﬁl the following criteria:

• Over 65 years of age 8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Lipid formulation Restricted • Prior anthracycline exposure in the adjuvant/ neo-adjuvant antibiotics->DOXORUBICIN HYDROCHLORIDE context

• Prior chest wall radiation to the heart

Myocet® is used as an alternative to docetaxel in these patients.

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic ® Myocet® Restricted Myocet is included in the latest pan-Birmingham Cancer Network formulary and will be funded for approved indications antibiotics->DOXORUBICIN HYDROCHLORIDE->Lipid formulation only

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic EPIRUBICIN HYDROCHLORIDE Restricted For oncological treatment by those experienced antibiotics

For oncological treatment by those experienced. 8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. IDARUBICIN HYDROCHLORIDE Restricted antibiotics For further details see the NPSA alert at this link DTC oﬃcer decision

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic For oncological treatment by those experienced or ophthalmology consultants MITOMYCIN Restricted antibiotics DTC oﬃcer decision

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Mitomycin C Kyowa® Restricted For oncological treatment by those experienced or ophthalmology consultants antibiotics->MITOMYCIN

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic MITOXANTRONE Restricted For oncological treatment by those experienced antibiotics

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Mitoxantrone Restricted For oncological treatment by those experienced antibiotics->MITOXANTRONE

8.1 Cytotoxic drugs->8.1.2 Anthracyclines and other cytotoxic Pixantrone will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this PIXANTRONE NICE-approved antibiotics pro forma

AZACITIDINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites Treatment by consultant haematologists in accordance with the NICR guidelines and criteria

For treatment in accordance with NICE guidelines and criteria This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. CAPECITABINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For further details see the NPSA alert at this link DTC oﬃcer decision

CLADRIBINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For oncological treatment by those experienced

In the treatment of ALL in paediatric patients <21 yrs="" who=""> relapsed or are refractory after receiving at least two prior regimens CLOFARABINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites and where there is no other treatment option. Treatment is restricted to patients in whom there is an intention to proceed to stem transplantation and who have had one previous transplant.

CYTARABINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For oncological treatment by those experienced

Cytarabine Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites->CYTARABINE For oncological treatment by those experienced

Treatment in accordance with NICE guidelines and criteria

FLUDARABINE PHOSPHATE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

FLUOROURACIL Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For oncological treatment by those experienced or ophthalmology consultants

Fluorouracil Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites->FLUOROURACIL For oncological treatment by those experienced or ophthalmology consultants

GEMCITABINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites Treatment in accordance with NICE guidelines and criteria

For oncological treatment by those experienced. MERCAPTOPURINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

For oncological treatment, or for immunological therapy by those experienced - only the 2.5mg tablets are stocked. This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. METHOTREXATE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For further details see the NPSA alert at this link The dose is usually weekly NPSA improving compliance with oral methotrexate guidelines

Methotrexate Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites->METHOTREXATE For oncological treatment, or for immunological therapy by those experienced

PEMETREXED Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites Treatment in accordance with NICE guidelines and criteria

This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. TIOGUANINE Restricted 8.1 Cytotoxic drugs->8.1.3 Antimetabolites For further details see the NPSA alert at this link

For oncological treatment by those experienced. ETOPOSIDE Restricted 8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and etoposide This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

Etoposide Restricted 8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and etoposide->ETOPOSIDE For oncological treatment by those experienced

VINBLASTINE SULFATE Restricted 8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and etoposide For oncological treatment by those experienced

8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and Vinblastine Restricted For oncological treatment by those experienced etoposide->VINBLASTINE SULFATE

VINCRISTINE SULFATE Restricted 8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and etoposide For oncological treatment by those experienced

8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and For oncological treatment by those experienced Vincristine Restricted etoposide->VINCRISTINE SULFATE DTC oﬃcer decision NICE - metastatic breast cancer and NSCLC. This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. VINORELBINE Restricted 8.1 Cytotoxic drugs->8.1.4 Vinca alkaloids and etoposide For further details see the NPSA alert at this link The capsules are non-formulary

In the formularly of the Cancer Drugs Fund. The paperwork must be completed before prescription. Usage outside the BEVACIZUMAB Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Bevacizumab indications set out in the CDF is non-formulary

BORTEZOMIB Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Bortezomib Treatment in accordance with NICE guidelines and criteria

CETUXIMAB Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Cetuximab Treatment in accordance with NICE guidelines and criteria

CRISANTASPASE Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Crisantaspase For oncological treatment by those experienced

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Dacarbazine DACARBAZINE Restricted For oncological treatment by those experienced and temozolomide

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Dacarbazine Dacarbazine Restricted For oncological treatment by those experienced and temozolomide->DACARBAZINE

Treatment in accordance with NICE guidelines and criteria 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Dacarbazine TEMOZOLOMIDE Restricted and temozolomide This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

For oncological treatment by those experienced. 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic HYDROXYCARBAMIDE Restricted This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. drugs->Hydroxycarbamide For further details see the NPSA alert at this link

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic Hydroxycarbamide Restricted For oncological treatment by those experienced drugs->Hydroxycarbamide->HYDROXYCARBAMIDE

Ipilimumab will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this IPILIMUMAB NICE-approved 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Ipilimumab pro forma

PENTOSTATIN Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Pentostatin Hairy cell leukaemia only!

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Platinum CARBOPLATIN Restricted For oncological treatment by those experienced compounds

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Platinum Carboplatin Restricted For oncological treatment by those experienced compounds->CARBOPLATIN

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Platinum CISPLATIN Restricted For oncological treatment by those experienced compounds

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Platinum Cisplatin Restricted For oncological treatment by those experienced compounds->CISPLATIN

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Platinum OXALIPLATIN Restricted Treatment in accordance with NICE guidelines and criteria compounds

For oncological treatment by those experienced. PROCARBAZINE Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Procarbazine This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic Procarbazine Restricted For oncological treatment by those experienced drugs->Procarbazine->PROCARBAZINE

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase Afatinib will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this pro AFATINIB NICE-approved inhibitors forma

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase In the formularly of the Cancer Drugs Fund. The paperwork must be completed before prescription. Usage outside the AXITINIB Restricted inhibitors indications set out in the CDF is non-formulary

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase In the formularly of the Cancer Drugs Fund. The paperwork must be completed before prescription. Usage outside the CRIZOTINIB Restricted inhibitors indications set out in the CDF is non-formulary

For patients who responded to imatinib but have become resistant. 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. DASATINIB Restricted inhibitors For further details see the NPSA alert at this link DTC oﬃcer decision

Only to be used in patients who strictly meet the NICE criteria. 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. ERLOTINIB Restricted inhibitors For further details see the NPSA alert at this link DTC oﬃcer decision

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase EVEROLIMUS Restricted On the pan-Birmingham Cancer Network formulary and restricted to those indications which will be funded only inhibitors

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase For ﬁrst-line treatment of locally advanced or metastatic non-small-cell lung cancer in patients who meet NICE guidance in GEFITINIB Restricted inhibitors TA192 ONLY

Treatment in accordance with NICE guidelines and criteria 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase IMATINIB Restricted This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. inhibitors For further details see the NPSA alert at this link

Treatment in accordance with NICE guidelines and criteria 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase NILOTINIB Restricted inhibitors This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. For further details see the NPSA alert at this link

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase PAZOPANIB Restricted Treatment in accordance with the NICE guidelines and criteria, or in accordance with the pan-Birmingham Network formulary inhibitors

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase Only for the indications listed in the Cancer Drugs Fund formulary by Consultant Oncologist/Haematologist - see RUXOLITINIB Restricted inhibitors http://www.england.nhs.uk/ourwork/pe/cdf/

Consultant oncologists for patients who have failed or are intolerant of interferon and other protein kinase inhibitors. 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase SORAFENIB Restricted This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. inhibitors For further details see the NPSA alert at this link

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase SUNITINIB Restricted Treatment in accordance with NICE guidelines and criteria inhibitors

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Protein kinase Vemurafenib will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this VEMURAFENIB NICE-approved inhibitors pro forma

DOCETAXEL Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Taxanes Treatment in accordance with NICE guidelines and criteria

PACLITAXEL Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Taxanes Treatment in accordance with NICE guidelines and criteria

NICE - NSCLC, ovarian and metastatic breast cancer --- Relapsed metastatic germ cell tumors -- 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic Paclitaxel Restricted Relapsed chemo sensitive endometrial tumors -- drugs->Taxanes->PACLITAXEL In combination with a platinum in head and neck tumors -- In neo-adjuvant or adjuvant breast cancer patients having an inadequate response to anthracycline based therapy

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Topoisomerase IRINOTECAN HYDROCHLORIDE Restricted In combination with 5FU for ﬁrst line metastatic colorectal cancer, in patients with high volume disease I inhibitors

8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Topoisomerase TOPOTECAN Restricted Treatment in accordance with NICE guidelines and criteria I inhibitors

Trabectedin will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this TRABECTEDIN NICE-approved 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Trabectedin pro forma

TRASTUZUMAB Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Trastuzumab Treatment in accordance with NICE guidelines and criteria

TRETINOIN Restricted 8.1 Cytotoxic drugs->8.1.5 Other antineoplastic drugs->Tretinoin For oncological treatment by those experienced

Antiproliferative Restricted 8.2 Drugs aﬀecting the immune response immunosuppressants

8.2 Drugs aﬀecting the immune response->8.2.1 Antiproliferative AZATHIOPRINE Restricted For oncological treatment, or for immunological therapy by those experienced immunosuppressants 8.2 Drugs aﬀecting the immune response->8.2.1 Antiproliferative Azathioprine Restricted For oncological treatment, or for immunological therapy by those experienced immunosuppressants->AZATHIOPRINE

For transplant rejection, treatment of SLE by Consultant Rheumaotlogists according to protocol, or other uses agreed by DTC

8.2 Drugs aﬀecting the immune response->8.2.1 Antiproliferative N.B. funding has been agreed with HoB and Sandwell PCT MYCOPHENOLATE MOFETIL Restricted immunosuppressants Drug Safety Update Mycophenolate mofetil (CellCept) and mycophenolic acid: risk of hypogammaglobulinaemia and risk of bronchiectasis

Corticosteroids and other Restricted 8.2 Drugs aﬀecting the immune response Thalidomide - for oncological treatment or for immunological therapy by those experienced immunosuppressants

For transplant rejection or licensed uses by dermatology, ophthalmology, and rheumatology consultants - all other use requires the approval of the DTC 8.2 Drugs aﬀecting the immune response->8.2.2 Corticosteroids and CICLOSPORIN Restricted Refractory Ulcerative Colitis: Child 3-18 years initially 0.5-1mg/kg twice daily; dose adjusted according to blood-ciclosporin other immunosuppressants concentration and response. DTC oﬃcer decision

8.2 Drugs aﬀecting the immune response->8.2.2 Corticosteroids and Capimune® Restricted other immunosuppressants->CICLOSPORIN

8.2 Drugs aﬀecting the immune response->8.2.2 Corticosteroids and Neoral® Restricted For new patients, Capimune is the cheapest brand other immunosuppressants->CICLOSPORIN

For transplant rejection or uses agreed by DTC DTC officer decision 8.2 Drugs affecting the immune response->8.2.2 Corticosteroids and TACROLIMUS Restricted other immunosuppressants See this safety information from the MHRA. The recommendation is that tacrolimus should be prescribed by brand Anti-lymphocyte monoclonal Restricted 8.2 Drugs affecting the immune response antibodies

Treatment in accordance with NICE guidelines and criteria 8.2 Drugs aﬀecting the immune response->8.2.3 Anti-lymphocyte RITUXIMAB Restricted monoclonal antibodies Dear Healthcare professional letter sent by manufacturer in November 2009 regarding progressive multifocal leukoencephalopathy

Other immunomodulating drugs Restricted 8.2 Drugs aﬀecting the immune response

For oncological/haematological treatment by those experienced 8.2 Drugs aﬀecting the immune response->8.2.4 Other INTERFERON ALFA Restricted check which brand or strength is available immunomodulating drugs->Interferon alfa DTC oﬃcer decision

8.2 Drugs aﬀecting the immune response->8.2.4 Other Roferon-A® Restricted Only the 18 megaunit preﬁlled syringe is stocked. All other strengths are non-formulary immunomodulating drugs->Interferon alfa->INTERFERON ALFA

8.2 Drugs aﬀecting the immune response->8.2.4 Other PEGINTERFERON ALFA Restricted Treatment in accordance with NICE guidelines and criteria immunomodulating drugs->Interferon alfa

8.2 Drugs aﬀecting the immune response->8.2.4 Other BACILLUS CALMETTE-GUÉRIN Restricted For oncological treatment by those experienced immunomodulating drugs->BCG bladder instillation

8.2 Drugs aﬀecting the immune response->8.2.4 Other Dimethyl fumarate will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use DIMETHYL FUMARATE NICE-approved immunomodulating drugs->Dimethyl fumarate via this pro forma

8.2 Drugs aﬀecting the immune response->8.2.4 Other Fingolimod will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this FINGOLIMOD NICE-approved immunomodulating drugs->Fingolimod pro forma

8.2 Drugs aﬀecting the immune response->8.2.4 Other LENALIDOMIDE Restricted immunomodulating drugs->Lenalidomide, pomalidomide, and Treatment in accordance with NICE guidelines and criteria thalidomide

8.2 Drugs aﬀecting the immune response->8.2.4 Other THALIDOMIDE Restricted immunomodulating drugs->Lenalidomide, pomalidomide, and Treatment in accordance with NICE guidelines and criteria thalidomide

8.2 Drugs aﬀecting the immune response->8.2.4 Other Mifamurtide will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this MIFAMURTIDE NICE-approved immunomodulating drugs->Mifamurtide pro forma

8.2 Drugs aﬀecting the immune response->8.2.4 Other Natalizumab will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via this NATALIZUMAB NICE-approved immunomodulating drugs->Natalizumab pro forma

Oestrogens Restricted 8.3 Sex hormones and hormone antagonists in malignant disease

8.3 Sex hormones and hormone antagonists in malignant For oncological treatment by those experienced DIETHYLSTILBESTROL Restricted disease->8.3.1 Oestrogens DTC oﬃcer decision

8.3 Sex hormones and hormone antagonists in malignant Diethylstilbestrol Restricted For oncological treatment by those experienced disease->8.3.1 Oestrogens->DIETHYLSTILBESTROL

8.3 Sex hormones and hormone antagonists in malignant ETHINYLESTRADIOL Restricted Consultants in medicine and paediatrics with special interest in diabetes and endocrinology disease->8.3.1 Oestrogens

Progestogens Restricted 8.3 Sex hormones and hormone antagonists in malignant disease

8.3 Sex hormones and hormone antagonists in malignant For oncological treatment by those experienced, gynaecology MEDROXYPROGESTERONE ACETATE Restricted disease->8.3.2 Progestogens DTC oﬃcer decision

8.3 Sex hormones and hormone antagonists in malignant MEGESTROL ACETATE Restricted For oncological treatment by those experienced disease->8.3.2 Progestogens

8.3 Sex hormones and hormone antagonists in malignant NORETHISTERONE On Formulary disease->8.3.2 Progestogens

Androgens Restricted 8.3 Sex hormones and hormone antagonists in malignant disease

8.3 Sex hormones and hormone antagonists in malignant Breast cancer Restricted disease->8.3.4 Hormone antagonists

8.3 Sex hormones and hormone antagonists in malignant ANASTROZOLE Restricted Second line, for use by medical and surgical Oncology consultants in line with NICE guidelines disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer

8.3 Sex hormones and hormone antagonists in malignant EXEMESTANE Restricted Second line, for use by medical and surgical Oncology consultants in line with NICE giudelines disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer

8.3 Sex hormones and hormone antagonists in malignant Second line, for use by medical and surgical Oncology consultants in line with NICE guidelines LETROZOLE Restricted disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer DTC oﬃcer decision

8.3 Sex hormones and hormone antagonists in malignant TAMOXIFEN Restricted For oncological treatment, or for immunological therapy by those experienced disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer

8.3 Sex hormones and hormone antagonists in malignant Tamoxifen Restricted disease->8.3.4 Hormone antagonists->8.3.4.1 Breast For oncological treatment, or for immunological therapy by those experienced cancer->TAMOXIFEN

Gonadorelin analogues and 8.3 Sex hormones and hormone antagonists in malignant gonadotrophin-releasing hormone Restricted disease->8.3.4 Hormone antagonists antagonists

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues 3.6 mg - Shared care with GP's GOSERELIN Restricted and gonadotrophin-releasing hormone antagonists->Gonadorelin 10.8 mg - For use at prostate clinic only! analogues

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues Zoladex® Restricted 3.6 mg - Shared care with GP's and gonadotrophin-releasing hormone antagonists->Gonadorelin analogues->GOSERELIN

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues Zoladex® LA Restricted 10.8 mg - For use at prostate clinic only! and gonadotrophin-releasing hormone antagonists->Gonadorelin analogues->GOSERELIN

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues LEUPRORELIN ACETATE Restricted For oncological treatment by those experienced and gonadotrophin-releasing hormone antagonists->Gonadorelin analogues 8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues for use in precocious puberty only TRIPTORELIN Restricted and gonadotrophin-releasing hormone antagonists->Gonadorelin DTC oﬃcer decision analogues

8.3 Sex hormones and hormone antagonists in malignant ABIRATERONE ACETATE Restricted disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues Restricted to patients to satisfy the requirements of the NICE guideline and gonadotrophin-releasing hormone antagonists->Anti-androgens

8.3 Sex hormones and hormone antagonists in malignant BICALUTAMIDE Restricted disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues For oncological treatment by those experienced and gonadotrophin-releasing hormone antagonists->Anti-androgens

8.3 Sex hormones and hormone antagonists in malignant CYPROTERONE ACETATE On Formulary disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists->Anti-androgens

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues Cyproterone Acetate On Formulary and gonadotrophin-releasing hormone antagonists->Anti- androgens->CYPROTERONE ACETATE

8.3 Sex hormones and hormone antagonists in malignant Enzalutamide will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its use via ENZALUTAMIDE NICE-approved disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues this pro forma and gonadotrophin-releasing hormone antagonists->Anti-androgens

8.3 Sex hormones and hormone antagonists in malignant FLUTAMIDE Restricted disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues For oncological treatment by those experienced and gonadotrophin-releasing hormone antagonists->Anti-androgens

8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues Flutamide Restricted For oncological treatment by those experienced and gonadotrophin-releasing hormone antagonists->Anti- androgens->FLUTAMIDE

8.3 Sex hormones and hormone antagonists in malignant Somatostatin analogues Restricted disease->8.3.4 Hormone antagonists

For treatment of endocrine neoplasia as agreed by DTC 8.3 Sex hormones and hormone antagonists in malignant LANREOTIDE Restricted Only the Autogel is stocked, the LA preparation is non-formulary disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin analogues DTC oﬃcer decision

8.3 Sex hormones and hormone antagonists in malignant For oncological treatment by those experienced OCTREOTIDE Restricted disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin analogues DTC oﬃcer decision

8.3 Sex hormones and hormone antagonists in malignant Depot preparation Restricted disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin For treatment of endocrine neoplasia as agreed by DTC analogues->OCTREOTIDE

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency FERROUS SULFATE On Formulary anaemias->9.1.1.1 Oral iron

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency Ferrous Sulfate On Formulary anaemias->9.1.1.1 Oral iron->FERROUS SULFATE

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency Ferrograd Folic® On Formulary anaemias->9.1.1.1 Oral iron->FERROUS SULFATE->With folic acid

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency FERROUS FUMARATE On Formulary Tablets only anaemias->9.1.1.1 Oral iron

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency SODIUM FEREDETATE On Formulary anaemias->9.1.1.1 Oral iron

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency Sytron® On Formulary anaemias->9.1.1.1 Oral iron->SODIUM FEREDETATE

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency Parenteral iron On Formulary Iron dextran (CosmoFer®) anaemias

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency FERRIC CARBOXYMALTOSE Restricted Gastroenterology and Obstetric patients only anaemias->9.1.1.2 Parenteral iron

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency IRON DEXTRAN On Formulary anaemias->9.1.1.2 Parenteral iron

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency CosmoFer® On Formulary anaemias->9.1.1.2 Parenteral iron->IRON DEXTRAN

9.1 Anaemias and some other blood disorders->9.1.1 Iron-deﬁciency IRON SUCROSE On Formulary DTC oﬃcer decision anaemias->9.1.1.2 Parenteral iron

9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in HYDROXOCOBALAMIN On Formulary megaloblastic anaemias

9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in Hydroxocobalamin On Formulary megaloblastic anaemias->HYDROXOCOBALAMIN

9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in FOLIC ACID On Formulary Only the 5mg capsules and syrup are stocked megaloblastic anaemias

9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in Folic Acid On Formulary 5 mg tablets only megaloblastic anaemias->FOLIC ACID

Treatment by Consultant Oncologists, Haematologists or Nephrologists in accordance with NICE guidelines and criteria 9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in DARBEPOETIN ALFA Restricted hypoplastic, haemolytic, and renal anaemias->Erythropoietins Darbepoetin is the long-acting ﬁrst line agent.

Treatment by Consultant Oncologists or Haematologists in accordance with NICE guidelines and criteria 9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in EPOETIN ALFA, BETA, and ZETA Restricted hypoplastic, haemolytic, and renal anaemias->Erythropoietins Darbepoetin is the long-acting ﬁrst line agent.

9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in DEFERIPRONE Restricted when Desferrioxamine is contra-indicated hypoplastic, haemolytic, and renal anaemias->Iron overload

9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in Iron poisoning and overload DESFERRIOXAMINE MESILATE Restricted hypoplastic, haemolytic, and renal anaemias->Iron overload DTC oﬃcer decision

9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in Desferrioxamine mesilate Restricted hypoplastic, haemolytic, and renal anaemias->Iron Iron poisoning and overload overload->DESFERRIOXAMINE MESILATE

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 9.1 Anaemias and some other blood disorders->9.1.4 Drugs used in ELTROMBOPAG NICE-approved For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. platelet disorders->Idiopathic thrombocytopenic purpura

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 9.1 Anaemias and some other blood disorders->9.1.4 Drugs used in ROMIPLOSTIM NICE-approved For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. platelet disorders->Idiopathic thrombocytopenic purpura

For all other patients please complete this pro forma.

9.1 Anaemias and some other blood disorders->9.1.6 Drugs used in Haematology/Oncology FILGRASTIM Restricted neutropenia Use the biosimilar product (Zarzio®) in new patients

9.1 Anaemias and some other blood disorders->9.1.6 Drugs used in Zarzio® Restricted neutropenia->FILGRASTIM

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and POTASSIUM CHLORIDE On Formulary electrolyte imbalance->9.2.1.1 Oral potassium

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and Kay-Cee-L® On Formulary electrolyte imbalance->9.2.1.1 Oral potassium->POTASSIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and Sando-K® On Formulary electrolyte imbalance->9.2.1.1 Oral potassium->POTASSIUM CHLORIDE 9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and POLYSTYRENE SULFONATE RESINS On Formulary electrolyte imbalance->9.2.1.1 Oral potassium->Management of hyperkalaemia

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and Calcium Resonium® On Formulary electrolyte imbalance->9.2.1.1 Oral potassium->Management of hyperkalaemia->POLYSTYRENE SULFONATE RESINS

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and SODIUM CHLORIDE On Formulary electrolyte imbalance->9.2.1.2 Oral sodium and water

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and Slow Sodium® On Formulary electrolyte imbalance->9.2.1.2 Oral sodium and water->SODIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and ORAL REHYDRATION SALTS (ORS) On Formulary electrolyte imbalance->9.2.1.2 Oral sodium and water->Oral rehydration therapy (ORT)

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and electrolyte imbalance->9.2.1.2 Oral sodium and water->Oral Dioralyte® On Formulary rehydration therapy (ORT)->ORAL REHYDRATION SALTS (ORS)->UK formulations

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and SODIUM BICARBONATE On Formulary Only the 500mg capsules are in the formulary - all other preparations are non-formulary electrolyte imbalance->9.2.1.3 Oral bicarbonate

9.2 Fluids and electrolytes->9.2.1 Oral preparations for ﬂuid and Sodium Bicarbonate On Formulary electrolyte imbalance->9.2.1.3 Oral bicarbonate->SODIUM Capsules only BICARBONATE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and SODIUM CHLORIDE On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Sodium Chloride Intravenous On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Infusion sodium->SODIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Sodium Chloride and Glucose On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Intravenous Infusion sodium->SODIUM CHLORIDE->With other ingredients

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Ringer's Solution for Injection On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium->SODIUM CHLORIDE->With other ingredients

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Sodium Lactate Intravenous On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Infusion, Compound sodium->SODIUM CHLORIDE->With other ingredients

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and GLUCOSE On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous glucose

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Glucose Intravenous Infusion On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous glucose->GLUCOSE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and POTASSIUM CHLORIDE On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Potassium Chloride and Glucose On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Intravenous Infusion potassium->POTASSIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Potassium Chloride and Sodium On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Chloride Intravenous Infusion potassium->POTASSIUM CHLORIDE

Potassium Chloride, Sodium 9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Chloride, and Glucose On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous Intravenous Infusion potassium->POTASSIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Potassium Chloride Concentrate, Restricted electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous NNU only Sterile potassium->POTASSIUM CHLORIDE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and SODIUM BICARBONATE On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Bicarbonate and lactate

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Sodium Bicarbonate Intravenous On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Bicarbonate Infusion and lactate->SODIUM BICARBONATE

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and Water for Injections On Formulary electrolyte imbalance->9.2.2.1 Electrolytes and water->Water

9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for ﬂuid and ALBUMIN SOLUTION On Formulary from bloodbank electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes

Addiphos® Restricted 9.3 Intravenous nutrition->Supplementary preparations TPN, CCS and Hypophosphataemia - order in CD book!

Additrace® Restricted 9.3 Intravenous nutrition->Supplementary preparations

Peditrace® Restricted 9.3 Intravenous nutrition->Supplementary preparations

Solivito N® Restricted 9.3 Intravenous nutrition->Supplementary preparations

Vitlipid N® Restricted 9.3 Intravenous nutrition->Supplementary preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium CALCIUM SALTS On Formulary supplements

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium Adcal® On Formulary supplements->CALCIUM SALTS->Oral preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium Calcichew® On Formulary supplements->CALCIUM SALTS->Oral preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium Sandocal® On Formulary supplements->CALCIUM SALTS->Oral preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium Calcium Gluconate On Formulary supplements->CALCIUM SALTS->Parenteral preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.1 Calcium Calcium Chloride On Formulary supplements->CALCIUM SALTS->Parenteral preparations

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.2 Hypercalcaemia CINACALCET Restricted Treatment in accordance with NICE guidelines and criteria and hypercalciuria

Magnesium On Formulary 9.5 Minerals->9.5.1 Calcium and magnesium Magnesium glycerophosphate available for Hypomagnesaemia

MAGNESIUM SULFATE On Formulary 9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.3 Magnesium

9.5 Minerals->9.5.1 Calcium and magnesium->9.5.1.3 Magnesium Sulfate Injection, BP On Formulary Magnesium->MAGNESIUM SULFATE

CORRECTION ! In critically ill patients, the dose of phosphate can be increased up to 500 micromol/kg (approx. 30 mmol in Phosphate supplements On Formulary 9.5 Minerals->9.5.2 Phosphorus adults), infused over 6–12 hours, according to severity.

Phosphate-Sandoz® On Formulary 9.5 Minerals->9.5.2 Phosphorus->9.5.2.1 Phosphate supplements

CALCIUM SALTS On Formulary 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents DTC oﬃcer decision

9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding Adcal® On Formulary agents->CALCIUM SALTS 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding Calcium-500 On Formulary agents->CALCIUM SALTS

9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding Phosex® Restricted Consultant nephrologists agents->CALCIUM SALTS

SEVELAMER CARBONATE Restricted 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents Consultant nephrologists in paents who sasfy the criteria in the pro-forma DTC oﬃcer decision

ZINC SULFATE Restricted 9.5 Minerals->9.5.4 Zinc TPN and Poisons Unit

Zinc Sulfate On Formulary 9.5 Minerals->9.5.4 Zinc->ZINC SULFATE

Vitamins A and D Restricted 9.6 Vitamins->9.6.1 Vitamin A->VITAMIN A Oral drops 5000IU - NNU

RIBOFLAVIN On Formulary 9.6 Vitamins->9.6.2 Vitamin B group

THIAMINE On Formulary 9.6 Vitamins->9.6.2 Vitamin B group

Thiamine On Formulary 9.6 Vitamins->9.6.2 Vitamin B group->THIAMINE

Pabrinex® On Formulary 9.6 Vitamins->9.6.2 Vitamin B group->THIAMINE

PYRIDOXINE HYDROCHLORIDE On Formulary 9.6 Vitamins->9.6.2 Vitamin B group

Pyridoxine On Formulary 9.6 Vitamins->9.6.2 Vitamin B group->PYRIDOXINE HYDROCHLORIDE

Vitamin B Tablets, Compound, 9.6 Vitamins->9.6.2 Vitamin B group->Oral vitamin B complex On Formulary DTC oﬃcer decision Strong preparations

ASCORBIC ACID On Formulary 9.6 Vitamins->9.6.3 Vitamin C

Ascorbic Acid On Formulary 9.6 Vitamins->9.6.3 Vitamin C->ASCORBIC ACID

ERGOCALCIFEROL On Formulary 9.6 Vitamins->9.6.4 Vitamin D

Calcium and Ergocalciferol On Formulary 9.6 Vitamins->9.6.4 Vitamin D->ERGOCALCIFEROL->With calcium

9.6 Vitamins->9.6.4 Vitamin D->ERGOCALCIFEROL->Pharmacological Ergocalciferol On Formulary strengths

ALFACALCIDOL On Formulary 9.6 Vitamins->9.6.4 Vitamin D

Alfacalcidol On Formulary 9.6 Vitamins->9.6.4 Vitamin D->ALFACALCIDOL

See the Trust guideline Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management For Adults and Children for guidance on prescribing vitamin D supplements COLECALCIFEROL Restricted 9.6 Vitamins->9.6.4 Vitamin D Oral drops 3000 IU are restricted to NNU

Fultium-D3® On Formulary 9.6 Vitamins->9.6.4 Vitamin D->COLECALCIFEROL

The Dissolve tablets are restricted to patients who cannot swallow the chewable tablets. Adcal-D3® Restricted 9.6 Vitamins->9.6.4 Vitamin D->COLECALCIFEROL->With calcium The Caplets are for general use. The chewable tablets are non-formulary

Vitamin E Restricted 9.6 Vitamins Second line - Tocopherol preparations on named patient basis

ALPHA TOCOPHERYL ACETATE Restricted 9.6 Vitamins->9.6.5 Vitamin E

Vitamin E Suspension Restricted 9.6 Vitamins->9.6.5 Vitamin E->ALPHA TOCOPHERYL ACETATE NNU and Paediatrics

MENADIOL SODIUM PHOSPHATE On Formulary 9.6 Vitamins->9.6.6 Vitamin K

Menadiol Phosphate On Formulary 9.6 Vitamins->9.6.6 Vitamin K->MENADIOL SODIUM PHOSPHATE

PHYTOMENADIONE On Formulary 9.6 Vitamins->9.6.6 Vitamin K

9.6 Vitamins->9.6.6 Vitamin K->PHYTOMENADIONE->Colloidal Konakion® MM On Formulary formulation

9.6 Vitamins->9.6.6 Vitamin K->PHYTOMENADIONE->Colloidal Konakion® MM Paediatric On Formulary formulation

Multivitamin preparations On Formulary 9.6 Vitamins Oral tablets for use in children and adults

Abidec® On Formulary 9.6 Vitamins->9.6.7 Multivitamin preparations

Dalivit® Restricted 9.6 Vitamins->9.6.7 Multivitamin preparations only if Abidec not available

9.8 Metabolic disorders->9.8.1 Drugs used in metabolic PENICILLAMINE Restricted Wilson's disease disorders->Wilson's disease

9.8 Metabolic disorders->9.8.1 Drugs used in metabolic TRIENTINE DIHYDROCHLORIDE Restricted Wilson's disease disorders->Wilson's disease

9.8 Metabolic disorders->9.8.1 Drugs used in metabolic Trientine Dihydrochloride Restricted Wilson's disease disorders->Wilson's disease->TRIENTINE DIHYDROCHLORIDE

Carnitine deﬁciency Restricted 9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders Endocrinology,consultant paediatricians

9.8 Metabolic disorders->9.8.1 Drugs used in metabolic Endocrinology,consultant paediatricians LEVOCARNITINE Restricted disorders->Carnitine deﬁciency DTC oﬃcer decision

9.8 Metabolic disorders->9.8.1 Drugs used in metabolic consultant paediatricians in emergency situations SODIUM PHENYLBUTYRATE Restricted disorders->Urea cycle disorders DTC oﬃcer decision

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal CELECOXIB Restricted Consultants anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Injection restricted to Theatres, ITU and pain team DICLOFENAC SODIUM Restricted anti-inﬂammatory drugs Oral restricted to second line use in patients for whom naproxen is not satisfactory

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Injection restricted to ITU, theatres and pain team Diclofenac Sodium Restricted anti-inﬂammatory drugs->DICLOFENAC SODIUM Oral restricted to second-line use in patients for whom naproxen is not satisfactory

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Arthrotec® Restricted Oral restricted to second-line use in patients for whom naproxen is not satisfactory anti-inﬂammatory drugs->DICLOFENAC SODIUM->With misoprostol

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal ETODOLAC On Formulary anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Lodine SR® On Formulary anti-inﬂammatory drugs->ETODOLAC->Modiﬁed release

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal FLURBIPROFEN Restricted Birmingham eye centre only anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Flurbiprofen Restricted Birmingham eye centre only anti-inﬂammatory drugs->FLURBIPROFEN

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal oro-dispersable tablets available (Melts) IBUPROFEN On Formulary anti-inﬂammatory drugs DTC oﬃcer decision

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Ibuprofen On Formulary oro-dispersable tablets available (Melts) anti-inﬂammatory drugs->IBUPROFEN

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal INDOMETACIN On Formulary anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Indometacin On Formulary anti-inﬂammatory drugs->INDOMETACIN

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal MEFENAMIC ACID Restricted Gynaecology anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Mefenamic Acid Restricted Gynaecology anti-inﬂammatory drugs->MEFENAMIC ACID

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal MELOXICAM Restricted Rheumatology, short term use anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal NABUMETONE On Formulary anti-inﬂammatory drugs 10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Nabumetone On Formulary anti-inﬂammatory drugs->NABUMETONE

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal NAPROXEN On Formulary First choice in patients requiring a non-steroidal anti-inflammatory and for whom ibuprofen is insufficient anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal First choice in patients requiring a non-steroidal anti-inflammatory and for whom ibuprofen is insufficient Naproxen On Formulary anti-inﬂammatory drugs->NAPROXEN

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal PIROXICAM Restricted use ibuprofen melts -- Feldene Melts Paediatricians only anti-inﬂammatory drugs

10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal Feldene® Restricted Feldene Melts Paediatricians only anti-inﬂammatory drugs->PIROXICAM

LOCAL CORTICOSTEROID 10.1 Drugs used in rheumatic diseases and gout->10.1.2 On Formulary INJECTIONS Corticosteroids->10.1.2.2 Local corticosteroid injections

10.1 Drugs used in rheumatic diseases and gout->10.1.2 Hydrocortisone acetate On Formulary Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS

10.1 Drugs used in rheumatic diseases and gout->10.1.2 Hydrocortistab® On Formulary Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS->Hydrocortisone acetate

10.1 Drugs used in rheumatic diseases and gout->10.1.2 Methylprednisolone acetate On Formulary Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS

10.1 Drugs used in rheumatic diseases and gout->10.1.2 Depo-Medrone® On Formulary Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS->Methylprednisolone acetate

10.1 Drugs used in rheumatic diseases and gout->10.1.2 Triamcinolone acetonide On Formulary Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that SODIUM AUROTHIOMALATE Restricted Rheumatology suppress the rheumatic disease process->Gold

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that Myocrisin® Restricted suppress the rheumatic disease process->Gold->SODIUM Rheumatology AUROTHIOMALATE

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that PENICILLAMINE Restricted Rheumatology, Wilson's disease suppress the rheumatic disease process->Penicillamine

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that Penicillamine Restricted suppress the rheumatic disease Rheumatology, Wilson's disease process->Penicillamine->PENICILLAMINE

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that HYDROXYCHLOROQUINE SULFATE On Formulary suppress the rheumatic disease process->Antimalarials

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that AZATHIOPRINE Restricted suppress the rheumatic disease process->Drugs aﬀecting the immune for oncology treatment and for immunological therapy by those experienced response

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that For transplant rejection or licensed uses by dermatology, ophthalmology, and rheumatology consultants - all other use CICLOSPORIN Restricted suppress the rheumatic disease process->Drugs aﬀecting the immune requires the approval of the DTC response

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that LEFLUNOMIDE Restricted suppress the rheumatic disease process->Drugs aﬀecting the immune Consultant Rheumatologists response

For oncological treatment or for immunological therapy by those experienced - 2.5mg tablets stocked only!

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. METHOTREXATE Restricted suppress the rheumatic disease process->Drugs aﬀecting the immune For further details see the NPSA alert at this link response The usual dose is weekly NPSA improving compliance with oral methotrexate guidelines

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that Methotrexate Restricted suppress the rheumatic disease process->Drugs aﬀecting the immune For oncological treatment or for immunological therapy by those experienced - 2.5mg tablets stocked only! response->METHOTREXATE

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use.

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. ABATACEPT NICE-approved suppress the rheumatic disease process->Cytokine modulators For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that ADALIMUMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that CERTOLIZUMAB PEGOL Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that ETANERCEPT Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that GOLIMUMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that INFLIXIMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use.

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. RITUXIMAB Restricted suppress the rheumatic disease process->Cytokine modulators For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that TOCILIZUMAB NICE-approved For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. suppress the rheumatic disease process->Cytokine modulators

For all other patients please complete this pro forma.

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that SULFASALAZINE On Formulary suppress the rheumatic disease process->Sulfasalazine

10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that Sulfasalazine On Formulary suppress the rheumatic disease process->Sulfasalazine->SULFASALAZINE

10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and COLCHICINE On Formulary cytotoxic-induced hyperuricaemia->Acute attacks of gout 10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and Colchicine On Formulary cytotoxic-induced hyperuricaemia->Acute attacks of gout->COLCHICINE

10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and ALLOPURINOL On Formulary cytotoxic-induced hyperuricaemia->Long-term control of gout

10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and Allopurinol On Formulary cytotoxic-induced hyperuricaemia->Long-term control of gout->ALLOPURINOL

10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and FEBUXOSTAT Restricted Treatment by Consultant rheumatologists in accordance with the NICE guidelines and criteria cytotoxic-induced hyperuricaemia->Long-term control of gout

10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and RASBURICASE Restricted cytotoxic-induced hyperuricaemia->Hyperuricaemia associated with named patients only cytotoxic drugs

10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that NEOSTIGMINE Restricted Theatres enhance neuromuscular transmission->Anticholinesterases

10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that Neostigmine Restricted enhance neuromuscular Theatres transmission->Anticholinesterases->NEOSTIGMINE

10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that PYRIDOSTIGMINE BROMIDE Restricted Neurology enhance neuromuscular transmission->Anticholinesterases

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle BACLOFEN On Formulary relaxants

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle Baclofen On Formulary relaxants->BACLOFEN

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle DANTROLENE SODIUM On Formulary DTC oﬃcer decision relaxants

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle DIAZEPAM On Formulary relaxants

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle TIZANIDINE Restricted Consultant neurologists and those with special interest in stroke or neurodisability relaxants

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle Tizanidine Restricted Consultant neurologists and those with special interest in stroke or neurodisability relaxants->TIZANIDINE

10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle QUININE On Formulary relaxants->Nocturnal leg cramps

10.3 Drugs for the treatment of soft-tissue disorders and topical pain HYALURONIDASE On Formulary relief->10.3.1 Enzymes->Hyaluronidase

10.3 Drugs for the treatment of soft-tissue disorders and topical pain Capsaicin Restricted Rheumatology, Pain team relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices

10.3 Drugs for the treatment of soft-tissue disorders and topical pain Zacin® Restricted relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and Rheumatology, Pain team poultices->Capsaicin

10.3 Drugs for the treatment of soft-tissue disorders and topical pain Axsain® Restricted relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and Rheumatology, Pain team poultices->Capsaicin

AZITHROMYCIN DIHYDRATE Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials Consultant ophthalmologists for the treatment of chlamydial infections only

CHLORAMPHENICOL On Formulary 11.3 Anti-infective eye preparations->11.3.1 Antibacterials

11.3 Anti-infective eye preparations->11.3.1 Chloramphenicol On Formulary Antibacterials->CHLORAMPHENICOL

11.3 Anti-infective eye preparations->11.3.1 Single use On Formulary Antibacterials->CHLORAMPHENICOL

11.3 Anti-infective eye preparations->11.3.1 Minims® Chloramphenicol On Formulary Antibacterials->CHLORAMPHENICOL->Single use

CIPROFLOXACIN Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials Pseudomonas aeruginosa infection in the eye and ear

11.3 Anti-infective eye preparations->11.3.1 Ciloxan® Restricted Antibacterials->CIPROFLOXACIN

FUSIDIC ACID Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials second line for conjunctivitis

11.3 Anti-infective eye preparations->11.3.1 Antibacterials->FUSIDIC Fucithalmic® Restricted ACID

GENTAMICIN On Formulary 11.3 Anti-infective eye preparations->11.3.1 Antibacterials 1.5% eye drops restricted for use in Corneal abscess only

G. Gentamicin 1.5% (Preservative free) is an unlicensed medicine; restricted for use in corneal abcess only when 11.3 Anti-infective eye preparations->11.3.1 Genticin® Restricted prescribed/recommended by an ophthalmologist, only preservative free drops are stocked in the trust. (insert link to Topical Antibacterials->GENTAMICIN Ophthalmic antimicrobial preparations formulary here). Prescribe in-house, not on FP10HP.

Consultant ophthalmologists in patients undergoing surgical procedures who are allergic to chloramphenicol LEVOFLOXACIN Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials Consultant ophthalmologists in patients undergoing intravitreal injections who are allergic to chloramphenicol and allergic to/intolerant of preservatives

11.3 Anti-infective eye preparations->11.3.1 Oftaquix® Restricted Antibacterials->LEVOFLOXACIN

OFLOXACIN Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials Not be used for the treatment of bacterial conjunctivitis

11.3 Anti-infective eye preparations->11.3.1 Exocin® Restricted Antibacterials->OFLOXACIN

PROPAMIDINE ISETIONATE Restricted 11.3 Anti-infective eye preparations->11.3.1 Antibacterials Acanthamoeba keratitis infection

ACICLOVIR On Formulary 11.3 Anti-infective eye preparations->11.3.3 Antivirals

Zovirax® On Formulary 11.3 Anti-infective eye preparations->11.3.3 Antivirals->ACICLOVIR

GANCICLOVIR Restricted 11.3 Anti-infective eye preparations->11.3.3 Antivirals Second line agent for patients non-responsive to or intolerant of aciclovir

Virgan® Restricted 11.3 Anti-infective eye preparations->11.3.3 Antivirals->GANCICLOVIR

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 BETAMETHASONE On Formulary Corticosteroids

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 DEXAMETHASONE On Formulary Corticosteroids

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 Minims® Dexamethasone On Formulary Corticosteroids->DEXAMETHASONE->Single use

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 Maxitrol® On Formulary Corticosteroids->DEXAMETHASONE->With antibacterials

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 FLUOROMETHOLONE Restricted Second line for patients who have experienced rise in intraoccular pressure with other corticosteroids Corticosteroids

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 LOTEPREDNOL ETABONATE Restricted second line for patietns who have experienced rise in intraoccular pressure with other corticosteroids Corticosteroids

For licensed preparations see below 11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 PREDNISOLONE On Formulary Corticosteroids G. prednisolone 0.1% (preserved) is an unlicensed medicine; restricted to ophthalmologist/ophthalmologist advice. Prescribe in-house, not on FP10HP

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 Predsol® On Formulary Corticosteroids->PREDNISOLONE

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 Pred Forte® On Formulary Corticosteroids->PREDNISOLONE Minims® Prednisolone Sodium 11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 On Formulary Phosphate Corticosteroids->PREDNISOLONE->Single use

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 DEXAMETHASONE Restricted Treatment by consultant ophthalmologists in accordance with the NICE guidelines and criteria Corticosteroids->Intravitreal corticosteroids

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 Ozurdex® Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. Corticosteroids->Intravitreal corticosteroids->DEXAMETHASONE

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.1 FLUOCINOLONE ACETONIDE NICE-approved For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. Corticosteroids->Intravitreal corticosteroids

For all other patients please complete this pro forma.

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.2 NEDOCROMIL SODIUM On Formulary Other anti-inﬂammatory preparations

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.2 OLOPATADINE On Formulary Other anti-inﬂammatory preparations

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.2 SODIUM CROMOGLICATE On Formulary Other anti-inﬂammatory preparations

11.4 Corticosteroids and other anti-inﬂammatory preparations->11.4.2 Sodium Cromoglicate On Formulary Other anti-inﬂammatory preparations->SODIUM CROMOGLICATE

ATROPINE SULFATE On Formulary 11.5 Mydriatics and cycloplegics->Antimuscarinics

11.5 Mydriatics and cycloplegics->Antimuscarinics->ATROPINE Atropine On Formulary SULFATE

11.5 Mydriatics and cycloplegics->Antimuscarinics->ATROPINE Minims® Atropine Sulphate On Formulary SULFATE->Single use

CYCLOPENTOLATE On Formulary 11.5 Mydriatics and cycloplegics->Antimuscarinics HYDROCHLORIDE

11.5 Mydriatics and cycloplegics->Antimuscarinics->CYCLOPENTOLATE Mydrilate® On Formulary HYDROCHLORIDE

Minims® Cyclopentolate 11.5 Mydriatics and cycloplegics->Antimuscarinics->CYCLOPENTOLATE On Formulary Hydrochloride HYDROCHLORIDE->Single use

TROPICAMIDE On Formulary 11.5 Mydriatics and cycloplegics->Antimuscarinics

Mydriacyl® On Formulary 11.5 Mydriatics and cycloplegics->Antimuscarinics->TROPICAMIDE

11.5 Mydriatics and Minims® Tropicamide On Formulary cycloplegics->Antimuscarinics->TROPICAMIDE->Single use

PHENYLEPHRINE HYDROCHLORIDE On Formulary 11.5 Mydriatics and cycloplegics->Sympathomimetics

11.5 Mydriatics and Minims® Phenylephrine On Formulary cycloplegics->Sympathomimetics->PHENYLEPHRINE Hydrochloride HYDROCHLORIDE->Single use

Ophthalmic suspension 0.25% only, all other preparations are non-formulary BETAXOLOL On Formulary 11.6 Treatment of glaucoma->Beta-blockers DTC oﬃcer decision

Betoptic® On Formulary 11.6 Treatment of glaucoma->Beta-blockers->BETAXOLOL Only the 0.25% suspension is available in the formulary

CARTEOLOL HYDROCHLORIDE Restricted 11.6 Treatment of glaucoma->Beta-blockers second line Consultants only

11.6 Treatment of glaucoma->Beta-blockers->CARTEOLOL Teoptic® Restricted HYDROCHLORIDE

TIMOLOL On Formulary 11.6 Treatment of glaucoma->Beta-blockers

Timolol On Formulary 11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL

Once-daily preparations Restricted 11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL as per eye glaucoma protocol

11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL->Once-daily Timoptol®-LA On Formulary preparations

With brimonidine Restricted 11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL second line as per eye glaucoma protocol

With dorzolamide Restricted 11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL second line after Brinzolomide as per eye glaucoma protocol

With latanoprost Restricted 11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL second line as per eye glaucoma protocol

11.6 Treatment of glaucoma->Prostaglandin analogues and Second line as per eye glaucoma protocol. The 300 micrograms/ml strength is being discontinued. Prescribers may prescrib BIMATOPROST Restricted prostamides the 100 micrograms/ml as a temporary measure while patients are reviewed for alternative treatment options.

11.6 Treatment of glaucoma->Prostaglandin analogues and Lumigan® Restricted prostamides->BIMATOPROST

11.6 Treatment of glaucoma->Prostaglandin analogues and Ganfort® Restricted second line for patients with insuﬃcient response to latanoprost prostamides->BIMATOPROST->With timolol

11.6 Treatment of glaucoma->Prostaglandin analogues and LATANOPROST Restricted as per eye glaucoma protocol prostamides

11.6 Treatment of glaucoma->Prostaglandin analogues and Xalatan® Restricted prostamides->LATANOPROST

11.6 Treatment of glaucoma->Prostaglandin analogues and Monopost® Restricted Second-line use, and only in patients who deﬁnitely require a preservative-free product prostamides->LATANOPROST->Single use

11.6 Treatment of glaucoma->Prostaglandin analogues and TAFLUPROST Restricted For use by opthalmology consultants and glaucoma fellows only prostamides

11.6 Treatment of glaucoma->Prostaglandin analogues and TRAVOPROST On Formulary prostamides

11.6 Treatment of glaucoma->Prostaglandin analogues and Travatan® On Formulary prostamides->TRAVOPROST

11.6 Treatment of glaucoma->Prostaglandin analogues and DuoTrav® Restricted prostamides->TRAVOPROST->With timolol

BRIMONIDINE TARTRATE Restricted 11.6 Treatment of glaucoma->Sympathomimetics second line as per eye protocol

11.6 Treatment of glaucoma->Sympathomimetics->BRIMONIDINE Brimonidine Tartrate On Formulary TARTRATE

11.6 Treatment of glaucoma->Sympathomimetics->BRIMONIDINE Combigan® Restricted second line as per eye protocol TARTRATE->With timolol

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and ACETAZOLAMIDE On Formulary systemic drugs

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Diamox® SR On Formulary systemic drugs->ACETAZOLAMIDE->Modiﬁed release

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and BRINZOLAMIDE On Formulary systemic drugs

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Azopt® On Formulary systemic drugs->BRINZOLAMIDE

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Consultant ophthalmologists only in patients intolerant of Cosopt®, or who are already taking brinzolamide and who require Azarga® Restricted systemic drugs->BRINZOLAMIDE->With timolol a beta blocker as well

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and DORZOLAMIDE Restricted second line after brinzolamide systemic drugs

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Dorzolamide Restricted systemic drugs->DORZOLAMIDE 11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Dorzolamide with Timolol Restricted systemic drugs->DORZOLAMIDE->With timolol

11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and Cosopt® Restricted second line after brinzolamide as per eye protocol systemic drugs->DORZOLAMIDE->With timolol

The 0.5% strength is not stocked PILOCARPINE On Formulary 11.6 Treatment of glaucoma->Miotics DTC oﬃcer decision

Pilocarpine Hydrochloride On Formulary 11.6 Treatment of glaucoma->Miotics->PILOCARPINE

Minims® Pilocarpine Nitrate On Formulary 11.6 Treatment of glaucoma->Miotics->PILOCARPINE->Single use

Minims® Lidocaine and On Formulary 11.7 Local anaesthetics->LIDOCAINE HYDROCHLORIDE Fluorescein

OXYBUPROCAINE HYDROCHLORIDE On Formulary 11.7 Local anaesthetics

Minims® Oxybuprocaine On Formulary 11.7 Local anaesthetics->OXYBUPROCAINE HYDROCHLORIDE Hydrochloride

PROXYMETACAINE On Formulary 11.7 Local anaesthetics HYDROCHLORIDE

Minims® Proxymetacaine On Formulary 11.7 Local anaesthetics->PROXYMETACAINE HYDROCHLORIDE

TETRACAINE HYDROCHLORIDE On Formulary 11.7 Local anaesthetics 0.5% strength only

Minims® Tetracaine On Formulary 11.7 Local anaesthetics->TETRACAINE HYDROCHLORIDE 0.5% strength only Hydrochloride

Acetylcysteine 5% licensed product commercially available and on formulary; Acetylcysteine 10% preserved (currently 11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, ACETYLCYSTEINE On Formulary unavailable, June 14) and Acetylcysteine 10% preservative free are unlicensed products and are restricted to corneal ocular lubricants, and astringents consultant only. Prescribe in-house not on FP10HP.

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Ilube® On Formulary ocular lubricants, and astringents->ACETYLCYSTEINE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, CARBOMERS On Formulary ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, GelTears® Restricted for use as a coupling agent ocular lubricants, and astringents->CARBOMERS

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Liquivisc® On Formulary ocular lubricants, and astringents->CARBOMERS

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Viscotears® Restricted In patients requiring a less frequent dosing interval ocular lubricants, and astringents->CARBOMERS

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, CARMELLOSE SODIUM On Formulary ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Celluvisc® On Formulary Only use the 0.5% strength if the 1% cannot be tolerated ocular lubricants, and astringents->CARMELLOSE SODIUM->Single use

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, HYPROMELLOSE On Formulary Only the 0.5% strength is in the formulary ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Isopto Plain® On Formulary ocular lubricants, and astringents->HYPROMELLOSE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, LIQUID PARAFFIN On Formulary ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Lacri-Lube® On Formulary ocular lubricants, and astringents->LIQUID PARAFFIN

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, VitA-POS® On Formulary ocular lubricants, and astringents->LIQUID PARAFFIN

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, MACROGOLS Restricted only the single use drops are in the formulary for patients intolerant of drops containing preservatives ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Systane® Restricted for patients intolerant of drops containing preservatives ocular lubricants, and astringents->MACROGOLS->Single use

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, POLYVINYL ALCOHOL On Formulary ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Liquiﬁlm Tears® On Formulary Unit dose eye drops only ocular lubricants, and astringents->POLYVINYL ALCOHOL

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Sno Tears® On Formulary ocular lubricants, and astringents->POLYVINYL ALCOHOL

for 0.9% solution use Normasol sachets

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, G.sodium chloride 5% (preserved) and Oc.sodium chloride 5% are unlicensed medicine;restricted to prescription by an SODIUM CHLORIDE On Formulary ocular lubricants, and astringents ophthalmologist. Prescribe in-house, not on FP10HP

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Sodium Chloride 0.9% Solutions On Formulary ocular lubricants, and astringents->SODIUM CHLORIDE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Balanced Salt Solution On Formulary ocular lubricants, and astringents->SODIUM CHLORIDE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Single use On Formulary use Normasol sachets ocular lubricants, and astringents->SODIUM CHLORIDE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, SODIUM HYALURONATE On Formulary the 0.18% strength is the preferred product ocular lubricants, and astringents

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Hyabak® On Formulary ocular lubricants, and astringents->SODIUM HYALURONATE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Hylo-Forte® On Formulary ocular lubricants, and astringents->SODIUM HYALURONATE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Vismed® Multi On Formulary ocular lubricants, and astringents->SODIUM HYALURONATE

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Clinitas® On Formulary ocular lubricants, and astringents->SODIUM HYALURONATE->Single use

11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deﬁciency, Vismed® On Formulary ocular lubricants, and astringents->SODIUM HYALURONATE->Single use

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic FLUORESCEIN SODIUM On Formulary and peri-operative preparations and photodynamic treatment->Ocular diagnostic preparations

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic Minims® Fluorescein Sodium On Formulary and peri-operative preparations and photodynamic treatment->Ocular diagnostic preparations->FLUORESCEIN SODIUM

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic ACETYLCHOLINE CHLORIDE Restricted and peri-operative preparations and photodynamic treatment->Ocular Theatres post-operative peri-operative drugs

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic APRACLONIDINE Restricted and peri-operative preparations and photodynamic treatment->Ocular On specialist advice of a glaucoma consultant or fellow, or prevention of post laser IOP spikes peri-operative drugs

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic Iopidine® Restricted and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->APRACLONIDINE I njection: Intracameral (use Aprokam®) or sub-conjunctival use only, in accordance with ophthalmology guidelines 11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic CEFUROXIME Restricted and peri-operative preparations and photodynamic treatment->Ocular Moxiﬂoxacin 300 micrograms in 0.3ml intracameral injection is an unlicensed medicine; restricted for patients who are peri-operative drugs unable to be given cefuroxime intracamerally

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic DICLOFENAC SODIUM On Formulary and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic Voltarol® Ophtha Multidose On Formulary and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->DICLOFENAC SODIUM

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic Voltarol® Ophtha On Formulary and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->DICLOFENAC SODIUM->Single use

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic KETOROLAC TROMETAMOL On Formulary and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs

11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic Acular® On Formulary and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->KETOROLAC TROMETAMOL

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic AFLIBERCEPT NICE-approved and peri-operative preparations and photodynamic For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. treatment->Subfoveal choroidal neovascularisation For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic RANIBIZUMAB NICE-approved and peri-operative preparations and photodynamic For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. treatment->Subfoveal choroidal neovascularisation For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic VERTEPORFIN Restricted and peri-operative preparations and photodynamic For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. treatment->Subfoveal choroidal neovascularisation For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. OCRIPLASMIN NICE-approved and peri-operative preparations and photodynamic treatment->Vitreomacular traction For all other patients please complete this pro forma.

BETAMETHASONE SODIUM 12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory On Formulary PHOSPHATE preparations->Corticosteroids

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory Vistamethasone® On Formulary preparations->Corticosteroids->BETAMETHASONE SODIUM PHOSPHATE

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory FLUMETASONE PIVALATE On Formulary preparations->Corticosteroids

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory With antibacterial Restricted ENT consultants preparations->Corticosteroids->FLUMETASONE PIVALATE

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory Locorten-Vioform® On Formulary preparations->Corticosteroids->FLUMETASONE PIVALATE->With antibacterial

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory HYDROCORTISONE On Formulary preparations->Corticosteroids

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory Gentisone® HC On Formulary preparations->Corticosteroids->HYDROCORTISONE->With antibacterial

PREDNISOLONE SODIUM 12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory On Formulary PHOSPHATE preparations->Corticosteroids

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inﬂammatory Predsol® On Formulary preparations->Corticosteroids->PREDNISOLONE SODIUM PHOSPHATE

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective CHLORAMPHENICOL Restricted ENT consultants preparations

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective Chloramphenicol Restricted ENT consultants preparations->CHLORAMPHENICOL

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective Locorten-Vioform® Restricted preparations->CLIOQUINOL->With corticosteroid ENT consultants

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective CLOTRIMAZOLE On Formulary preparations

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective GENTAMICIN On Formulary preparations

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective Gentisone® HC On Formulary preparations->GENTAMICIN->With corticosteroid

12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective NEOMYCIN SULFATE On Formulary preparations

Olive Oil On Formulary 12.1 Drugs acting on the ear->12.1.3 Removal of ear wax

Sodium Bicarbonate On Formulary 12.1 Drugs acting on the ear->12.1.3 Removal of ear wax

12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal AZELASTINE HYDROCHLORIDE Restricted ENT consultants allergy->Antihistamines

12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal BECLOMETASONE DIPROPIONATE On Formulary allergy->Corticosteroids

12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal Beclometasone On Formulary allergy->Corticosteroids->BECLOMETASONE DIPROPIONATE

BETAMETHASONE SODIUM 12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal On Formulary PHOSPHATE allergy->Corticosteroids

12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal Vistamethasone® On Formulary allergy->Corticosteroids->BETAMETHASONE SODIUM PHOSPHATE

12.2 Drugs acting on the nose->12.2.1 Drugs used in nasal MOMETASONE FUROATE Restricted ENT consultants, second line only allergy->Corticosteroids

12.2 Drugs acting on the nose->12.2.2 Topical nasal EPHEDRINE HYDROCHLORIDE On Formulary decongestants->Sympathomimetics

12.2 Drugs acting on the nose->12.2.2 Topical nasal Ephedrine On Formulary decongestants->Sympathomimetics->EPHEDRINE HYDROCHLORIDE

12.2 Drugs acting on the nose->12.2.2 Topical nasal XYLOMETAZOLINE HYDROCHLORIDE On Formulary decongestants->Sympathomimetics

12.2 Drugs acting on the nose->12.2.2 Topical nasal Xylometazoline On Formulary decongestants->Sympathomimetics->XYLOMETAZOLINE HYDROCHLORIDE

12.2 Drugs acting on the nose->12.2.3 Nasal preparations for Bactroban Nasal® On Formulary infection->Nasal staphylococci

12.2 Drugs acting on the nose->12.2.3 Nasal preparations for Naseptin® On Formulary infection->Nasal staphylococci Drugs for oral ulceration and On Formulary 12.3 Drugs acting on the oropharynx Restricted Item -- Gelclair - ENT consultants and oncology inﬂammation

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration BENZYDAMINE HYDROCHLORIDE On Formulary and inﬂammation

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration CORTICOSTEROIDS On Formulary and inﬂammation

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration LOCAL ANAESTHETICS On Formulary and inﬂammation

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration Lidocaine On Formulary and inﬂammation->LOCAL ANAESTHETICS

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration SALICYLATES On Formulary and inﬂammation

12.3 Drugs acting on the oropharynx->12.3.1 Drugs for oral ulceration Choline Salicylate Dental Gel, BP On Formulary and inﬂammation->SALICYLATES->Choline salicylate

12.3 Drugs acting on the oropharynx->12.3.2 Oropharyngeal MICONAZOLE On Formulary anti-infective drugs->Oropharyngeal fungal infections

12.3 Drugs acting on the oropharynx->12.3.2 Oropharyngeal NYSTATIN On Formulary anti-infective drugs->Oropharyngeal fungal infections

Lozenges and sprays On Formulary 12.3 Drugs acting on the oropharynx use Bradosol or Merocets

12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, CHLORHEXIDINE GLUCONATE On Formulary and dentifrices

12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, Chlorhexidine On Formulary and dentifrices->CHLORHEXIDINE GLUCONATE

12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, HYDROGEN PEROXIDE On Formulary and dentifrices

Hydrogen Peroxide Mouthwash, 12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, On Formulary BP and dentifrices->HYDROGEN PEROXIDE

12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, SODIUM CHLORIDE On Formulary and dentifrices

Sodium Chloride Mouthwash, 12.3 Drugs acting on the oropharynx->12.3.4 Mouthwashes, gargles, On Formulary Compound, BP and dentifrices->SODIUM CHLORIDE

12.3 Drugs acting on the oropharynx->12.3.5 Treatment of dry BioXtra® On Formulary mouth->Local treatment

12.3 Drugs acting on the oropharynx->12.3.5 Treatment of dry Glandosane® On Formulary mouth->Local treatment

12.3 Drugs acting on the oropharynx->12.3.5 Treatment of dry Salivix® Restricted Oncology and immunology mouth->Local treatment

12.3 Drugs acting on the oropharynx->12.3.5 Treatment of dry PILOCARPINE HYDROCHLORIDE On Formulary mouth->Systemic treatment

13.2 Emollient and barrier preparations->13.2.1 Emollients->Non- Emulsifying Ointment, BP On Formulary proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->Non- Hydrous Ointment, BP On Formulary proprietary emollient preparations

Liquid and White Soft Paraﬃn 13.2 Emollient and barrier preparations->13.2.1 Emollients->Non- On Formulary Ointment, NPF proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->Non- Paraﬃn, White Soft, BP On Formulary proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->Non- Paraﬃn, Yellow Soft, BP On Formulary proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Cetraben® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Diprobase® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 E45® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Unguentum M® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 ZeroAQS® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Zerobase® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Zerocream® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Zeroguent® On Formulary Emollients->Proprietary emollient preparations

13.2 Emollient and barrier preparations->13.2.1 Calmurid® On Formulary Emollients->Preparations containing urea

With antimicrobials Restricted 13.2 Emollient and barrier preparations->13.2.1 Emollients Dermatology Dermol 500 lotion

Dermatology 13.2 Emollient and barrier preparations->13.2.1 Emollients->With Dermol® Restricted antimicrobials Only the Dermol 500 lotion is in the formulary

13.2 Emollient and barrier preparations->13.2.1 Emollients->13.2.1.1 Aqueous Cream, BP On Formulary Emollient bath and shower preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->13.2.1.1 Balneum® On Formulary Emollient bath and shower preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->13.2.1.1 Dermalo® On Formulary Emollient bath and shower preparations

13.2 Emollient and barrier preparations->13.2.1 Emollients->13.2.1.1 Doublebase® On Formulary Emollient bath and shower preparations

Dermatology 13.2 Emollient and barrier preparations->13.2.1 Emollients->13.2.1.1 Dermol® Restricted Emollient bath and shower preparations->With antimicrobials Only the Dermol 600 product is in the formulary

13.2 Emollient and barrier preparations->13.2.2 Barrier Zinc and Castor Oil Ointment, BP On Formulary preparations->Non-proprietary barrier preparations

13.2 Emollient and barrier preparations->13.2.2 Barrier Metanium® On Formulary preparations->Proprietary barrier preparations

13.2 Emollient and barrier preparations->13.2.2 Barrier Sprilon® On Formulary preparations->Proprietary barrier preparations

13.2 Emollient and barrier preparations->13.2.2 Barrier Sudocrem® On Formulary preparations->Proprietary barrier preparations

CALAMINE On Formulary 13.3 Topical local anaesthetics and antipruritics

Calamine On Formulary 13.3 Topical local anaesthetics and antipruritics->CALAMINE

CROTAMITON On Formulary 13.3 Topical local anaesthetics and antipruritics

DOXEPIN HYDROCHLORIDE Restricted 13.3 Topical local anaesthetics and antipruritics 3rd line on named patient basis only

LEVOMENTHOL On Formulary 13.3 Topical local anaesthetics and antipruritics Levomenthol Cream, BP On Formulary 13.3 Topical local anaesthetics and antipruritics->LEVOMENTHOL Only the 1% cream is in the formulary

TOPICAL LOCAL ANAESTHETICS On Formulary 13.3 Topical local anaesthetics and antipruritics

HYDROCORTISONE On Formulary 13.4 Topical corticosteroids

Hydrocortisone On Formulary 13.4 Topical corticosteroids->HYDROCORTISONE

Canesten HC® On Formulary 13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials

Daktacort® On Formulary 13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials

Fucidin H® Restricted 13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Microbiology approval

Nystaform-HC® Restricted 13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Gastrostomy sites

Timodine® On Formulary 13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials

HYDROCORTISONE BUTYRATE On Formulary 13.4 Topical corticosteroids

Locoid® On Formulary 13.4 Topical corticosteroids->HYDROCORTISONE BUTYRATE Only the cream and ointment is in the formulary

BETAMETHASONE ESTERS On Formulary 13.4 Topical corticosteroids

Betamethasone Valerate On Formulary 13.4 Topical corticosteroids->BETAMETHASONE ESTERS

Betnovate® On Formulary 13.4 Topical corticosteroids->BETAMETHASONE ESTERS The Lotion is non-formulary

Betnovate-RD® On Formulary 13.4 Topical corticosteroids->BETAMETHASONE ESTERS

With salicylic acid Restricted 13.4 Topical corticosteroids->BETAMETHASONE ESTERS Dermatology

13.4 Topical corticosteroids->BETAMETHASONE ESTERS->With salicylic Diprosalic® Restricted Dermatology acid

With antimicrobials Restricted 13.4 Topical corticosteroids->BETAMETHASONE ESTERS Dermatology

13.4 Topical corticosteroids->BETAMETHASONE ESTERS->With Betamethasone and clioquinol Restricted Dermatology antimicrobials

13.4 Topical corticosteroids->BETAMETHASONE ESTERS->With Betamethasone and neomycin Restricted Dermatology antimicrobials

13.4 Topical corticosteroids->BETAMETHASONE ESTERS->With Lotriderm® Restricted Dermatology antimicrobials

CLOBETASOL PROPIONATE Restricted 13.4 Topical corticosteroids Dermatology and consultants in the Vulval Disorders Clinic

Dermovate® Restricted 13.4 Topical corticosteroids->CLOBETASOL PROPIONATE Dermatology

Clobetasol with neomycin and 13.4 Topical corticosteroids->CLOBETASOL PROPIONATE->With Restricted Dermatology nystatin antimicrobials

CLOBETASONE BUTYRATE Restricted 13.4 Topical corticosteroids Dermatology

Eumovate® Restricted 13.4 Topical corticosteroids->CLOBETASONE BUTYRATE

13.4 Topical corticosteroids->CLOBETASONE BUTYRATE->With Trimovate® Restricted Dermatology and Mr Wolverson's patients with pruritus ani antimicrobials

FLUDROXYCORTIDE On Formulary 13.4 Topical corticosteroids

Haelan® On Formulary 13.4 Topical corticosteroids->FLUDROXYCORTIDE

Dr D Thompson's patients with hypersensitivities FLUOCINOLONE ACETONIDE Restricted 13.4 Topical corticosteroids DTC oﬃcer's decision

MOMETASONE FUROATE On Formulary 13.4 Topical corticosteroids

Elocon® On Formulary 13.4 Topical corticosteroids->MOMETASONE FUROATE

TRIAMCINOLONE ACETONIDE On Formulary 13.4 Topical corticosteroids

13.4 Topical corticosteroids->TRIAMCINOLONE ACETONIDE->With Aureocort® On Formulary antimicrobials

13.5 Preparations for eczema and psoriasis->13.5.1 Preparations for ICHTHAMMOL On Formulary Ichthammol in glycerol only eczema->Topical preparations for eczema

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 13.5 Preparations for eczema and psoriasis->13.5.1 Preparations for ALITRETINOIN Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. eczema->Oral retinoid for eczema

For all other patients please complete this pro forma.

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for CALCIPOTRIOL Restricted psoriasis->Topical preparations for psoriasis->Vitamin D and Dermatology analogues

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Calcipotriol Restricted psoriasis->Topical preparations for psoriasis->Vitamin D and analogues->CALCIPOTRIOL

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for TACALCITOL Restricted psoriasis->Topical preparations for psoriasis->Vitamin D and Dermatology analogues

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Curatoderm® Restricted psoriasis->Topical preparations for psoriasis->Vitamin D and analogues->TACALCITOL

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for TARS On Formulary psoriasis->Topical preparations for psoriasis->Tars

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Non-proprietary preparations On Formulary Coal tar and crude coal tar in yellow soft paraﬃn preparations psoriasis->Topical preparations for psoriasis->Tars->TARS

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Sebco® On Formulary psoriasis->Topical preparations for psoriasis->Tars->TARS->Proprietary preparations

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for DITHRANOL On Formulary psoriasis->Topical preparations for psoriasis->Dithranol

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Dithranol Ointment, BP On Formulary psoriasis->Topical preparations for psoriasis->Dithranol->DITHRANOL->Non-proprietary preparations

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for Dithrocream® On Formulary psoriasis->Topical preparations for psoriasis->Dithranol->DITHRANOL->Proprietary preparations

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for SALICYLIC ACID On Formulary psoriasis->Topical preparations for psoriasis->Salicylic acid

13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for ACITRETIN Restricted Consultant dermatologists as per protocol psoriasis->Oral retinoids for psoriasis

Hydroxycarbamide is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions Drugs aﬀecting the immune Restricted 13.5 Preparations for eczema and psoriasis for it. response For further details see the NPSA alert at this link

Consultant dermatologists only, see also Chapters 8 and 10 for other uses 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting CICLOSPORIN Restricted the immune response It should be prescribed by brand. Patients should not be swapped between brands

For immunological therapy by those experienced - only the 2.5mg tablets are stocked. See also Chapters 8 and 10. This is an oral anti-cancer drug and so F1 doctors must not prescribe it, nor may they transcribe prescriptions for it. 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting METHOTREXATE Restricted For further details see the NPSA alert at this link the immune response The dose is usually weekly NPSA improving compliance with oral methotrexate guidelines 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting PIMECROLIMUS NICE-approved This drug is not routinely stocked in the Trust. To use it please complete this pro forma the immune response

13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting TACROLIMUS Restricted Dermatology and Ophthalmology the immune response

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting ADALIMUMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. the immune response->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting ETANERCEPT Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. the immune response->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting INFLIXIMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. the immune response->Cytokine modulators

For all other patients please complete this pro forma.

This will be available in the Trust for patients who meet the NICE criteria if a clinician requests its use. 13.5 Preparations for eczema and psoriasis->13.5.3 Drugs aﬀecting USTEKINUMAB Restricted For Sandwell and West Birmingham CCG patients a Blueteq form will have to be completed for each patient. the immune response->Cytokine modulators

For all other patients please complete this pro forma.

13.6 Acne and rosacea->13.6.1 Topical preparations for BENZOYL PEROXIDE On Formulary acne->Benzoyl peroxide and azelaic acid

13.6 Acne and rosacea->13.6.1 Topical preparations for With antimicrobials Restricted Dermatology acne->Benzoyl peroxide and azelaic acid->BENZOYL PEROXIDE

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical ANTIBACTERIALS Restricted Dermatology antibacterials for acne

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical Dalacin T® On Formulary antibacterials for acne->ANTIBACTERIALS

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical ADAPALENE Restricted Dermatology retinoids and related preparations for acne

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical Diﬀerin® Restricted Dermatology retinoids and related preparations for acne->ADAPALENE

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical ISOTRETINOIN Restricted Consultant Dermatologists as per protocol retinoids and related preparations for acne

13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical Dermatology TRETINOIN Restricted retinoids and related preparations for acne DTC oﬃcer decision

13.6 Acne and rosacea->13.6.2 Oral preparations for acne->Hormone CO-CYPRINDIOL Restricted Dermatology, Endocrinology and Gynaecology treatment for acne

13.6 Acne and rosacea->13.6.2 Oral preparations for acne->Hormone Co-cyprindiol Restricted Dermatology, Endocrinology and Gynaecology treatment for acne->CO-CYPRINDIOL

13.6 Acne and rosacea->13.6.2 Oral preparations for acne->Oral ISOTRETINOIN Restricted Consultant Dermatologists as per protocol retinoid for acne

13.6 Acne and rosacea->13.6.2 Oral preparations for acne->Oral Isotretinoin Restricted Consultant Dermatologists as per protocol retinoid for acne->ISOTRETINOIN

SALICYLIC ACID Restricted 13.7 Preparations for warts and calluses Dermatology

Occlusal® Restricted 13.7 Preparations for warts and calluses->SALICYLIC ACID Dermatology

Salactol® On Formulary 13.7 Preparations for warts and calluses->SALICYLIC ACID

Salatac® Restricted 13.7 Preparations for warts and calluses->SALICYLIC ACID Dermatology

SILVER NITRATE On Formulary 13.7 Preparations for warts and calluses also Applicator 75% and solution 0.5%

GUM and treatment of basal cell carcinoma (and no other indications) by consultant dermatologists IMIQUIMOD Restricted 13.7 Preparations for warts and calluses->Anogenital warts use in vulval disorders clinic under Professor Luesley DTC oﬃcer decision

PODOPHYLLOTOXIN On Formulary 13.7 Preparations for warts and calluses->Anogenital warts

Sunsense® Ultra Restricted 13.8 Sunscreens and camouﬂagers->13.8.1 Sunscreen preparations Dermatology - the preferred product is Sunsense Ò Ultra

13.8 Sunscreens and camouﬂagers->13.8.1 Sunscreen DICLOFENAC SODIUM Restricted Dermatology preparations->Photodamage

13.8 Sunscreens and camouﬂagers->13.8.1 Sunscreen FLUOROURACIL Restricted Consultant Dermatologists preparations->Photodamage

Camouﬂagers Restricted 13.8 Sunscreens and camouﬂagers Dermatology

13.9 Shampoos and other preparations for scalp and hair Capasal® On Formulary conditions->Shampoos

13.9 Shampoos and other preparations for scalp and hair Selsun® On Formulary conditions->Shampoos

13.9 Shampoos and other preparations for scalp and hair Polytar® On Formulary conditions->Other scalp preparations

13.9 Shampoos and other preparations for scalp and hair Polytar Plus® On Formulary conditions->Other scalp preparations

13.9 Shampoos and other preparations for scalp and hair FINASTERIDE Restricted Dermatology conditions->Androgenetic alopecia

13.10 Anti-infective skin preparations->13.10.1 Antibacterial MUPIROCIN On Formulary preparations->13.10.1.1 Antibacterial preparations only used topically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial NEOMYCIN SULFATE On Formulary generic formulation to be used preparations->13.10.1.1 Antibacterial preparations only used topically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial POLYMYXINS On Formulary preparations->13.10.1.1 Antibacterial preparations only used topically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial Polyfax® On Formulary preparations->13.10.1.1 Antibacterial preparations only used topically->POLYMYXINS

13.10 Anti-infective skin preparations->13.10.1 Antibacterial SILVER SULFADIAZINE Restricted Burns and patients of Mr Porter who have been checked for sensitivty to sulphonamides preparations->13.10.1.1 Antibacterial preparations only used topically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial FUSIDIC ACID Restricted preparations->13.10.1.2 Antibacterial preparations also used Microbiology approval systemically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial Treatment of Rosacea and fungating wounds METRONIDAZOLE Restricted preparations->13.10.1.2 Antibacterial preparations also used for Rosacea use Acea gel 0.75% 40g systemically

13.10 Anti-infective skin preparations->13.10.1 Antibacterial Acea® Restricted preparations->13.10.1.2 Antibacterial preparations also used systemically->METRONIDAZOLE

13.10 Anti-infective skin preparations->13.10.1 Antibacterial Anabact® Restricted preparations->13.10.1.2 Antibacterial preparations also used systemically->METRONIDAZOLE

AMOROLFINE On Formulary 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations CLOTRIMAZOLE On Formulary 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations

13.10 Anti-infective skin preparations->13.10.2 Antifungal Clotrimazole On Formulary preparations->CLOTRIMAZOLE

KETOCONAZOLE On Formulary 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations

MICONAZOLE NITRATE On Formulary 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations

13.10 Anti-infective skin preparations->13.10.2 Antifungal Miconazole On Formulary preparations->MICONAZOLE NITRATE

NYSTATIN On Formulary 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations

TERBINAFINE Restricted 13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations Dermatology

ACICLOVIR On Formulary 13.10 Anti-infective skin preparations->13.10.3 Antiviral preparations

13.10 Anti-infective skin preparations->13.10.3 Antiviral Aciclovir On Formulary preparations->ACICLOVIR

13.10 Anti-infective skin preparations->13.10.4 Parasiticidal MALATHION On Formulary preparations->Malathion

13.10 Anti-infective skin preparations->13.10.4 Parasiticidal PERMETHRIN On Formulary preparations->Permethrin

13.10 Anti-infective skin preparations->13.10.4 Parasiticidal Permethrin On Formulary preparations->Permethrin->PERMETHRIN

13.10 Anti-infective skin preparations->13.10.5 Preparations for minor Cetrimide Cream, BP On Formulary cuts and abrasions

13.10 Anti-infective skin preparations->13.10.5 Preparations for minor Proﬂavine Cream, BPC On Formulary cuts and abrasions

13.10 Anti-infective skin preparations->13.10.5 Preparations for minor Magnesium Sulfate Paste, BP On Formulary cuts and abrasions->Preparations for boils

13.10 Anti-infective skin preparations->13.10.5 Preparations for minor Collodion, Flexible, BP On Formulary cuts and abrasions->Collodion

13.10 Anti-infective skin preparations->13.10.5 Preparations for minor Histoacryl® On Formulary cuts and abrasions->Skin tissue adhesive

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 ALCOHOL On Formulary Alcohols and saline

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 Industrial Methylated Spirit, BP On Formulary Alcohols and saline->ALCOHOL

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 SODIUM CHLORIDE On Formulary Alcohols and saline

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 Sodium Chloride On Formulary Alcohols and saline->SODIUM CHLORIDE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 Normasol® On Formulary Alcohols and saline->SODIUM CHLORIDE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.1 Steripod® Sodium Chloride On Formulary Alcohols and saline->SODIUM CHLORIDE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 CHLORHEXIDINE On Formulary Chlorhexidine salts

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 Chlorhexidine 0.05% On Formulary Chlorhexidine salts->CHLORHEXIDINE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 Hibiscrub® On Formulary Chlorhexidine salts->CHLORHEXIDINE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 Hydrex® On Formulary Chlorhexidine salts->CHLORHEXIDINE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 Unisept® On Formulary Chlorhexidine salts->CHLORHEXIDINE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.2 Tisept® On Formulary Chlorhexidine salts->CHLORHEXIDINE->With cetrimide

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.3 CETRIMIDE On Formulary Cationic surfactants and soaps

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.4 POVIDONE–IODINE On Formulary Iodine

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.6 HYDROGEN PEROXIDE On Formulary Hydrogen peroxide cream 1.5% restricted to Dermatology Oxidisers and dyes

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.6 Hydrogen Peroxide Solution, BP On Formulary Oxidisers and dyes->HYDROGEN PEROXIDE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.6 POTASSIUM PERMANGANATE On Formulary Oxidisers and dyes

Potassium Permanganate 13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.6 On Formulary Solution Oxidisers and dyes->POTASSIUM PERMANGANATE

13.11 Skin cleansers, antiseptics, and desloughing agents->13.11.6 Permitabs® On Formulary Oxidisers and dyes->POTASSIUM PERMANGANATE

Hirudoid® On Formulary 13.13 Topical circulatory preparations

BCG vaccines On Formulary 14.4 Vaccines and antisera

14.4 Vaccines and antisera->BCG vaccines->BACILLUS CALMETTE- Bacillus Calmette-Guérin Vaccine On Formulary GUÉRIN VACCINE->Intradermal

Tuberculin Puriﬁed Protein On Formulary 14.4 Vaccines and antisera->BCG vaccines->Diagnostic agents Derivative

Diphtheria vaccines Restricted 14.4 Vaccines and antisera

Diphtheria-containing vaccines 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- Restricted for children under 10 years CONTAINING VACCINES

Diphtheria, Tetanus, Pertussis (Acellular, Component), 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- Poliomyelitis (Inactivated) and Restricted CONTAINING VACCINES->Diphtheria-containing vaccines for children Childhood immunisation schedule, Children under the age of 10, basic course Haemophilus Type b Conjugate under 10 years Vaccine (Adsorbed)

Adsorbed Diphtheria, Tetanus, 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- Pertussis (Acellular, Component) Restricted CONTAINING VACCINES->Diphtheria-containing vaccines for children Before school or nursery school entry, children under the age of 10, single booster dose and Poliomyelitis (Inactivated) under 10 years Vaccine

Adsorbed Diphtheria [low dose], 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- Tetanus, Pertussis (Acellular, Restricted CONTAINING VACCINES->Diphtheria-containing vaccines for children Before school or nursery school entry, children under the age of 10, single booster dose Component) and Poliomyelitis under 10 years (Inactivated) Vaccine

Diphtheria-containing vaccines 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- for children over 10 years and Restricted CONTAINING VACCINES adults

Adsorbed Diphtheria [low dose], 14.4 Vaccines and antisera->Diphtheria vaccines->DIPHTHERIA- Tetanus and Poliomyelitis Restricted CONTAINING VACCINES->Diphtheria-containing vaccines for children Before leaving school or before employment or further education, single booster dose (Inactivated) Vaccine over 10 years and adults

14.4 Vaccines and antisera->Haemophilus type b conjugate Menitorix® Restricted As per protocol vaccine->HAEMOPHILUS TYPE B CONJUGATE VACCINE Hepatitis A vaccine Restricted 14.4 Vaccines and antisera

14.4 Vaccines and antisera->Hepatitis A vaccine->HEPATITIS A Single component Restricted Occupational Health VACCINE

14.4 Vaccines and antisera->Hepatitis A vaccine->HEPATITIS A With typhoid vaccine Restricted Occupational Health VACCINE

Hepatitis B vaccine Restricted 14.4 Vaccines and antisera

14.4 Vaccines and antisera->Hepatitis B vaccine->HEPATITIS B Single component Restricted Occupational Health, Paediatrics VACCINE

Inﬂuenza vaccines On Formulary 14.4 Vaccines and antisera use cheapest brand available

Measles, Mumps and Rubella Restricted 14.4 Vaccines and antisera Paediatrics (MMR) vaccine

MEASLES, MUMPS AND RUBELLA 14.4 Vaccines and antisera->Measles, Mumps and Rubella (MMR) Restricted Paediatrics and Maternity VACCINE, LIVE vaccine

Meningococcal vaccines On Formulary 14.4 Vaccines and antisera

Combined vaccines Restricted 14.4 Vaccines and antisera->Pertussis vaccine see under individual preparation

Pneumococcal vaccines Restricted 14.4 Vaccines and antisera on immunology advice, asplenia or splenic dysfunction

Pneumococcal polysaccharide 14.4 Vaccines and antisera->Pneumococcal Restricted on immunology advice, asplenia or splenic dysfunction vaccine vaccines->PNEUMOCOCCAL VACCINE

Pneumococcal polysaccharide 14.4 Vaccines and antisera->Pneumococcal Restricted on immunology advice, asplenia or splenic dysfunction conjugate vaccine (adsorbed) vaccines->PNEUMOCOCCAL VACCINE

Rabies vaccine Restricted 14.4 Vaccines and antisera Occupational Health

Rotavirus vaccine Restricted 14.4 Vaccines and antisera In accordance with national guidelines

ROTAVIRUS VACCINE Restricted 14.4 Vaccines and antisera->Rotavirus vaccine In accordance with national guidelines

Tetanus vaccines On Formulary 14.4 Vaccines and antisera DTC oﬃcer decision

Typhoid vaccines On Formulary 14.4 Vaccines and antisera

Polysaccharide vaccine with Restricted 14.4 Vaccines and antisera->Typhoid vaccines->TYPHOID VACCINE Occupational Health hepatitis A vaccine

14.4 Vaccines and antisera->Typhoid vaccines->TYPHOID Vivotif® Restricted This is currently the only typhoid vaccine available VACCINE->Typhoid vaccine, live (oral)

Occupational health only in accordance with DH guidelines Varicella–zoster vaccines Restricted 14.4 Vaccines and antisera DTC oﬃcer decision

14.4 Vaccines and antisera->Varicella–zoster vaccines->VARICELLA- Varilrix® Restricted ZOSTER VACCINE

Normal immunoglobulin Restricted 14.5 Immunoglobulins

NORMAL IMMUNOGLOBULIN Restricted 14.5 Immunoglobulins->14.5.1 Normal immunoglobulin

on Immunology/ Haematology advice, idiopathic thrombocytopenic purpura, Kawasaki syndrome, on Neurological advice for proven Guillain-Barre syndrome There is a national shortage of intravenous immunoglobulin and supplies are being rationed by the manufacturers. The DTC has drawn up a list of permitted indications and all requests for use must be approved by an oﬃcer of the DTC, or Medical 14.5 Immunoglobulins->14.5.1 Normal immunoglobulin->NORMAL Director. For futher information on the DoH's response to the current situation, follow the links on the DTC's home page. For intravenous use Restricted IMMUNOGLOBULIN DTC oﬃcer decision There is a national shortage of intravenous immunoglobulin and supplies are being rationed by the manufacturers. The DTC has drawn up a list of permitted indications and all requests for use must be approved by an officer of the DTC, or Medical Director. Link: http://swbhweb/upload/pdf/IVIg.pdf

Disease-speciﬁc Restricted 14.5 Immunoglobulins On Immunology/ Haematology advice immunoglobulins

Anti-D immunoglobulin will be made available in the Trust for patients who meet the NICE criteria if a clinician requests its ANTI-D (Rh0) IMMUNOGLOBULIN NICE-approved 14.5 Immunoglobulins->14.5.3 Anti-D (Rh0) immunoglobulin use via this pro forma

14.5 Immunoglobulins->14.5.3 Anti-D (Rh0) immunoglobulin->ANTI-D Rhophylac® Restricted This product is supplied by Haematology (Rh0) IMMUNOGLOBULIN

Drugs used for intravenous Restricted 15.1 General anaesthesia->15.1.1 Intravenous anaesthetics anaesthesia

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs ETOMIDATE Restricted Theatres only used for intravenous anaesthesia

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs Etomidate-Lipuro® Restricted Theatres, ITU used for intravenous anaesthesia->ETOMIDATE

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs 10mg/ ml - Neonates, for caudal anaesthesia in paediatrics by those experienced --- KETAMINE Restricted used for intravenous anaesthesia 50mg/ ml - Theatres, ITU, A&E, pain team

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs Only the 200mg in 20ml and 25mg in 5ml products are for general use. The 500mg in 10ml product is restricted to Theatres, Ketalar® Restricted used for intravenous anaesthesia->KETAMINE ITU, A&E, pain team

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs PROPOFOL Restricted Theatres, ITU used for intravenous anaesthesia

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs Propofol Restricted Theatres, ITU. The 2% product is non-formulary used for intravenous anaesthesia->PROPOFOL

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs Diprivan® Restricted Theatres, ITU. The 2% product is non-formulary used for intravenous anaesthesia->PROPOFOL

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs THIOPENTAL SODIUM Restricted Theatres, ITU, A&E used for intravenous anaesthesia

15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs Thiopental Restricted Theatres, ITU, A&E used for intravenous anaesthesia->THIOPENTAL SODIUM

Volatile liquid anaesthetics Restricted 15.1 General anaesthesia->15.1.2 Inhalational anaesthetics

15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile DESFLURANE Restricted Theatres liquid anaesthetics

15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile ISOFLURANE Restricted Theatres liquid anaesthetics

15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile SEVOFLURANE Restricted Theatres liquid anaesthetics

Theatres Nitrous oxide Restricted 15.1 General anaesthesia->15.1.2 Inhalational anaesthetics Entonox available in diﬀerent sizes

15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Nitrous NITROUS OXIDE Restricted Theatres oxide

ATROPINE SULFATE On Formulary 15.1 General anaesthesia->15.1.3 Antimuscarinic drugs DTC oﬃcer decision

15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->ATROPINE Atropine On Formulary SULFATE

Theatres, ITU GLYCOPYRRONIUM BROMIDE Restricted 15.1 General anaesthesia->15.1.3 Antimuscarinic drugs DTC Oﬃcer decision

15.1 General anaesthesia->15.1.3 Antimuscarinic Glycopyrronium bromide Restricted drugs->GLYCOPYRRONIUM BROMIDE

15.1 General anaesthesia->15.1.3 Antimuscarinic With neostigmine metilsulfate Restricted drugs->GLYCOPYRRONIUM BROMIDE

HYOSCINE HYDROBROMIDE On Formulary 15.1 General anaesthesia->15.1.3 Antimuscarinic drugs

15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->HYOSCINE Hyoscine On Formulary HYDROBROMIDE 15.1 General anaesthesia->15.1.4 Sedative and analgesic DIAZEPAM On Formulary peri-operative drugs->15.1.4.1 Benzodiazepines

15.1 General anaesthesia->15.1.4 Sedative and analgesic LORAZEPAM On Formulary peri-operative drugs->15.1.4.1 Benzodiazepines

the 10mg in 2ml and 10mg in 5ml strengths are restricted to ITU. 15.1 General anaesthesia->15.1.4 Sedative and analgesic MIDAZOLAM Restricted peri-operative drugs->15.1.4.1 Benzodiazepines The 50mg in 50ml, 5mg in 5ml and buccal products are available for general use

15.1 General anaesthesia->15.1.4 Sedative and analgesic Midazolam On Formulary peri-operative drugs->15.1.4.1 Benzodiazepines->MIDAZOLAM

15.1 General anaesthesia->15.1.4 Sedative and analgesic TEMAZEPAM On Formulary peri-operative drugs->15.1.4.1 Benzodiazepines

15.1 General anaesthesia->15.1.4 Sedative and analgesic KETOROLAC TROMETAMOL Restricted 30mg in 1ml only - Theatre recovery, ITU peri-operative drugs->15.1.4.2 Non-opioid analgesics

15.1 General anaesthesia->15.1.4 Sedative and analgesic ALFENTANIL Restricted The 5mg in 10ml and 1mg in 2ml strengths are restricted to Theatres peri-operative drugs->15.1.4.3 Opioid analgesics

15.1 General anaesthesia->15.1.4 Sedative and analgesic FENTANYL Restricted Theatres, ITU, Pain team and Consultants in palliative care peri-operative drugs->15.1.4.3 Opioid analgesics

15.1 General anaesthesia->15.1.4 Sedative and analgesic Fentanyl Restricted Theatres, ITU, Pain team, and Consultants in palliative care peri-operative drugs->15.1.4.3 Opioid analgesics->FENTANYL

Theatres, ITU 15.1 General anaesthesia->15.1.4 Sedative and analgesic REMIFENTANIL Restricted N.B. only the 1mg preparation is stocked for theatres; 5mg vials strictly for ITU use only peri-operative drugs->15.1.4.3 Opioid analgesics DTC oﬃcer decision

15.1 General anaesthesia->15.1.5 Neuromuscular blocking ATRACURIUM BESILATE Restricted Theatres, ITU, NNU drugs->Non-depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking Theatres, ITU, NNU Atracurium Restricted drugs->Non-depolarising neuromuscular blocking drugs->ATRACURIUM BESILATE The 250mg in 25ml product is available for general use

15.1 General anaesthesia->15.1.5 Neuromuscular blocking MIVACURIUM Restricted Theatres, ITU drugs->Non-depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking Mivacron® Restricted Theatres, ITU drugs->Non-depolarising neuromuscular blocking drugs->MIVACURIUM

15.1 General anaesthesia->15.1.5 Neuromuscular blocking PANCURONIUM BROMIDE Restricted NNU drugs->Non-depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking Pancuronium Restricted drugs->Non-depolarising neuromuscular blocking NNU drugs->PANCURONIUM BROMIDE

15.1 General anaesthesia->15.1.5 Neuromuscular blocking ROCURONIUM BROMIDE Restricted Theatres, ITU drugs->Non-depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking VECURONIUM BROMIDE Restricted Theatres, ITU drugs->Non-depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking SUXAMETHONIUM CHLORIDE Restricted Theatres, ITU, A&E drugs->Depolarising neuromuscular blocking drugs

15.1 General anaesthesia->15.1.5 Neuromuscular blocking Suxamethonium Chloride Restricted drugs->Depolarising neuromuscular blocking drugs->SUXAMETHONIUM Theatres, ITU, A&E CHLORIDE

15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular NEOSTIGMINE METILSULFATE Restricted Theatres blockade->Anticholinesterases

15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular Neostigmine Restricted Theatres blockade->Anticholinesterases->NEOSTIGMINE METILSULFATE

NEOSTIGMINE WITH 15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular Restricted Theatres GLYCOPYRRONIUM BROMIDE blockade->Anticholinesterases

15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular SUGAMMADEX Restricted Only stocked in Windmill Theatre at City and First ﬂoor Theatres at Sandwell blockade->Other drugs for reversal of neuromuscular blockade

15.1 General anaesthesia->15.1.7 Antagonists for central and FLUMAZENIL On Formulary respiratory depression

15.1 General anaesthesia->15.1.7 Antagonists for central and Flumazenil On Formulary respiratory depression->FLUMAZENIL

15.1 General anaesthesia->15.1.7 Antagonists for central and NALOXONE HYDROCHLORIDE On Formulary respiratory depression

DANTROLENE SODIUM On Formulary 15.1 General anaesthesia->15.1.8 Drugs for malignant hyperthermia

15.1 General anaesthesia->15.1.8 Drugs for malignant Dantrium Intravenous® On Formulary hyperthermia->DANTROLENE SODIUM

BUPIVACAINE HYDROCHLORIDE On Formulary 15.2 Local anaesthesia->Bupivacaine

Bupivacaine On Formulary 15.2 Local anaesthesia->Bupivacaine->BUPIVACAINE HYDROCHLORIDE

15.2 Local anaesthesia->Bupivacaine->BUPIVACAINE Bupivacaine and Adrenaline On Formulary HYDROCHLORIDE->With adrenaline

LEVOBUPIVACAINE On Formulary 15.2 Local anaesthesia->Levobupivacaine

LIDOCAINE HYDROCHLORIDE On Formulary 15.2 Local anaesthesia->Lidocaine lidocaine 2% with adrenaline 1 in 80,000 is restricted to dental, ENT and local anaesthesia by those experienced

Lidocaine hydrochloride On Formulary 15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE 2% injection - maximum injected concentration not to be greater than 1% injections

15.2 Local anaesthesia->Lidocaine->LIDOCAINE Lidocaine On Formulary 2% injection - maximum injected concentration not to be greater than 1% HYDROCHLORIDE->Lidocaine hydrochloride injections

15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->With Xylocaine® On Formulary adrenaline

Lidocaine injections for dental Restricted 15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE Dental use, ENT and general anaesthesia by those experienced with the product. use

15.2 Local anaesthesia->Lidocaine->LIDOCAINE Instillagel® On Formulary HYDROCHLORIDE->Lidocaine for surface anaesthesia

15.2 Local anaesthesia->Lidocaine->LIDOCAINE Laryngojet® On Formulary HYDROCHLORIDE->Lidocaine for surface anaesthesia

15.2 Local anaesthesia->Lidocaine->LIDOCAINE LMX 4® On Formulary HYDROCHLORIDE->Lidocaine for surface anaesthesia

15.2 Local anaesthesia->Lidocaine->LIDOCAINE Versatis® Restricted HYDROCHLORIDE->Lidocaine for surface anaesthesia Pain Clinic for neuropathic pain

15.2 Local anaesthesia->Lidocaine->LIDOCAINE Xylocaine® On Formulary HYDROCHLORIDE->Lidocaine for surface anaesthesia

PRILOCAINE HYDROCHLORIDE Restricted 15.2 Local anaesthesia->Prilocaine Theatres

Dental theatres For dental use Restricted 15.2 Local anaesthesia->Prilocaine->PRILOCAINE HYDROCHLORIDE currently not available - use lidocaine with adrenaline

Theatres. ROPIVACAINE HYDROCHLORIDE Restricted 15.2 Local anaesthesia->Ropivacaine The 400mg in 200ml infusion is restricted to the Enhanced Recevery protocol only

TETRACAINE Restricted 15.2 Local anaesthesia->Tetracaine Neonates only

Knitted Viscose Primary Dressing, On Formulary A5.1 Basic wound contact dressings->A5.1.1 Low adherence dressings N-A Ultra for use within the Trust BP 1993 Paraﬃn Gauze Dressing, BP 1993 On Formulary A5.1 Basic wound contact dressings->A5.1.1 Low adherence dressings Jelonet for use within the Trust

Atrauman® Restricted A5.1 Basic wound contact dressings->A5.1.1 Low adherence dressings Only for patients with allergy to silicone

Absorbent Perforated Dressing A5.1 Basic wound contact dressings->A5.1.2 Absorbent dressings->For On Formulary Mepore for use within the Trust with Adhesive Border lightly exuding wounds

Absorbent Cellulose Dressing A5.1 Basic wound contact dressings->A5.1.2 Absorbent dressings->For On Formulary Mesorb for use within the Trust with Fluid Repellent Backing moderately to heavily exuding wounds

A5.2 Advanced wound dressings->A5.2.1 Hydrogel dressings->Hydrogel Aquaform® On Formulary application (amorphous)

5 x 7 cm for NNU and Hand Surgery only---- A5.2 Advanced wound dressings->A5.2.3 Soft polymer Mepitel® Restricted dressings->Without absorbent pad 20 x 30 cm for use by Wound Care Nurse Specialists only

A5.2 Advanced wound dressings->A5.2.3 Soft polymer dressings->With Mepilex Border for use by Wound Care Nurse Specialists only Mepilex® Restricted absorbent pad DTC oﬃcer decision

A5.2 Advanced wound dressings->A5.2.4 Hydrocolloid DuoDERM® Extra Thin On Formulary dressings->Without adhesive border

A5.2 Advanced wound dressings->A5.2.4 Hydrocolloid Aquacel® Restricted for use by Wound Care Nurse Specialists only dressings->Hydrocolloid-ﬁbrous dressings

Polyurethane Foam Dressing, BP A5.2 Advanced wound dressings->A5.2.5 Foam dressings->For lightly to Restricted Lyoform T - as tracheostomy dressing - ITU/ ENT 1993 moderately exuding wounds

Polyurethane Foam Film Dressing A5.2 Advanced wound dressings->A5.2.5 Foam dressings->For On Formulary Allevyn adhesive for use within the Trust with Adhesive Border moderately to heavily exuding wounds

Polyurethane Foam Film Dressing A5.2 Advanced wound dressings->A5.2.5 Foam dressings->For On Formulary Allevyn Compression for use within the Trust without Adhesive Border moderately to heavily exuding wounds

A5.2 Advanced wound dressings->A5.2.5 Foam dressings->For Cavi-Care® Restricted use by ENT only moderately to heavily exuding wounds

Algosteril® On Formulary A5.2 Advanced wound dressings->A5.2.6 Alginate dressings

CliniSorb® Odour Control Restricted A5.2 Advanced wound dressings->A5.2.8 Odour absorbent dressings for use by Wound Care Nurse Specialists only Dressings

Povidone–iodine Fabric Dressing Restricted A5.3 Antimicrobial dressings->A5.3.2 Iodine for use by A & E and Wound Care Nurse Specialists only